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Abstract 
Investigation of small-diameter decellularised 
artery as a potential scaffold for vascular tissue 
engineering 
Evelyn M. Campbell 
The successful replacement of small-diameter blood vessels, affected by 
cardiovascular disease, with natural and synthetic bypass grafts remains limited due 
to long-term patency issues. The development of a small-diameter tissue engineered 
blood vessel (TEBV), with equivalent biomechanical properties to the vessel being 
replaced, may provide a potential solution. This thesis aims to determine the 
biomechanical properties of porcine coronary arteries (PCA) and the corresponding 
natural matrix scaffold of the artery through short-term decellularisation providing 
vital information for the development of an optimum TEBV, while also establishing 
the potential of this natural matrix scaffold to be used as a vascular tissue 
engineering scaffold. 
The natural matrix scaffold of small-diameter (< 4 mm) PCA was achieved through a 
short-term decellularisation method to limit the natural degradation of the tissue. The 
biomechanical properties of PCA and the corresponding natural matrix scaffold of 
the artery were established. Tubular segments of PCA, up to 60 mm in length, were 
perfused with 0.1 м sodium hydroxide for 6 to 12 hours to achieve the natural matrix 
scaffold. Uniaxial tensile and inflation tests confirmed the scaffold maintains its non-
linear response, however a less stiff, more distensible low-load response and stiffer 
high-load response was found compared to non-decellularised sections. Vascular 
smooth muscle cells were successfully seeded to the luminal and abluminal surfaces 
and lateral edges of decellularised sections and attachment and infiltration of the 
xenogeneic cells after 15 days confirmed the viability of the scaffold as a suitable 
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environment for cell growth and infiltration. The maintenance of the internal elastic 
lamina provided a suitable surface for the attachment of endothelial cells. 
Biomechanical tests of the cell-infiltrated scaffold confirmed a recovery of the native 
artery distensibility. Additionally, the bare scaffold remained viable for 30 days 
under pulsatile flow at physiological pressures confirming its potential as a TEBV 
scaffold. 
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Chapter 1 Introduction  
1.1 Cardiovascular Disease 
Cardiovascular disease (CVD) remains the principal cause of mortality and 
morbidity worldwide accounting for an estimated 17.3 million deaths or 30% 
globally in 2008 [1]. This figure is projected to reach 26.3 million by 2030. In 
Ireland CVD is the principal cause of death for both men and women, however, the 
percentage of deaths has fallen from a peak of 51% in 1980, to 41% in 1999, and 
now 32.9% in 2011 [2,3], see Figure 1.1. This reduction can be attributed to a 
number of factors including increased public health awareness, earlier access and 
treatment of acute cardiovascular events such as heart attack and stroke, surgical 
advancements, and continuing development of medical devices. The treatment of 
CVD results in a major economic burden accounting for an estimated €192 billion in 
the European Union in 2008 [4] and an estimated $286 billion in the United States in 
2011 [5]. These figures are a combination of direct costs including hospitalisation, 
medication, and physician costs, and indirect costs accounting for production losses 
due to morbidity and mortality.  
The most prevalent form of CVD is coronary artery disease (CAD) accounting for an 
estimated 7.3 million deaths globally in 2008 [1]. A build-up of atherosclerotic 
plaque in the inner wall of the arteries supplying the myocardium results in a stiffer 
vessel and narrowed lumen. Depending on the severity of the stenosis, current 
treatments to revascularise a stenosed artery include drug therapy, angioplasty,
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stenting, and coronary artery bypass grafting (CABG). In 2009, 163,149 CABG 
procedures were performed in the United States [5]. Autologous blood vessel grafts 
or synthetic grafts are successfully used to bypass medium- and large-diameter 
diseased vessels (> 6 mm) [6]. However, for small-diameter vessels such as the 
coronary arteries, a mismatch between the biomechanical properties of both natural 
and synthetic grafts and the native vessel can compromise the long-term patency of 
the bypass grafts making them less than ideal substitutes [7,8]. This is demonstrated 
in Figure 1.2 where the mechanical property of compliance of various bypass grafts 
used in the femoral-popliteal position is compared. There is a clear correlation 
between decreased compliance in relation to that of the host vessel and a decrease in 
 
Figure 1.1: Principal causes of death in Ireland in 2011 [2]. 
 
Figure 1.2: Biomechanical mismatch of current bypass grafts compared to the host 
artery; and the patency rates of the bypass grafts (adapted from [7]). 
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patency rates. This mismatch can lead to flow instabilities, thrombus formation, and 
intimal hyperplasia resulting in long-term graft failure [9]. The development of a 
small-diameter graft with corresponding biomechanical properties may overcome 
these limitations and improve the long-term patency rates for small-diameter 
applications such as CABG. 
1.2 Objectives 
Despite all the research efforts to date, there is still an unmet clinical need for small 
diameter vascular grafts or tissue engineered blood vessels (TEBVs) – extracellular 
matrix (ECM) based constructs present an exciting alternative because of their innate 
biomechanical properties. Clearly, the development of bypass grafts from coronary 
arteries would be highly advantageous as the vessel size and biomechanical 
properties would match that of the host vessel. In an effort to produce ECM-based 
TEBVs that match the structural, chemical, and biomechanical properties of native 
vessels, allogeneic and xenogeneic blood vessels have been decellularised providing 
a scaffold for the migration and growth of native endothelial cells and smooth muscle 
cells [10,11]. The ECM, consisting of structural and functional proteins, remains 
once the vascular cells have been removed. Due to the small size of coronary vessels, 
their numerous branches, and their limited accessibility no study has been carried out 
to-date to examine decellularisation of human or porcine coronary arteries and the 
resulting effect on their biomechanical properties.  
For complete decellularisation, the ECM must be appropriately disrupted to allow for 
access to all cells and to provide a path for their subsequent removal. This disruption 
needs to be minimized in order to maintain native ECM biomechanical and 
biological properties [12]. A combination of chemical, enzymatic, and physical 
treatments have been used with treatment times ranging from 4 hours to several 
weeks. However, biomechanical degradation will occur simultaneously in these 
samples once removed from their native environment. Consequently, it is critical to 
establish a short-term decellularisation method to retain the native biomechanical 
properties as much as possible.  
 4 
 
Additionally, a comprehensive understanding of the biomechanical properties of 
native blood vessels will aid in the development of comparative TEBVs. CABG is 
the most common bypass surgery performed, however, test data on the 
biomechanical properties of the coronary arteries is limited [13]. A thorough 
examination of the biomechanical properties and permeability of non-decellularised 
coronary arteries and the corresponding natural matrix scaffold is therefore necessary 
as it would provide vital insights into the ideal biomechanical properties for TEBVs 
and TEBV scaffolds.  
To determine its potential as a TEBV scaffold the cell attachment capabilities of the 
natural matrix scaffold must be ascertained. A non-thrombogenic lining of the lumen 
of the scaffold which can support endothelial cells is required. The porosity of the 
scaffold should be adequate for vascular smooth muscle cell infiltration while 
withstanding physiological blood flow. Biomechanical analysis of the repopulated 
natural matrix scaffold will establish its suitability as a TEBV and determine the 
effect of the seeded cells in comparison to the biomechanical properties of non-
decellularised and decellularised vessels. 
A functional small-diameter TEBV graft which is biomechanically and biologically 
compatible with host vessels could improve long-term graft patency rates. 
Furthermore, it could provide suitable vessels for in vitro studies of vascular biology 
and the mechanisms of vascular disease and for pre-clinical tests of pharmacological 
and interventional treatments [14]. In order to achieve these goals the following 
objectives need to be realised, see also Figure 1.3:  
1. Decellularisation: 
 Development of a short-term decellularisation protocol to obtain tubular 
sections of the natural matrix scaffold of small-diameter porcine coronary 
arteries (PCA) established and verified by histological and 
immunocytochemical analysis. 
2. Biomechanical Evaluation: 
 Characterisation of the biomechanical properties and permeability of    
non-decellularised PCA and the corresponding natural matrix scaffold 
using a range of biomechanical tests and analysis.  
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3. Scaffold Repopulation 
 Determination of the suitability of the natural matrix scaffold of PCA as an 
environment for the growth of smooth muscle, endothelial, and stem cells. 
 Characterisation of the proliferation, migration, and infiltration of 
repopulated cells in the scaffold under static and dynamic test conditions. 
 Evaluation of the biomechanical properties of the repopulated scaffold. 
4. Vascular Graft 
 Determination of the effect of physiological pulsatile flow on 
decellularised PCA. 
 Validation of the scaffold for human use by the seeding of human cells. 
 
Figure 1.3: Flowchart outlining the major project objectives. 
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Chapter 2 Literature Review 
2.1 Coronary Arteries 
The cardiovascular system consists of the heart, the systemic circulation, and the 
pulmonary circulation. The coronary circulation, part of the systemic circulation, 
supplies oxygenated blood to the myocardium of the heart. The coronary arteries are 
the only branches of the ascending aorta, originating in the left and right aortic 
sinuses directly above the aortic valve [15]. Located just below the epicardial 
membrane in the coronary and interventricular sulci, the right coronary artery (RCA) 
supplies oxygenated blood to the right atrium and ventricle and the left main 
coronary artery supplies the left atrium and ventricle, see Figure 2.1. The left main 
coronary artery soon bifurcates into the left anterior descending coronary artery 
(LAD) and the left circumflex coronary artery (LCX). Blood flow within the 
coronary circulation is regulated by: 
 coronary perfusion pressure,  
 intramyocardial pressure,  
 and control of smooth muscle [16].  
Coronary perfusion pressure is the pressure difference between the aorta, where the 
coronary arteries originate, and the right atrium into which the coronary circulation 
empties. Intramyocardial pressure is due to the numerous branches extending from 
the main coronary arteries into the myocardium. As the heart contracts during 
systole, there is little blood flow in the coronary circulation as the vessels are 
compressed. Consequently, the coronary circulation receives most of its perfusion 
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during diastole as the heart muscle relaxes and high pressure blood flows into the 
coronary arteries due to aortic recoil [16,17]. Smooth muscle tone is controlled by 
the autonomic nervous system and metabolites [16]. 
2.1.1 Structure and Function  
The structure and function of arteries is highly dependent on location within the 
arterial tree. Arteries are generally divided into two categories; elastic arteries and 
muscular arteries. Elastic arteries are the largest arteries in the body and include the 
aorta, common carotid, and common iliac arteries. Muscular arteries are generally 
small- and medium-sized blood vessels and include the coronary and brachial 
arteries. Like all arteries, the small-diameter muscular coronary arteries consist of 
three layers; the tunica intima, tunica media, and tunica adventitia as shown in  
Figure 2.2.  
The tunica intima lines the lumen of the vessel and consists of a basal lamina and a 
monolayer of endothelial cells. It forms a smooth non-thrombogenic lining and acts 
as a selective barrier to plasma lipids and lipoproteins. The thin basal lamina, 
comprising of type IV collagen, fibronectin, proteoglycans, and laminin, provides a 
surface on which endothelial cells grow and a limited amount of structural support. 
Endothelial cells are flat, elongated cells, 10 - 15 μm wide and 25 - 50 μm long, 
orientated in the direction of blood flow [16]. Additionally, in coronary arteries there 
 
Figure 2.1: Location of the main coronary arteries of the heart [18]. 
 8 
 
is a subendothelial layer of connective tissue and longitudinally orientated smooth 
muscle cells [16,19].  
The internal elastic lamina, consisting of a fenestrated sheet of elastin, separates the 
tunica intima from the tunica media. A major differentiation between muscular and 
elastic arteries is the presence or absence of elastic laminae, sheets of elastin fibres, 
in the tunica media. Depending on the size of the elastic artery, there can be up to 
sixty layers of concentrically arranged elastic laminae separated by vascular smooth 
muscle cells (vSMCs). The tunica media of muscular arteries, however, do not 
contain elastic laminae. Instead, vSMCs, 100 μm long and 5 μm diameter, are the 
dominant components surrounded by a matrix of loose elastin and collagen fibres 
[16]. The helical orientation of vSMCs in the media also varies depending on artery 
type and location within the vasculature. In coronary arteries, vSMC in proximity to 
the internal elastic laminae are aligned in the longitudinal direction, see             
Figure 2.3 (A), the orientation of which does not change with vessel dilation or 
contraction. vSMC orientation becomes increasingly circumferential towards the 
external elastic lamina, see Figure 2.3 (B), the pitch of which alters upon vessel 
 
Figure 2.2: Schematic of the components the muscular arterial wall (adapted from 
[19]). 
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contraction or dilation. vSMCs regulate the lumen diameter and synthesise the 
collagen and elastin fibres of the media [16,19].  
The external elastic lamina separates the tunica media from the tunica adventitia. 
This layer is less distinct in muscular arteries than in elastic arteries. The tunica 
adventitia anchors the blood vessel to the surrounding tissue, provides stability, and 
delivers nutrients to the vSMCs in the media. It consists of a dense network of type I 
collagen bundles and elastin fibres, fibroblasts, nerves, and blood vessels. Fibroblasts 
maintain the tunica adventitia, in particular the synthesis of type I collagen. The 
 
Figure 2.3: Orientation of smooth muscle cells in the media of (A) typical and    
(B) atypical muscular arteries. Smooth muscle cells of the coronary arteries are 
arranged in a longitudinal direction close to the internal elastic lamina, similar to 
(A), moving to a more circumferential orientation towards the external elastic 
lamina, similar to (B) [19].   
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tunica adventitia of elastic arteries is of the order of 10% of the wall thickness which 
increases to 50% for muscular arteries [17]. 
2.1.2 Biomechanical Properties 
The complex structure of the arterial wall described above gives rise to a highly   
non-linear, anisotropic, heterogeneous, viscoelastic material. Arterial biomechanics 
are dependent on artery type (muscular or elastic) and location within the 
vasculature. However, general principles apply to all arteries and a range of 
biomechanical tests are used to determine specific arterial biomechanical properties.  
Uniaxial tensile tests are widely used to characterise the non-linear behaviour of 
arteries [20-23]. Collagen is the main load-bearing element of an artery and provides 
resistance to systolic blood pressure. Cross-linked elastin polypeptide chains form 
elastic fibres to provide the elastic recoil of the artery after a pressure pulse. 
Determined by uniaxial tensile tests, the stress-strain response of arteries exhibit a   
J-shaped non-linear stress-stiffening behaviour [23], see Figure 2.4 (A). The response 
of elastin, which undergoes large extensions at low loads, dominates the initial linear 
region of the curve. Collagen fibres, undulated in their physiological form, straighten 
out at this early stage [16]. As the collagen fibres are recruited they begin to bear the 
load and a large increase in stress over small strains is observed. Roach and Burton 
[24] illustrated the individual contributions of collagen and elastin in human iliac 
arteries by selective digestion of each protein, see Figure 2.4 (B). Elastin was 
digested by trypsin resulting in a collagen-based material that stiffened almost 
immediately under tension and demonstrated little extension. Digesting collagen 
from the artery using formic acid, the resulting elastin-based material exhibited large, 
almost linear extension under tension. Elastin fibres can withstand uniaxial 
extensions up to 150%, yet return to their original formation on unloading [16], 
whereas collagen can only extend between 10 - 15% [25]. Elastin has a Young’s 
Modulus of 0.06 MPa which is low compared to axially orientated type I collagen 
exhibiting a stiffness of 100 MPa [25]. The modulus of elasticity or Young’s 
Modulus is defined as the slope of the elastic region of the stress-strain curve. Due to 
non-linearity of arterial tissue an incremental Young’s Modulus must be obtained to 
determine the stiffness of the material. The elastin dominated toe region is commonly 
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defined by extending the final linear region to the x-axis and recording the intercept 
[23], see Figure 2.4 (A). In addition to the dominant contributions of collagen and 
elastin to the stress-strain response, the complex nature of the vascular wall indicates 
that other ECM elements and the cells, in particular vSMCs, play a role in the 
response [16]. Van Andel et al. [13] found the difference in the stress-strain response 
of the main coronary arteries between individuals/pigs was greater than the 
difference between arteries from the same heart. 
Uniaxial tensile tests in one direction do not, however, offer a full characterisation of 
arterial tissue due to anisotropy. Differing responses are exhibited axially, 
circumferentially and radially. This is illustrated by the stress-stretch curves of the 
individual layers of human coronary arteries tested in the longitudinal and 
circumferential directions [20], see Figure 2.5. The stress-stretch response of each 
layer is clearly different while individually they exhibit different behaviour in the 
longitudinal and circumferential directions. Circumferentially orientated intima and 
adventitia stiffen at a higher stretch than their corresponding longitudinal segments 
whereas the opposite is true of the media. 
 
Figure 2.4: Non-linearity of arterial tissue. (A) Typical non-linear stress-strain 
response of soft tissue to uniaxial tensile test (adapted from [23]). (B) Stress-strain 
response of fresh arterial tissue and of collagen and elastin as a result of selective 
digestion [24]. 
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An artery is subjected to longitudinal stretch and internal blood pressure in vivo, 
however, once excised these stresses are released [25,26]. The artery recoils in the 
longitudinal direction and relaxes circumferentially into its no-load state [25], see 
Figure 2.6 (A). Bergel et al. [27] identified that the application of longitudinal strain 
affected the pressure-volume curve, and so, for mechanical tests a pre-stretch should 
be applied to mimic in situ conditions. The pre-stretch ratio is calculated as the 
length of the segment in situ divided by the length of the segment in its no-load state. 
The pre-stretch ratio for arteries is dependent on species and location of the vessel 
within the arterial tree [28].  
Residual stresses remain in the arterial wall when in the no-load configuration. The 
magnitude of residual stress is dependent on the location of the artery in the arterial 
tree, vessel size, thickness/radius ratio, curvature of the vessel, and tissue 
remodelling [25]. The vessel springs open into the zero stress state when cut radially 
to fully relieve the internal wall stresses [25], see Figure 2.6 (A). A common measure 
of residual stresses in the artery wall is the opening angle in the zero stress state. This 
is measured as the angle from the centre point of the inner wall to the outer edges 
[29,30], see Figure 2.6 (B-C).  
 
Figure 2.5: Arterial anisotropy: layer-specific longitudinal and circumferential 
stress-stretch curves for human coronary arteries [20]. 
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Arteries are viscoelastic due to the arterial wall containing viscous fluid-like material 
and solid material. The properties of viscoelasticity are exhibited by creep, stress 
relaxation and hysteresis. Creep is the time-dependent change in strain due to a 
constant load. Stress relaxation is the time-dependent stress response due to a 
constant strain. Elastin, collagen, and smooth muscle of the arterial wall contribute to 
stress relaxation [25]. Hysteresis is exhibited by the non-coincidental loading and 
unloading curves of the stress-strain response and is a result of energy dissipation 
during the load cycle [26], see Figure 2.7 (A). Additionally, the initial stress-strain 
 
Figure 2.6: Residual stresses in arterial wall. (A) Pulmonary and ileal arteries in 
their physiological load (top), no-load (middle), and zero stress (bottom) 
configurations [25]. (B-C) Schematic of the measurement of opening angle;       
(B) no-load state and (C) zero stress state. WT = wall thickness, Co = external 
circumference, Ci = internal circumference, zs = zero stress [30]. 
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curve of soft tissue acquired for a specimen is not repeatable upon reloading. 
Therefore, preconditioning is carried out to obtain a repeatable reference state for 
stress-strain characteristics [31]. A cyclic test imposed upon arterial tissue exhibits a 
hysteresis loop, however this loop decreases with following cycles. The hysteresis 
loops decrease rapidly at first before reaching a steady state. The number of 
preconditioning cycles required to reach this state vary from as few as 2 to greater 
than 10 cycles, depending on the type of material being studied and the type of test 
being performed [26,31], see Figure 2.7 (B). 
2.1.3 Porcine Coronary Arteries 
The use of human tissue in research is limited due to ethical, health and safety, and 
availability reasons. Unlimited availability, rapid growth, low infection risk, and low 
cost have led to the extensive use of pigs in research [32]. The pig is widely used in 
cardiovascular research due to the perception that the circulatory system is almost 
identical to that of humans. In fact, the quadrupedal stance of the pig versus the 
bipedal stance for humans results in gross morphological differences in the hearts of 
the two species. Despite this, the porcine coronary arterial circulation is almost 
anatomically identical to the human circulation [33,34]. A combination of these 
factors led to the use of porcine hearts and, in particular, porcine coronary arteries in 
this study. 
 
Figure 2.7: (A) Energy dissipation and (B) preconditioning of soft tissue [26]. 
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A number of biomechanical differences between human and porcine coronary 
arteries have been identified in a limited number of studies in the literature, see  
Table 2.1. Porcine arteries in general have a higher pre-stretch ratio than human 
arteries [13,20]. The pre-stretch ratio of human coronary arteries has been reported 
between 1.04 [20] and 1.1 [13], while porcine coronary arteries have a pre-stretch 
ratio of 1.3 [13]. Roy et al. [36] showed that altering the pre-stretch of a vessel can 
be influence the vessel compliance. Therefore, a blood vessel or TEBV could 
potentially be tuned to match the compliance of the native vessel. Additionally, van 
Andel et al. [13] found porcine coronary arteries to be 3 times more elastic than 
human coronary arteries. However, in general, arteries of young pigs, usually 6 to 9 
months, and aged human arteries are tested. With aging, human arteries exhibit 
intimal and medial thickening and an increase in the collagen:elastin ratio resulting 
in a stiffer vessel [16]. For both human and porcine coronary arteries, the variability 
in the stress-strain response of arteries from the same heart (LAD, RCA, and LCX) 
has been found to be lower than the variability between individuals [13].  
Table 2.1: Comparison of human (HCA) and porcine (PCA) coronary artery 
properties. n/a: not available. 
 Units HCA PCA 
Wall Thickness  mm 
0.87 ± 023 [20] 
0.89 ± 0.21 [13] 
0.74 ± 0.17 [13] 
0.22 ± 0.03 [30] 
External Diameter  mm 
4.5 ± 0.3 [20] 
3.54 ± 0.51 [13] 
3.44 ± 0.39 [13] 
2.43 ± 0.34 [30] 
Pre-stretch - 
1.04 [20] 
1.1 [13] 
1.3 [13] 
Burst Pressure  mmHg 
Up to 200 mmHg
*
  
[13]  
Up to 300 mmHg
*
  
[13]  
Elasticity  % 20 [13] 60 – 70 [13] 
Opening Angle ° n/a 
75 [35] 
169 [30] 
*
Established during inflation test. Tears in tissue occured above the stated pressures. 
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2.1.4 Coronary Artery Disease and Interventions 
As previously stated, coronary artery disease (CAD) is the most prevalent form of 
cardiovascular disease and the leading cause of death in the western world. 
Atherosclerosis is a type of arteriosclerosis which affects medium- and large-sized 
arteries. It is a chronic inflammatory disease resulting in a localised thickening, 
stiffening, and remodelling of the intima of arteries. The development and 
progression of atherosclerosis is highly dependent on the location of the artery in the 
vasculature where local structural components and mechanical forces act [37].  In 
particular, arteries with complex geometries such as coronary, cerebral, and carotid 
arteries are susceptible to atherosclerosis due to blood flow hemodynamics and 
mechanical forces at localised sites. The curvature and many bifurcations of the 
coronary arteries can result in adaptive intimal thickening in localised areas, 
however, this is not an indication of disease [38], see Figure 2.8. Although regions of 
intimal thickening are more susceptible to the development of atherosclerosis than 
other regions, the progression of the disease is not dependent on it.  
The abnormal expression of adhesion molecules due to a dysfunction of the 
endothelium results in a localised accumulation of monocytes from the blood stream. 
Upon migration into the intima, the monocytes convert to macrophages and then 
foam cells following the uptake of low-density lipoproteins. Foam cells secrete 
growth factors and chemotactic factors resulting in the migration of proliferating 
smooth muscle cells from the media and an increase in the uptake of macrophages 
and T-cells from the circulating blood [39,40]. Initially, the artery responds to the 
thickening of the inner wall by vasodilation to maintain the patency of the vessel 
lumen. The lesion will eventually intrude on the vessel lumen with a continuation of 
the inflammatory process, increasing the size of the lesion [40]. 
In a series of reports the American Heart Association classified atherosclerotic 
lesions based on histological composition ranging in increasing severity from types I 
to VIII [37,41], see Figure 2.8. Types I to III, the early stages of the disease, are 
clinically silent and do not impede the lumen of the vessel. Type IV atheroma and 
type V fibroatheroma differ in the nature of the fibromuscular layer facing the lumen 
of the vessel. In type IV lesions this layer is composed mainly of the original intima,  
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although it may have undergone some intimal thickening depending on location 
within the arterial tree. However, in type V lesions, a thick fibrous cap is formed 
consisting of smooth muscle cells and connective tissue, in particular collagen. Type 
IV and V lesions can develop fissures, hematoma, and/or thrombus, progressing the 
 
Figure 2.8: Schematic of intimal hyperplasia and stages of atherosclerosis. Six 
identical cross-sections of left anterior descending coronary arteries indicating 
intimal thickening and atherosclerosis at this location [41]. 
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disease to type VI with increased lesion size and decreased lumen patency. The lipid 
core has calcified in type VII lesions and in type VIII there is no lipid core and 
fibrous tissue dominates. 
The onset of CAD ranges from symptomless to severe depending on the degree of 
the occlusion. Mild onset of CAD is indicated by angina pectoris, where transient or 
intermittent ischemia and vessel occlusion occurs due to thrombus formation. 
Myocardial infarctions are severe, acute events during which blood supply is reduced 
or cut off to areas of the myocardium. The majority of myocardial infarctions are 
caused by the fibrous cap breaking open and releasing the contents of the lipid core 
which leads to blood clot formation [17]. This clot can lead to a total or partial 
stenosis in a region of the coronary circulation resulting in a localised reduction of 
blood flow to the myocardium [17].  
Many coronary artery stenotic lesions, diagnosed by coronary angiography, can be 
treated using minimally-invasive techniques. Percutaneous transluminal coronary 
angioplasty (PTCA) is a minimally-invasive procedure where a balloon-tipped 
catheter is guided to the diseased area. The balloon is inflated, dilating and reopening 
the narrowed vessel, and the balloon is subsequently deflated and removed [43]. 
Stenting is a variation of PTCA where a cylindrical scaffold is crimped over the 
balloon. Inflating the balloon expands the stent which remains permanently in the 
vessel to maintain vessel patency as shown in Figure 2.9. Angioplasty is associated 
 
Figure 2.9: Percutaneous transluminal coronary angioplasty with stenting of the 
left anterior descending coronary artery (adapted from [42]). 
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with low risk, short recovery time, and minimal hospitalisation; however, it is not 
always indicated as the optimum approach for revascularisation and has limited  
long-term success [44]. 
Coronary artery bypass grafting (CABG) is the optimum treatment where there is 
stenosis of the left main coronary artery or multiple stenoses [45-47]. CABG is an 
invasive surgical procedure requiring open heart surgery and is therefore a higher 
risk procedure requiring longer hospitalisation and recovery time. However, the 
American Heart Association reported a mortality rate of less than 1% in patients less 
than 65 years old with no severe left ventricular dysfunction or congestive heart 
failure. Additionally, 5- and 10-year survival rates were reported to be 92% and     
81%, respectively [47]. Oxygen-rich blood is rerouted from the aorta around the 
stenosis through a graft to the coronary artery, see Figure 2.10. Due to the nature of 
the vessel being replaced, for small-diameter (< 6 mm) applications such as CABG 
autologous grafts are the preferred option. Segments of the greater saphenous vein 
and the in situ left internal thoracic artery have the highest long-term success rates as 
autologous blood vessel grafts to-date [45]. 40 - 60% of vein grafts and 90% of left 
 
Figure 2.10: Coronary artery bypass grafting of stenosed coronary arteries using 
autologous grafts; the saphenous vein for the right coronary artery and the left 
internal thoracic artery for the left anterior descending coronary artery [42]. 
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internal thoracic arteries are patent within 10 years of bypass surgery [47]. Other 
natural grafts used include bovine left internal thoracic arteries (50% patency at        
1 year) and cryopreserved homologous saphenous vein and glutaraldehye-treated 
homologous umbilical vein (50% at 3 to 13 months) [47]. In certain circumstances, 
where autologous grafts are unavailable or unsuitable due to previous myocardial 
revascularisation, peripheral arterial reconstruction, or varicose vein ligation 
procedures, synthetic polymer grafts are required [45]. Polyethylene terephthalate 
(PET or Dacron) and polytetrafluoroethylene (PTFE) grafts are considered as a last 
resort having limited success. Synthetic grafts are rigid and cannot adapt diameter in 
response to changes in blood flow as native vessels can. Therefore, the patency of 
PTFE grafts 1 year post bypass has been reported as 60% [47].  
The long-term success rates of CABG procedures are limited due to atherosclerosis 
and occlusion of the bypass vessel. The failure of these grafts is influenced by a 
mismatch in the mechanical properties between the bypass grafts and the native 
vessel [7]. In particular, an incompatibility in compliance, the dimensional change 
with respect to luminal pressure change, has been identified as a marker for graft 
failure. A compliance mismatch can lead to intimal hyperplasia at the anastomosis 
and thrombotic occlusions. Excessive mechanical stress at the anastomosis can result 
in endothelial wall injury, a precursor for the development of atherosclerosis. In 
addition, hemodynamic wall shear stress affects the biochemistry and permeability of 
endothelial cells. A low mean wall shear stress has been identified as a marker for 
atherosclerotic development and intimal hyperplasia.  
The high incidence of CAD and the limited long-term outcome of the intervention 
procedures points to the need for an improved bypass graft with matching 
biomechanical and structural properties.  
2.2 Tissue Engineering and Tissue Engineered Blood 
Vessels 
Organ or tissue transplants, surgical reconstruction, and support via a mechanical 
device are the most common treatments for tissues or organs impaired as a result of 
 21 
 
disease, trauma, or congenital defects [48]. While these treatments assist in 
maintaining and sustaining life, they are not ideal solutions. Each year an increasing 
number of people die while on organ transplant waiting lists [14,49,50]. In Ireland, 
20 - 35% of patients on the heart transplant list die while waiting, whereas of the 
small proportion of suitable donors only 24 - 42% donate [50]. These statistics are 
indicative of all types of transplant procedures worldwide demonstrating that the 
critical shortage of donors severely limits transplant procedures. Surgical 
reconstruction is also hampered by a shortage of donor tissue and donor site 
morbidity [51]. Mechanical devices, such as kidney dialysis machines, cannot match 
the functionality of the organs they replace. Only a limited range of the functions 
required to maintain an organs’ viability can be performed leading to long-term 
deterioration [48]. These limitations have stimulated research into the development 
of alternative solutions.   
Tissue engineering is a multidisciplinary field combining the specialities of 
mechanical, material, and chemical engineering with molecular and cellular biology 
to develop biological substitutes which restore, maintain, or improve tissue or organ 
function [48,52,53]. The objective is the design, construction, modification, growth, 
and maintenance of living tissues to replace or augment diseased, injured, or 
defective tissue. Progress is being made in the development of tissue engineered 
organs and tissues for the human body including blood vessels [36,54,55], heart 
valves [56,57], ligaments and tendons [58], cartilage [59], bone [60], bladder [61], 
skin [62], and trachea [63].   
The most common tissue engineering approach involves seeding cells onto a scaffold 
or matrix which is cultivated in vitro, see Figure 2.11. Autologous cells, isolated 
from the patient, are the ideal cell source as they do not elicit an immune response 
and hence avoid potential rejection. The scaffold, either natural or synthetic, provides 
structural and mechanical stability, determines the 3-D morphology, supports tissue 
ingrowth, and aids in the formation of tissue structure. External stimuli including 
mechanical stimulation and chemical factors enhance tissue development. 
There is much research into the development of a small-diameter tissue engineered 
blood vessel (TEBV) to provide an alternative graft for CABG and other           
small-diameter applications to overcome current limitations and to improve        
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long-term patency rates [8,36,54,55,64-66]. In 1986, Weinberg and Bell [67] 
produced the first completely biological TEBV comprising of a collagen gel, 
endothelial cells, smooth muscle cells and adventitial fibroblasts. Unfortunately, 
without the support of a Dacron mesh, this graft could support pressures of less than 
10 mmHg. Since then, there have been many advances in the field of TEBVs. It is 
critically important for the development of a small-diameter TEBV that the 
structural, chemical and mechanical properties are equivalent to the native vessel to 
maintain patency. Key requirements include haemocompatibility, sufficient 
mechanical strength, compliance and elasticity, and biocompatibility. These 
requirements are proving to be a challenge and no truly compatible TEBV has been 
developed to date. 
2.2.1 Tissue Engineering Blood Vessel Scaffolds 
Current research into a suitable scaffold material for a viable TEBV is divided into 
two categories; synthetic polymers and natural matrix proteins. Biological scaffolds 
have the advantage that they are generally biocompatible, naturally occurring,     
non-toxic materials and are therefore favourable for cell attachment. However, they 
are susceptible to rapid degradation, weak mechanical properties, batch 
 
Figure 2.11: In vitro tissue engineering schematic (adapted from [51]). 
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inconsistencies, and the possibility of disease transmission [68]. Synthetic materials 
for TEBVs are biodegradable or non-biodegradable. The main advantages of       
non-biological scaffolds include accurate control of material properties, ready 
availability, cost effectiveness, ease of manufacture, and reduced batch variations. 
Toxic residuals as a result of the manufacturing process and poor cellular interaction, 
however, are among the disadvantages [68]. For biodegradable materials there is the 
added disadvantage of the by-products of scaffold degradation eliciting an 
inflammatory response [68]. 
Synthetic materials implanted often lead to an inflammatory response by the host and 
can trigger a process of events including the activation of platelets and leukocytes 
and the initiation of thrombogenesis and intimal hyperplasia [14]. These responses 
are a major cause of failure for implanted synthetic grafts. A solution is to seed 
endothelial cells on the blood contacting surface of the graft preventing the host 
blood from contacting the polymer, although there is difficulty surrounding the 
retention of the cells once implanted [14]. There is a wide range of                       
non-biodegradable synthetic materials for vascular grafts, the most widely accepted 
being polyethylene terephthalate (PET) or Dacron for medium- to large-size grafts 
and expanded polytetrafluoroethylene (ePTFE) for small-diameter vascular grafts 
[7,69,70]. Biodegradable synthetic materials used as vascular grafts or scaffolds 
include polyglycolic acid (PGA) [71-73] and polylactic acid [74]. One approach for 
the use of biodegradable polymer materials is the implantation of a graft which 
degrades over time as tissue remodelling occurs in and around the graft. The second 
approach is the growth of vascular tissue ex vivo on a biodegradable scaffold prior to 
implantation [69]. However, studies of biodegradable TEBV have reported lower 
mechanical properties in comparison to native blood vessels [72] and a lack of elastin 
fibres [73]. Dahl et al. [72] compared porcine common carotid arteries to engineered 
PGA scaffolds seeded with porcine carotid SMCs. The engineered vessels had 
statistically significant lower burst pressure (107 ± 14 mmHg vs. 443 ± 55 mmHg), 
lower maximum stress (1.4 ± 0.25 MPa vs. 6.58 ± 0. 97 MPa), and lower mean 
compliance (3.5 ± 0.2 % per 100 mmHg vs. 18.7 ± 4.1 % per 100 mmHg) than the 
native vessel. 
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TEBV scaffolds consisting of natural matrix proteins are achieved by a gelation 
process or electrospinning of proteins, or the decellularisation of natural allogeneic 
or xenogeneic tissue. Biological scaffolds are generally composed of only one or 
some extracellular matrix components, and therefore synthesised scaffolds often do 
not prove to be an exact biological and structural match for native vessels as they 
lack other required elements. Nevertheless, they have improved compliance 
characteristics in comparison to synthetic materials. Appropriate decellularisation, 
however, can result in the natural matrix scaffold of allogeneic or xenogeneic tissue 
containing all of the extracellular matrix components. Decellularisation of blood 
vessels will be discussed further in Section 2.3. 
The extracellular matrix (ECM), a complex mixture of functional and structural 
proteins, remains once cells are removed from an organ or tissue [12]. The ECM is 
composed mainly of proteins, including collagen, elastin, fibronectin, laminin, and 
glycosaminoglycans [26]. It is maintained by the cells it encompasses, such as 
fibroblasts and vSMCs. The functions of the ECM are to maintain the shape of a 
tissue by providing it with strength and resilience, to provide a biologically active 
scaffold on which the cells can migrate and adhere, to regulate cell phenotype, to act 
as an anchor for proteins including growth factors and enzymes, and to allow the 
diffusion of nutrients, ions, hormones and metabolites between the capillary network 
and cells through its aqueous environment [26]. The composition and ultrastructure 
of the ECM is dependent on the tissue from which it is harvested, the species of 
origin, and decellularisation method. ECM has been derived and utilised in tissue 
engineering applications from tissues including blood vessels, skin, nerves, skeletal 
muscle, ligaments, and liver [12]. 
Collagen is the main protein in the body, consisting of approximately 25 – 30% of all 
protein [26]. There are many different forms of collagen; types I, II, III, and IV being 
the most common in the body, while types V, VI, and VIII are also present. The 
ECM of vascular tissue contains type IV in the tunica intima, types I, III and V in the 
tunica media and type I in the tunica adventitia. Type IV collagen occurs as a porous 
network and is found in the basement membrane of all vascular tissues. It provides a 
scaffold for the attachment of endothelial cells, with the adhesion molecules 
fibronectin and laminin aiding cell attachment. Type I and type III collagen exist in 
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the form of fibres and give structural support when in tension. Type V collagen is 
associated with the vSMCs in the tunica media. In the vasculature, types I and III are 
synthesised by the smooth muscle cells and fibroblasts while type IV is synthesized 
by the endothelial cells. The amino acid sequence of type I collagen has remained 
highly conserved through evolution leading to it being a primary candidate for 
xenogeneic and allogeneic scaffolds exhibiting low antigenicity [75]. Collagen is 
important for biological and mechanical characteristics of vascular substitutes, 
however, it has a negative inflammatory and thrombogenic response. Collagen 
contact with blood activates leukocytes and platelets, triggering thrombosis and 
intimal hyperplasia, to a greater degree than basal lamina and elastic laminae [76]. 
Therefore it should not be used as a blood-contacting surface in a vascular graft. 
However, collagen may have a positive role in the revascularisation of a matrix given 
that a collagen matrix attracts more vSMCs than the elastic laminae [76]. Without 
supplementary support, however, a collagen gel is unable to support physiological 
pressures [67]. 
Vascular elastin is synthesized mainly by vSMCs, but also by specialised fibroblasts 
and possibly endothelial cells [26]. It forms a mesh-like structure that is loose, 
amorphous, but highly cross-linked resulting in its elastic response over large 
deformations. It also inhibits the proliferation and migration of vSMCs preventing 
the formation of a neointima and the stenosis of arteries [68]. The degradation of 
elastin in arteries plays a primary role in the formation of aneurysms and vascular 
dissections. Liu et al. [76] investigated the effect of allogeneic elastic laminae upon 
implantation. Primarily composed of elastin, it plays a role in structural stability and 
elasticity, and regulation of cellular activity of blood vessels. It was found that elastic 
laminae had a neutral thrombogenic and inflammatory response and, therefore, is a 
potential blood-contacting surface for a vascular graft. Elastin has been incorporated 
into biological scaffolds in combination with collagen through electrospinning [77]. 
Fibrin gel has also shown potential as an ECM scaffold due to good cell adhesion 
properties and increased production of ECM proteins [74,78]. It consists of 
fibrinogen and thrombin which can be isolated from recipient blood. However, 
similar to collagen, it requires support in order to withstand physiological pressures. 
Tschoeke et al. [74] augmented the fibrin gel with a biodegradable poly(L/D)lactide 
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mesh. Nevertheless, mechanical properties were still inadequate for the graft to 
perform as a TEBV. Unseeded grafts achieved a burst pressure of 21 ± 6 mmHg. A 
maximum burst pressure of 466 ± 78 mmHg was achieved after seeding the graft 
with a combination of smooth muscle cells, endothelial cells and fibroblasts cultured 
in a bioreactor for 21 days.  
A further biological material which has been examined as a potential TEBV scaffold 
is bacterial cellulose which can be fabricated into tubes for small-diameter 
applications [79]. This biomaterial has exhibited favourable biological and 
mechanical properties including low thrombogenicity, favourable cell attachment 
capabilities, non-linearity, and good mechanical strength.  
2.2.2 Cell Source for TEBV Scaffold 
Cells are required within a TEBV scaffold for tissue growth, function, and repair. 
The cells used should be non-immunogenic, highly proliferative, easy to harvest, and 
be capable of differentiating into specific cell types [80]. For TEBVs, endothelial 
cells (ECs) are required as a non-thrombogenic blood-scaffold interface, and smooth 
muscle cells are required to produce extracellular matrix proteins, in particular 
collagen and elastin, and to provide smooth muscle tone for the regulation of lumen 
diameter. Autologous vSMCs and ECs isolated from a blood vessel explant are the 
ideal candidate for seeding a scaffold. However, they are an inadequate source for in 
vitro scaffold population due to limited proliferation potential and reduced matrix 
production of smooth muscle cells, particularly for aged donors [80-82]. The use of 
xenogeneic and allogeneic vSMCs and ECs is restricted due to the host immune 
response and potential for disease transmission. 
Bone marrow-derived mesenchymal stem cells (MSCs) show great potential as an 
autologous cell source for the population of TEBV scaffolds. They are easily isolated 
and rapidly expanded in vitro and have been shown to differentiate into both vSMCs 
and ECs under certain conditions [82-85]. Additionally, as they do not express the 
major histocompatibility complex II antigens associated with immune rejection they 
can potentially be used as an allogeneic cell source. Therefore, MSC-seeded 
scaffolds may have potential as off-the-shelf TEBVs for emergency procedures. 
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Another type of adult stem cell, endothelial progenitor cells (EPCs), derived from 
bone marrow or from umbilical cord blood, have also shown the potential to 
proliferate, migrate, and differentiate into mature ECs [81,84].  
Taking a different approach, L’Heureux et al. [86,87] examined the potential of 
human fibroblasts as a cell source. Using a sheet-based tissue engineering technique 
and fibroblasts obtained from human skin they produced a completely biological 
TEBV without the support of a scaffold. However, the time required to produce these 
vessels limits their long term potential given that it was approximately 28 weeks. 
The advantage of controlled application of mechanical stimuli to encourage tissue 
maturation and extracellular matrix formation in a cell-seeded scaffold has been 
established. In a study seeding ovine myofibroblasts and endothelial cells onto a 
bioabsorbable polymer scaffold for 28 days, DNA and collagen content of scaffolds 
under pulsatile conditions was significantly greater in comparison to static controls 
[88]. The pulsatile sections also showed improved mechanical properties over the 
static control. Burst strength increased continuously to significant levels over static 
samples (326.3 ± 24 mmHg vs. 50 ± 5 mmHg at 28 days) and improved suture 
retention (64.3 ± 5 g vs. 12 ± 3 g) and wall thickness (0.73 ± 0.04 mm vs.             
0.50 ± 0.1 mm) levels were also observed. While the biomechanical properties 
obtained in the study presented in [88] were too weak to be suitable for in vivo 
implantation, the advantages of a pulsatile system were shown. Similar 
biomechanical trends were found after pulsatile culture conditions of a polyglycolic 
acid scaffold seeded with smooth muscle cells [89]. 
2.3 Decellularisation 
TEBV scaffolds prepared from the natural arterial scaffold show great potential, 
provided that the native biomechanical properties are retained. In an effort to produce 
TEBVs that match the structural, chemical, and biomechanical properties of the 
native vessel, allogeneic and xenogeneic blood vessels have been decellularised 
using a range of techniques creating scaffolds for the migration and growth of native 
endothelial cells and smooth muscle cells [8,10,11,90-92]. Allogeneic and 
xenogeneic tissues elicit an inflammatory response or immune-mediated rejection; 
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however the removal of cells can reduce this effect [12]. Many different animals 
[8,11,29,55,76,85,90,92-94] have been used to determine the viability of 
decellularisation methods on a variety of blood vessels including the aorta [76,94], 
carotid artery [8,29,85,90,92], iliac artery [54,94], umbilical artery [95], saphenous 
vein [55], and iliac vein [94] for the development of a TEBV. However, despite the 
prevalence of coronary artery disease and the requirement for a suitable             
small-diameter vascular graft no study has been carried out to-date to examine 
decellularisation of human or porcine coronary arteries. 
Complete decellularisation is accomplished by disrupting the cell membrane, 
disassociating cellular components from the ECM, solubilising cytoplasmic and 
nuclear components, and removing cellular fragments and residual chemicals from 
the remaining ECM [12]. This has been achieved using combinations of chemical, 
enzymatic, and physical treatments [12]. The minimum decellularisation time 
reported has been over 4 hours for rat aorta where agitation in sodium hydroxide 
(NaOH) for 1 hour followed by 3 hours of vigorous agitation in PBS achieved rapid 
decellularisation [76]. However, the majority of decellularisation protocols take from 
several days [85,92,94] to weeks [29,90]. Other studies have shown that mechanical 
properties of biological materials alter dramatically with time once harvested from 
the body [22,93]. A disadvantage of lengthy decellularisation methods is the 
timescale over which they occur. The longer the decellularisation time the greater the 
natural degradation of the tissue which will have an effect on the biomechanical 
properties of the resulting scaffold. Lengthy decellularisation times may also reduce 
the clinical and commercial viability of such TEBVs given the high costs associated 
with prolonged culture periods. Consequently, it is critical to establish a short-term 
decellularisation method to retain the native biomechanical properties and 
architecture aiding the development of a potentially viable TEBV.  
Physical methods of decellularisation such as snap freezing, mechanical force, and 
mechanical pressure cause disruption of the cell membrane and the release of cellular 
components [12]. However, these treatments are generally coupled with a chemical 
or enzymatic treatment as they are insufficient to accomplish complete cell removal. 
In fact, freeze-thaw cycles have been employed as an initial step to open up the 
arterial matrix to allow for better infiltration of the subsequent reagents [85,91]. 
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Physical methods also assist in the rinsing and removal of cellular material from the 
ECM [12]. Mechanical agitation, using magnetic stirrers, orbital shakers, and low 
profile rollers, and mechanical sonication are frequently used in conjunction with a 
chemical treatment to aid with cell lysis and the removal of cellular components 
[12,55,76,85,91,92,96].  
Chemical treatments cause the disruption of cell membranes and the bonds 
responsible for intercellular and extracellular connections [12]. Alkaline and acid 
treatments solubilise the cytoplasmic component of cells and disrupt nucleic acids. 
Deoxycholic acid [97], ammonium hydroxide [29,64,98,99], and sodium hydroxide 
[76] have been used to decellularise various blood vessels. Non-ionic detergents are 
widely used due to their inaction on the protein-protein interactions within the tissue 
architecture while the lipid-lipid and lipid-protein interactions are disrupted [12]. 
Triton X-100 is the most frequently used non-ionic detergent [29,36,64,65,90,       
98-101]. The wide range of concentrations (0.1% [102], 0.25%[100], 1% 
[29,36,65,90,100], 2% [92]), treatment times (24 hours [65,100], 48 hours [36],      
72 hours [29,92,98,99], 96 hours [64], 216 hours [90]), and blood vessels (aorta, 
carotid artery, and femoral artery) along with other combined methods makes it 
difficult to assess the effectiveness of Triton X-100. Both Dahl et al. [65] and 
Fitzpatrick et al. [100] reported ineffective decellularisation after 24 hours of 
treatment with 1% Triton X-100, although, both treatments were used in conjunction 
with other methods. Additionally, Zhao et al. [85] reported difficulty with complete 
cell removal and poor repopulated cell growth with Triton X-100. Ionic detergents 
solubilise cytoplasmic and nuclear cellular membranes; however, proteins are 
denatured due to the disruption of protein-protein interactions [12]. The most widely 
used ionic detergents in decellularisation protocols are sodium dodecyl sulphate 
[36,54,55,91,100,103] and sodium deoxycholate [54,100,102,104]. SDS achieves 
almost complete nuclear and cytoplasmic protein removal; however, the tissue 
structure is disrupted and there is a loss of collagen integrity. Schaner et al. [55] 
treated human saphenous vein with SDS at concentrations between 0.01% to 0.1% 
and physical agitation for a period of 16 hours. A concentration of 0.075% SDS or 
more resulted in the removal of all endothelial cells from the luminal surface of the 
vein and 94% of cells throughout the cell wall were also removed. Light microscopy 
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indicated that the collagen fibre content in the vessel wall remained stable while the 
elastin fibre content decreased slightly. However, Tsai et al. [103] decellularised rat 
aorta for a period of 2 hours using 0.075% SDS and while there was no quantitative 
results reported on the resulting matrix, hematoxylin and eosin staining of the    
cross-section identified an extremely porous, loose connective tissue matrix. Sodium 
deoxycholate causes even greater disruption of the native tissue structure [12]. 
Zwitterionic detergents combine the decellularisation characteristics of ionic and 
non-ionic detergents. Proteins are denatured to a greater extent than non-ionic 
detergents but to a lesser extent than ionic detergents [12].                                         
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) has been 
used to decellularise arterial tissue where the morphology of collagen and elastin 
remains intact [65,95]. Detergents must be completely removed from the tissue prior 
to implantation as detergent residuals may be cytotoxic and inhibit cell adhesion, 
migration, and proliferation [105]. 
Enzymatic treatments disrupt cell membranes and intercellular and extracellular 
bonds [12]. Trypsin is commonly used as an enzymatic treatment for 
decellularisation [10,29,90,92,96,99,104,106]. It is generally used in conjunction 
with a detergent process; however, Walles et al. [106] used it in isolation. Following 
48 hours of treatment, they reported complete decellularisation and the retention of a 
well-preserved matrix.  McFetridge et al. [107] decellularised porcine carotid arteries 
using a combination of a solvent and Trypsin-EDTA. Prolonged treatment time 
resulted in ECM damage, where, at 72 hours several sections exhibited complete loss 
of vessel architecture. Other enzymatic treatments utilised for decellularisation of 
blood vessels include RNase and DNase [10,85]. 
Effective decellularisation and matrix preservation is highly dependent on vessel 
type as demonstrated by Goissis et al. [94] who used an identical alkaline 
decellularisation method on various canine arteries and veins. The decellularisation 
procedure was carried out for time periods between 54 and 84 hours. Cell removal 
and collagen and elastin preservation depended on the vessel type (artery or vein) 
and vessel location (thoracic aorta, abdominal aorta, femoral iliac artery). Almost 
complete removal of thoracic aorta and abdominal aorta vSMCs occurred after        
36 hours; however, vSMCs remained in the femoral iliac artery after 48 hours of 
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treatment. The arteries exhibited a high degree of matrix preservation after 48 hours 
treatment, although there was a reduction and fragmentation of both collagen and 
elastin. In contrast, the veins showed no resemblance to native vessels. This is due to 
the thick medial layer and multiple elastic laminae of elastic arteries which is absent 
in veins. This highlights the need to customise a decellularisation method based on 
the vessel type and is demonstrated by the wide range of treatment times and 
concentrations outlined above. 
The majority of decellularisation protocols are performed in conjunction with 
mechanical agitation, mainly in the form of mechanical shakers or stirrers. However, 
efficient decellularisation is highly dependent on vessel thickness and density [108]. 
Decellularisation by agitation results in a non-uniform distribution of fluids 
throughout the thickness of the tissue as the fluid-contacting surfaces are subjected to 
prolonged and higher concentrations of fluid compared to the inner tissue. 
Decellularisation by perfusion, therefore, offers a more consistent method through 
uniform convective flow and a transmural pressure difference encouraging cells and 
cellular debris out of the tissue.  
The shortest time for successful decellularisation in the literature is sodium 
hydroxide (NaOH) treatment which is a form of alkaline decellularisation. Liu et al. 
[76] degraded cellular and matrix components of flat specimens of rat aortae. The 
result was an elastic lamina-collagen scaffold with and without the basal lamina 
depending on the treatment time. A treatment time of 1 hour followed by 3 hours in 
phosphate buffered saline to remove residual chemicals and vascular debris resulted 
in a scaffold without the basal lamina and with the majority of cell nuclei and smooth 
muscle cell α-actin filaments removed. Tsai et al. [103] decellularised murine aorta 
in a slightly shorter time, however, the resulting scaffold showed major structural 
disruption under histological examination.  
To the best of the authors’ knowledge no study has previously investigated or 
successfully decellularised small-diameter muscular coronary arteries. However, this 
blood vessel potentially offers the best match as a TEBV graft. The most common 
blood vessel used in decellularisation and repopulation studies to produce a TEBV is 
the elastic carotid artery [8,29,85,90,92] which, depending on the species of origin, 
can have a considerably larger internal diameter than the coronary arteries and may 
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prove to be an unsuitable replacement for the muscular coronary arteries. Many of 
the studies highlighted above focused on the removal of cells from the tissue and 
overlooked the effect on the biomechanical properties which is vital to obtain a 
compatible vessel. Additionally, there is no study of the biomechanical properties of 
decellularised porcine coronary arteries, which could critically inform the 
development of other grafts. 
2.3.1 Biomechanical Properties of Decellularised Scaffolds 
The wide range of species, blood vessels, timescales, and decellularisation protocols 
described above indicate the difficulty in optimising an approach to achieve a 
decellularised scaffold suitable as a TEBV scaffold. While the removal of cellular 
components is vital to suppress the immune response, the biomechanical properties 
of the scaffold are equally important. For TEBVs in particular, the scaffold should 
withstand physiological pressures and match the compliance of the native vessel. 
Many decellularisation studies determine the effectiveness of the protocol but 
perform no biomechanical analysis [10,76,98,103]. 
Biomechanical properties are altered as a result of decellularisation due to the 
removal of cellular components and potential damage to the ECM components. 
However the decellularisation methods outlined above do not take into account the 
natural degradation of the tissue once removed from the body. Soft tissues, including 
arteries, are obtained from cadavers or animals for experimental and clinical 
applications and are stored for short periods of time in physiological solutions 
[13,31] or frozen over longer periods [23,109]. Stemper et al. [22] reported that 
following refrigeration of arterial tissue in physiological solution for 48 hours there 
is significant decrease in the stress at failure and in the Young’s Modulus. Chow and 
Zhang [93] also reported a decrease in the initial slope and an increase in the final 
slope of the stress-strain response after 48 hours at 4 °C. This demonstrates the need 
to perform decellularisation over a short time period soon after slaughter as changes 
occur naturally in the tissue.  
Venkatasubramanian et al. [23] performed a study of the preservation methods of 
arteries. The stress-strain response of segments frozen to -20 °C revealed a shift to 
 33 
 
the left of the curve compared to fresh segments. Histological examination 
highlighted no significant damage to the ECM. However, cell injury was observed in 
the form of cytoplasmic contraction, nuclear condensation, and 10% cell necrosis. 
Conversely, Chow and Zhang [93] reported a significant reduction in collagen 
content after 1 week storage at -20 °C and -80 °C, corresponding to a more 
distensible tissue with an increased final stiffness. A number of studies have frozen 
tissue prior to or post decellularisation [8,92,94,99,105,107]. In some cases this was 
short-term freeze-thaw cycles to initiate decellularisation. However, in others it was 
the standard method to store tissue for unspecified periods of time yet it was not 
considered as potentially damaging to the resulting matrix. 
A key factor for vascular substitutes is ultimate strength which is commonly 
measured as the burst pressure; the value at which the vessel ruptures or bursts when 
pressurised [110]. An inadequate burst pressure could lead to serious implications 
such as acute rupture and anastomotic degeneration [55]. In an extensive study of 
age- and risk-appropriate human saphenous veins and internal mammary arteries, 
which are favourable substitutes for CABG procedures, burst pressures of          
1,599 ± 877 mmHg and 3,196 ± 164 mmHg, respectively, were reported [66]. These 
results signify the higher ultimate strength of arteries in comparison to veins 
suggesting that veins are not ideal replacements for arteries. Other studies of the 
burst pressure of human saphenous veins yield higher results of 2,250 mmHg [70], 
1,680 ± 307 mmHg [86], and 2,480 ± 470 mmHg [55] most likely as a result of 
younger, healthier vessels. Human umbilical arteries, an option as a TEBV scaffold, 
were reported to have a burst pressure of approximately 800 mmHg [111], 
significantly lower than that of saphenous vein and internal mammary artery. All 
recorded values, however, are multiples of the normal physiological blood pressure 
range of 80 – 120 mmHg. Decellularised human saphenous vein achieved burst 
pressures of 2,380 ± 620 mmHg, indicating no significant difference to that of     
non-decellularised samples [55]. Roy et al. [36] found fresh porcine common carotid 
arteries CCA to have an average burst pressure of 3,124 mmHg while decellularised 
vessels ruptured at a significantly lower 2,338 mmHg. These results indicate that 
burst pressures appropriate for implantation are achievable for decellularised 
materials. Conversely, decellularised porcine carotid arteries undergoing inflation 
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tests by Heine et al. [104] failed between 120 and 200 mmHg further highlighting the 
impact of different decellularisation methods on arteries. 
The effect of decellularisation on the stress-strain response is dependent on the 
method of decellularisation and also the origin of the blood vessel. Some studies 
report a significantly stiffer and less extensible response as a result of 
decellularisation [29,95,107]. However Fitzpatrick et al. [100] found the response of 
porcine aorta decellularised by three separate methods to be more distensible with a 
lower stiffness in comparison to fresh vessels. Williams et al. [29] performed 
uniaxial tensile tests on fresh and enzymatically decellularised rabbit carotid arteries. 
While scanning electron microscopy (SEM), transmission electron microscopy and 
histology showed the preservation of the major components of the ECM, uniaxial 
tensile tests demonstrated a significant stiffening of the decellularised artery in 
comparison to fresh vessels. The tensile modulus increased from 2.29 ± 0.24 MPa to 
3.48 ± 0.72 MPa following decellularisation. The decellularised tissue also exhibited 
almost no extension at low loads with the extensibility of native vessels             
(79.18 ± 5.7 %) decreasing following decellularisation (8.25 ± 0.95 %). Loosening 
and uncrimping of collagen fibres observed in the adventitia by SEM may have 
contributed in part to this stiffening.  
Quantification of the opening angle before and after decellularisation will provide an 
insight into the loss or retention of residual stresses within the arterial wall. It has 
been reported that the opening angle significantly decreases as a result of the removal 
of smooth muscle cells by decellularisation from the arterial wall [29,36], see   
Figure 2.12. Williams et al. [29] reported the opening angle of fresh rabbit carotid 
arteries decrease from 107° to 66.7° following decellularisation while Roy et al. [36] 
reported a decrease from 69° to 26° in the opening angle of porcine common carotid 
arteries. 
A further parameter of interest is the permeability of the scaffold which must be 
balanced to allow for the ingrowth of cells into the scaffold and for the transport of 
nutrients into and waste products out of the scaffold. Additionally, the permeability 
should not affect the scaffolds ability to withstand physiological blood flow. To the 
author’s knowledge there is only one study in which a measure of permeability has 
been taken for blood vessels [108]. This was carried out over 72 hours during which 
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the human umbilical vein was decellularised by perfusion and the transmural fluid 
flow was measured. Therefore, the permeability of the non-decellularised and 
decellularised scaffold was not directly measured. 
Arterial compliance is a measure of vessel distensibility. It is dependent on location 
within the arterial tree, age, and pathology. For example, a vessel with 
atherosclerosis will be less compliant, that is, stiffer; while a vessel with an aneurysm 
may be more compliant [112]. It is critical for the compliance of an implanted graft 
or a cell-seeded scaffold to match that of the vessel it is being grafted to. A 
compliance mismatch can result in complications brought about by the discontinuity 
of blood-flow velocity at the site of the anastomosis. An increase in wall shear stress 
can result in endothelial cell damage. A decrease in wall shear stress results in areas 
of blood stagnation leading to increased interaction of the vessel wall and platelets 
[113]. Due to high local pulsatile stress at the anastomosis, the less compliant the 
graft/scaffold relative to the blood vessel the greater the occurrence of arterial 
hypertrophy. The compliance mismatch of bypass grafts in comparison to the artery 
being replaced is illustrated in Figure 2.13. It is evident that the compliance of the 
saphenous vein does not match that of the external iliac artery; the vein is a stiffer 
vessel [9,113]. The synthetic grafts, Dacron and ePTFE, are significantly different to 
both the artery and the vein. As the saphenous vein is the most successful bypass 
graft to date, this indicates that there is a correlation between graft compliance and 
success rate. The graft patency rates for current bypass grafts, both synthetic and 
 
Figure 2.12: Opening angle of (A) non-decellularised and (B) decellularised rabbit 
carotid artery (adapted from [29]). 
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biologic, are identified in Table 2.2 where the relationship between graft compliance 
and patency is clearly highlighted [113].  
Studies where biomechanical properties are assessed compare decellularised matrices 
to the non-decellularised tissue they were derived from to determine the effect of 
decellularisation and evaluate the potential of the decellularised scaffold for use as a 
TEBV scaffold. However, they do not compare the biomechanical properties to the 
Table 2.2: Comparison of graft compliance and graft patency for infrainguinal 
bypass 1 and 2 years postoperative [113]. 
 
Compliance 
(%mmHg
-1
x10
-2
) 
1-year patency 
(%) 
2-year patency 
(%) 
Host Artery 5.9 - - 
Saphenous Vein 4.4 88 84 
Umbilical Vein 3.7 83 80 
Bovine Heterograft 2.6 65 59 
Dacron 1.9 65 42 
ePTFE 1.6 60 42 
 
Figure 2.13:  Compliance of the internal iliac artery in comparison to the greater 
saphenous vein, and synthetic materials Dacron and ePTFE [113]. 
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vessels they are aiming to replace, in particular the coronary arteries. As previously 
stated, no study has decellularised coronary arteries and therefore there is no 
published research on the biomechanical properties of the natural matrix scaffold of 
coronary arteries. 
2.3.2 Repopulation of Decellularised Scaffolds and Resulting 
Biomechanical Properties 
Decellularisation of allogeneic or xenogeneic blood vessels removes the vascular 
cells and therefore should not elicit a host immune response upon implantation. 
Consequently, decellularised scaffolds can potentially be implanted as bare grafts, 
given adequate ultimate strength, where autologous circulating cells and migrating 
cells from adjacent tissue repopulate the scaffold. Alternatively, the decellularised 
scaffold can be pre-seeded with suitable cells prior to implantation. The nature of the 
blood-contacting surface of the scaffold will determine the requirement for 
endothelial cell-seeding prior to implantation. As previously stated, it is vital that an 
appropriate non-thrombogenic blood-graft interface be achieved [76]. Many studies 
have seeded endothelial cells to the luminal surface of decellularised scaffolds in 
vitro to assess the scaffold capability for cell attachment and monolayer formation 
[10,64,90,95,96,107]. The endothelial cells were sourced from human saphenous 
vein [10,64], human umbilical vein [90,95] and porcine aorta [107]. Decellularised 
human umbilical arteries implanted in rats resulted in thrombus occlusion of five out 
of the eleven grafts within hours of implantation due to the dense collagen matrix of 
the scaffold [95]. Quint et al. [114] implanted endothelial cell-seeded and non-seeded 
decellularised collagen-based scaffolds into pigs. Non-seeded vessels were 
completely occluded after 30 days (thrombus formation due to collagenous wall); 
however, seeded vessels were 100% patent. Kaushal et al. [98] reported similar 
results with endothelial-progenitor cell-seeded decellularised scaffolds which 
remained patent up to 130 days while non-seeded scaffolds developed thrombus 
within 15 days. 
The structure of the decellularised scaffold has an influence on cell infiltration in 
terms of porosity/permeability and the barriers of the internal elastic lamina and 
external elastic lamina. Decellularised umbilical arteries implanted in rats as 
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abdominal aortic interposition grafts showed no infiltration of the original scaffold 
after 8 weeks possibly due to the dense collagen matrix [95]. However, 
decellularised ovine pulmonary trunks and porcine carotid arteries exhibited 
cellularity throughout the matrices after 20 weeks and 9 weeks, respectively [105]. In 
an effort to improve cell infiltration of the medial layer of decellularised scaffolds a 
number of studies have altered the native structure [92,99]. Yazdani et al. [99] 
removed the adventitial layer following decellularisation to provide seeded vSMCs 
direct access to the media. However, this resulted in significant differences, such as 
increased distensibility and decreased elastic modulus, in the stress-strain response in 
comparison to native arteries due to the removal of type I collagen of the adventitia. 
Additionally, after 2 weeks of bioreactor culture, vSMC cell count was equal for 
adventitia-intact and adventitia-denuded scaffolds and it appears that cells did not 
penetrate the external elastic lamina but formed layers of cells and deposited matrix 
above it. In addition to removing the adventitial layer, Sheridan et al. [92] introduced 
needles into the media to directly inject cells. However, without further treatment to 
increase porosity, seeded vSMCs remained localised to the area they were injected 
into and did not migrate across elastic laminae. 
The majority of studies do not assess biomechanical properties of reseeded 
decellularised scaffolds, although many would argue that the ability to withstand 
physiological pressures in vivo in an animal model suggests adequate biomechanical 
properties. However, an understanding of the biomechanical alteration that occurs as 
a result of recellularisation could direct future development of TEBV scaffolds. 
Schenke-Layland et al. [115] performed uniaxial tensile tests of repopulated 
decellularised porcine pulmonary valves. Ovine endothelial cells and myofibroblasts 
were seeded onto decellularised porcine valves. Decellularised valves show 
significant reduction in radial and circumferential tensile strength compared to fresh 
valves, however, after 16 days in dynamic culture the repopulated valves exhibit 
similar biomechanical properties to fresh values [115]. Limited biomechanical tests 
have been performed on repopulated tubular segments of decellularised blood 
vessels. Recently, Heine et al. [104] performed inflation tests and uniaxial tensile 
tests on native, decellularised, and in vitro vSMC- and EC-repopulated porcine 
carotid arteries. Decellularised vessels showed decreased radial distensibility (113% 
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compared to 135% for native arteries), decreased tensile and tear strength, and 
increased longitudinal elongation after 2 weeks of culture. However, recellularised 
arteries displayed improved biomechanical properties with a radial distensibility of 
127%, increased tensile strength and tear strength, and comparable longitudinal 
elongation to native arteries. Dahan et al. [90] demonstrated improved biomechanical 
properties due to cell seeding of porcine carotid arteries which reversed the effect of 
decellularisation on the biomechanical properties, see Figure 2.14.  
2.4 Summary 
The increasing rate and detection of coronary artery disease are furthering the 
development of biologically and biomechanically equivalent bypass grafts to 
improve long-term patency. A summary of the native artery, current bypass grafts, 
and the world-leaders in the development of a small-diameter tissue engineered 
blood vessel is shown in Table 2.3. The challenges to produce a viable TEBV 
scaffold/graft for CABG include achieving a small-diameter graft with comparable 
biomechanical properties, which can withstand cyclic blood pressure, is thrombus 
resistant, immunologically compatible and readily available for emergency 
procedures. Widespread advances in the field of tissue engineering, in particular in 
 
Figure 2.14:  Uniaxial tensile tests of native, decellularised and recellularised 
porcine carotid arteries [90]. 
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the area of decellularisation of blood vessels, are coming to terms with these 
challenges. In fact, an autologous stem-cell seeded decellularised vein graft was 
recently implanted in a 9 year old girl as an extrahepatic portal vein bypass which 
remained patent for 9 months [116]. An additional vein graft was required to restore 
patency and augment the original graft after 1 year to due to obstruction of the vessel 
by surrounding tissue. However, while this graft performed admirably as a vein graft 
with low blood pressures (13 - 20 mmHg) it may not translate to the high pressure 
coronary arteries.   
Decellularisation has been performed on a wide range of blood vessels from different 
species and using a wide range of protocols. Biomechanical properties of 
decellularised vessels have been evaluated against the original blood vessel. 
However, for CABG, it is actually the biomechanical properties of the coronary 
arteries that should be targeted. Despite the wide range of blood vessels examined as 
potential scaffolds, there is no study of the natural matrix scaffold of coronary 
arteries. 
A concern with current decellularisation methods is the timescale over which they 
occur. Along with the potential alteration of biomechanical properties due to 
decellularisation, the components of the arterial wall naturally degrade over time. 
Therefore, a short-term decellularisation method is required to maintain the natural 
biomechanical properties. 
Clearly, the development of a small-diameter bypass scaffold/graft prepared from the 
natural matrix scaffold of coronary arteries may result in a biologically and 
biomechanically equivalent structure which meets many of the current TEBV 
challenges.    
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Chapter 3 Short-term Decellularisation of 
a Small-diameter Porcine Coronary Artery 
Decellularisation of allogeneic and xenogeneic blood vessels has been widely 
examined as a method to achieve a structurally and biomechanically compatible 
scaffold for vascular tissue engineering. This has been driven by the limited        
long-term patency of synthetic and natural grafts as a result of a biomechanical 
mismatch with the native vessels they bypass. The use of allogeneic or xenogeneic 
grafts is limited by the host immune response. However, decellularisation of these 
blood vessels negates the immunological response whilst potentially maintaining the 
biomechanical and biological characteristics of the vessel. A wide range of 
decellularisation methods are employed in the literature, however, the time frames 
within which these methods are performed are extensive, ranging from days to 
weeks. As natural degradation of tissue occurs gradually upon removal from the 
body, achieving decellularisation within a short time period could limit this natural 
degradation. The most common blood vessels necessitating bypass are the         
small-diameter muscular coronary arteries. Located in the coronary and 
interventricular sulci of the heart and with numerous associated branches, these 
vessels are more difficult to harvest than other blood vessels commonly used as 
potential tissue engineering blood vessel (TEBV) scaffolds. Consequently, these 
vessels have not previously been decellularised and assessed as potential TEBV 
scaffolds. Additionally, many decellularisation methods are performed on lengths 
and dimensions of blood vessels unsuitable for use as a TEBV. The most common 
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blood vessel decellularised is the carotid artery which, depending on the source, 
generally has a larger diameter than human coronary arteries [90,99,107]. 
Furthermore, the carotid arteries are elastic and, therefore, differ structurally to the 
muscular coronary arteries. In addition to using a vessel with equivalent dimensions 
and structure to the coronary arteries, minimising the effect of the decellularisation 
method on the extracellular matrix is vital to maintain native biomechanical 
properties and to provide a suitable structure for cell attachment, infiltration and 
growth. In particular, maintaining an appropriate blood-contacting surface to line the 
lumen of the vessel is vital to prevent inflammation and thrombus formation upon 
implantation. This surface should also provide a suitable platform for the attachment 
and growth of endothelial cells, critical for regulation of a blood vessel. 
Therefore, to achieve a structurally and biomechanically equivalent small-diameter 
natural matrix scaffold suitable for use in coronary bypass surgery a number of 
criteria should be met: 
 Maintain the native tissue structure of the tunica intima, tunica media and 
tunica adventitia; 
 Minimise the time taken to achieve decellularisation; 
 Minimise the effect of decellularisation on the extracellular matrix of the 
tissue, in particular the load-bearing collagen and elastin fibres; 
 Maintain a suitable luminal surface. 
This chapter presents a method to decellularise lengths of small-diameter, muscular 
porcine coronary arteries (PCA) using a short-term decellularisation method 
developed and analysed using histological and immunohistochemical methods.  
3.1 Materials and Methods 
3.1.1 Tissue Harvesting and Preparation 
Hearts from pigs weighing approximately 90 kg and aged 6 months were obtained 
from an abattoir within one hour of slaughter. The hearts were transported in sterile 
0.9% saline (S6546, Sigma-Aldrich) at room temperature and perfused with fresh 
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0.9% saline to remove residual blood from the atrial and ventricular chambers and 
the coronary circulation, see Figure 3.1 (A). The small-diameter (internal diameter of     
< 4 mm) PCA were excised immediately. Segments of the left anterior descending 
(LAD), left circumflex (LCX) and right (RCA) coronary arteries were exposed using 
standard dissection tools. Briefly, the tools included Metzenbaum scissors (501253, 
World Precision Instruments, UK) to spread and separate the epicardium from the 
PCA, Potts-Smith scissors (503250, World Precision Instruments, UK) for cutting 
epicardium and branches of PCA, Mosquito forceps (15921, World Precision 
Instruments, UK) for manipulating excess tissue, and a scalpel to cut the tissue in 
close proximity to the PCA. A dye was injected into the lumen of the coronary 
arteries through the openings in the aortic sinuses, see Figure 3.1 (D). The dye 
highlighted the location of the numerous branches of PCA, each of which was 
ligated, to allow for fluid to flow through a 3D tubular section, see Figure 3.1 (B-C). 
Sections of artery up to 60 mm in length were carefully dissected from the 
epicardium and myocardium and stored in 0.9% saline at room temperature until 
further use. The coronary arteries excised had similar thicknesses and internal 
diameters and sections of PCA were only used where the internal diameter was 
greater than 1.5 mm.  
3.1.2 Decellularisation 
A chemical decellularisation protocol used by Liu et al. [76] for flat segments of rat 
aorta was modified for use on PCAs. 0.1м sodium hydroxide (NaOH, S8045,  
Sigma-Aldrich) was used to disrupt the cells and 0.9% saline removed chemical 
residue and cellular debris over a period of 3 hours. Preliminary tests of 5 x 5 mm 
flat sections and short (< 5 mm) cylindrical sections of PCA, with no branches 
ligated, were carried out by immersion and under constant agitation using a magnetic 
stirrer to gain an understanding of the effect of 0.1м NaOH, see Figure 3.2.  
Segments up to 40 mm in length were required for biomechanical tests and also for 
potential use as a TEBV scaffold. Therefore, a perfusion system was developed 
similar to that of Villegas Montoya and McFetridge [108] to improve the infiltration 
of 0.1м NaOH along the length of the artery, see Figure 3.3. Natural polypropylene 
barbs (MTLL004-6, Value Plastics, CO, USA), 1.6 mm in diameter, were inserted 
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Figure 3.1: Excision of coronary arteries from a porcine heart. (A) An intact heart 
with epicardium obscuring the coronary arteries; (B) left anterior descending 
coronary artery in situ with the branches highlighted by injected dye; (C) ex vivo 
section of left anterior descending coronary artery with all branches ligated; and 
(D) the main coronary arteries, branching from the aortic sinuses, excised and 
identified. 
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into the arterial lumen at either end and mounted horizontally in a flow chamber, see 
Figure 3.3 (C). A fluid reservoir at a height of 100 mmHg containing either 0.1м 
NaOH or 0.9% saline was frequently replenished. A peristaltic pump (323, Watson 
Marlow, UK) circulated the fluid at a frequency of 2 Hz [108] establishing a flow 
rate of 60 ml/min. A pressure transducer (DTXPlus, BD Medical Systems, NJ, USA) 
inserted into the lumen of the vessel monitored the pressure. The flow chamber was 
filled with either 0.1м NaOH or 0.9% saline once the vessel has been monitored for 
substantial leaks. Four flow chambers could be attached to the perfusion system 
simultaneously to produce four decellularised PCAs. Sections were treated in 0.1м 
NaOH for time periods between 1 and 12 hours followed by 3 hours in 0.9% saline to 
assess for appropriate decellularisation. 
3.1.3 Histological Analysis 
The effectiveness of the decellularisation procedure was determined by histology. 
Cross-sections of tissue were stained to visualise the various components of the 
tissue. Non-decellularised and decellularised sections of PCA were processed for
 
Figure 3.2: Decellularisation by agitation. (A) Flat or cylindrical segments of 
porcine coronary artery immersed in either 0.1ᴍ NaOH or 0.9% saline and 
agitated by a mechanical stirrer. (B) Close-up of magnet and arterial segment 
contained in a cassette for protection from the rotating magnet. 
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Figure 3.3: Decellularisation by perfusion. (A) Schematic of set-up; (B) peristaltic 
pump connected to flow chamber; (C) close-up of porcine coronary artery, with all 
branches ligated, mounted horizontally in a flow chamber; and (D) four flow 
chambers connected in parallel with mounted porcine coronary arteries. 
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staining using a standard methodology. Briefly, ring segments of PCA, 
approximately 2 mm in length, were sectioned and fixed in 10% formalin (361387P, 
VWR, UK) overnight. The segments were dehydrated in increasing concentrations of 
ethanol (EtOH), from 70% to 100%, and cleared in xylene substitute (Sigma-Aldrich 
A5597). Infiltration of paraffin (39503002, Paraplast X-TRA, McCormick Scientific) 
into the tissue occurred by immersing the segments for 2 hours at 60 °C. The 
segments were embedded in cassettes (720-0295, VWR, UK) with fresh paraffin and 
cooled at -20 °C. Cross-sections, 5 µm thick, were obtained using a Leica RM2125 
RT microtome and mounted on slides for staining.  
To process the slide-mounted sections for staining the slides were moved through 
xylene substitute, decreasing concentrations of EtOH, from 100% to 70%, and 
distilled water to remove paraffin and hydrate the sections. Subsequent to staining 
the slides were dehydrated through increasing concentrations of EtOH, from 95% to 
100%, and cleared in xylene substitute. The sections were examined by light 
microscopy using an Olympus BX-51 microscope and images were obtained with an 
integrated Olympus DP50 camera. See Appendix A for detailed protocol. 
3.1.3.1 Hematoxylin and Eosin Stain 
Hematoxylin and eosin (H&E, GHS216 and HT110216, Sigma-Aldrich) stains the 
nucleus of a cell blue-black [124], therefore indicating the presence or absence of 
cells throughout the vascular wall. The sections were stained in hematoxylin and 
eosin for 10 minutes and 1 minute, respectively. See Appendix A for detailed 
protocol. 
3.1.3.2 Modified Verhoeff Van Gieson Elastic Stain 
Modified Verhoeff Van Gieson Elastic (HT-25A, Sigma-Aldrich) stains elastin   
blue-black to black. The slides were placed in Working Elastic Stain solution for             
10 minutes, differentiated in Working Ferric Chloride Solution, and stained in Van 
Gieson Solution for 2 minutes.  
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3.1.3.3 Masson’s Trichrome Stain 
Masson’s Trichrome (HT-15, Sigma-Aldrich) stains collagen blue and muscle fibres 
and cytoplasm red. The sections were treated overnight with Bouin’s Solution, a 
mordant, at room temperature. The slides were then placed in working Weigert’s iron 
hematoxylin solution, Biebrich scarlet-acid fuchsin, working 
phosphotungstic/phosphomolybdic acid solution, and aniline blue solution for           
5 minutes each followed by 1% acetic acid for 2 minutes.  
3.1.4 Immunocytochemical and Immunohistochemical Analysis 
4’,6-diamidino-2-phenylindole (DAPI) is a blue fluorescent nucleic acid stain that 
preferentially stains DNA [125]. Ring sections of non-decellularised and 
decellularised PCA were opened flat, fixed in 10% formalin overnight, and washed 
in phosphate buffered saline (PBS, P4417, Sigma-Aldrich) three times. The sections 
were stained with a 1/1000 dilution of DAPI (D9542, Sigma-Aldrich) for 15 minutes 
and washed three times in PBS. The luminal and abluminal surfaces were examined 
using a fluorescent microscope (Olympus BX-51) and images were taken using an 
integrated Olympus DP30BW camera.  
Slide-mounted cross-sections of non-decellularised and decellularised PCAs were 
also stained with a 1/1000 dilution of DAPI for 1 minute to image nuclear material 
throughout the thickness of the tissue. In addition to the fluorescent images of the 
cross-sections, corresponding black and white images were obtained to identify the 
structure of the artery along with the nuclear material. This was beneficial for 
decellularised sections in particular as the arterial layers could be identified despite 
an absence of nuclear material. This was achieving by obtaining a snapshot image of 
the section using the Olympus DP30BW camera. 
3.2 Results 
Sections treated by agitation were analysed by DAPI staining of the luminal and 
abluminal surfaces. Figure 3.4 shows the effect of 0.1ᴍ NaOH treatment on the 
luminal surface with time. A high density of clearly defined circular nuclei was 
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visible on the smooth surface of the untreated section. After 4 hours of 0.1ᴍ NaOH 
treatment (plus a further 3 hours in 0.9% saline) nuclei were still visible on the 
luminal surface, however, at a lower density and not as well defined. There were no 
cells visible after 12 hours and the surface was a smooth, continuous layer. However, 
after 18 hours treatment, in addition to no cells being visible, the pocketed 
appearance of the luminal surface suggested that significant damage of the 
underlying matrix had occurred, see Figure 3.4 (D). For a scaffold to perform as a 
viable TEBV it must be of a particular length with no branches, or at least with 
branches ligated. When flat 5 x 5 mm sections of PCA were decellularised for           
9 hours, there were no cells visible throughout the scaffold as shown by H&E 
staining, see Figure 3.5 (B). However, the same protocol applied to a 40 mm length 
of PCA resulted in insufficient cell removal in central sections of the vessel, see 
Figure 3.5 (C). Therefore, decellularisation by perfusion was used as a more uniform 
method for cell removal, see Figure 3.5 (D). 
 
Figure 3.4: Effect of 0.1ᴍ NaOH treatment on porcine coronary arteries with time. 
DAPI staining of the luminal surface of flat sections of (A) 18 hours untreated 
porcine coronary artery and (B) 4 hours, (C) 12 hours, and (D) 18 hours agitation 
treated porcine coronary arteries. Scale bar: 200 μm. 
 
 52 
 
A combination of stains was used to determine the presence or absence of cells from 
the vascular wall and, therefore, the effectiveness of the decellularisation procedure. 
H&E staining of cross-sections of non-decellularised PCA clearly indicates the 
presence of cells throughout the vascular wall by the blue-black staining of the 
nuclei, see Figure 3.6. The compact medial layer and the looser adventitial layer of 
the vascular wall can be clearly distinguished in the images. The endothelial cells 
(ECs) of the intima, defined by their round nuclei, line the luminal surface of the 
vessel. The thick medial layer contains the elongated nuclei of vascular smooth 
muscle cells (vSMCs) orientated in the circumferential direction. The adventitia, the 
outer layer, contains the rounded nuclei of fibroblasts. There is no visible alteration 
in the cellular components of non-decellularised tissue following 9 hours in 0.9% 
saline, see Figure 3.6 (D–F). Figure 3.7 shows the progression of decellularisation 
with time. 0.1ᴍ NaOH treatment has an immediate effect on the cells of the vascular 
 
Figure 3.5: Effect of 0.1ᴍ NaOH treatment on porcine coronary arteries with time. 
DAPI staining of the luminal surface of flat sections of (A) 18 hours untreated 
porcine coronary artery and (B) 4 hours, (C) 12 hours, and (D) 18 hours agitation 
treated porcine coronary arteries. i: intima, m: media, a: adventitia, l: luminal 
surface, ab: abluminal surface. Magnification: 10x. 
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wall as shown in Figure 3.7 (A–C). Cells are still visible throughout all layers 
however they are not as clearly defined as those of non-decellularised sections. After 
8 hours decellularisation, the majority of the vessel wall is clear of nuclear material, 
however, there is a band of nuclei in the media near the external elastic lamina, 
Figure 3.7 (G–I). A decellularisation time of 9 hours or more was found to disrupt all 
cell nuclei, see Figure 3.7 (J–L). There is a loosening of both the medial and 
adventitial layers as a result of 0.1ᴍ NaOH treatment with increasing effect 
corresponding to increased treatment times. After 15 hours decellularisation larger 
pores are seen in both the media and adventitia, see Figure 3.7 (P–R).  
DAPI staining of the cross-sections of non-decellularised and 0.1ᴍ NaOH treated 
PCA confirm the finding by H&E staining that cells are present within the vascular 
wall of non-decellularised and 6 hour treated PCA, see Figure 3.8 (A–F). There is no 
nuclear material visible after 9 hours of treatment, see Figure 3.8 (G–L). DAPI 
staining of the nucleic acid on the intimal and adventitial surfaces of                     
non-decellularised PCA also shows the presence of cells across the surfaces, see 
Figure 3.9 (A–B). The size difference of the nuclei of ECs lining the luminal surface 
and the fibroblasts of the adventitia is evident. ECs form a uniform, single layer 
across the luminal surface while the fibroblasts are scattered across the abluminal 
surface. The adventitia is more difficult to image due to its porous, fibrous nature as 
 
Figure 3.6: H&E staining of non-decellularised porcine coronary arteries         
(A–C) immediately after excision and (D–F) after 9 hours in 0.9% saline.              
i: intima, m: media, a: adventitia. Magnification: (A, D) 10x, (B-C, E-F) 20x. 
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Figure 3.7: H&E staining of the cross-sections of porcine coronary arteries treated 
with 0.1ᴍ NaOH by perfusion for between 1 and 12 hours and 0.9% saline for       
3 hours. l: luminal surface, m: media, ab: abluminal surface. Magnification: (A, 
D, G, J, M, P) 10x, (B-C, E-F, H-I, K-L, N-O, Q-R) 20x. 
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Figure 3.8: DAPI staining of the cross-sections of (A-D) non-decellularised and 
(E-L) 0.1ᴍ NaOH-treated porcine coronary arteries. i: intima, m: media,               
a: adventitia, l: luminal surface, ab: abluminal suface.  Scale bar: 200 µm.  
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Figure 3.9: DAPI staining of the luminal and abluminal surfaces of                    
(A-B) non-decellularised and (C-D) 9 hour decellularised porcine coronary 
arteries. Scale bar: 200 µm. 
opposed to the smooth, flat surface on the endothelium. After 9 hours perfusion 
decellularisation treatment, no cells are visible on either the luminal or abluminal 
surfaces of PCA, see Figure 3.9 (C-D). 
Modified Verhoeff Van Gieson Elastic stain establishes the presence of elastin 
throughout the vascular wall by staining blue-black, see Figure 3.10. As expected 
with muscular arteries there are no bands of elastic laminae in the medial layer of the 
tissue although small amounts of elastin fibres are visible. The internal elastic lamina 
is prominent on the luminal side of all sections irrespective of decellularisation 
treatment. There are thick bundles of elastin fibres in the adventitia which loosen 
with increased decellularisation treatment times. Additionally, Modified Verhoeff 
Van Gieson elastic stains muscle yellow. This accounts for the yellow trace in the 
media of non-decellularised and 9 hour non-decellularised sections, see Figure 3.10 
(A-F), while it is not visible in the treated sections. Masson’s Trichrome stain 
highlights the presence of collagen throughout the vascular wall, staining blue, see 
Figure 3.11. Additionally, smooth muscle and cytoplasm stain red. While smooth 
muscle and cytoplasm are visible throughout the media of non-decellularised 
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Figure 3.10: Modified Verhoeff Van Gieson Elastic staining of the cross-sections 
of (A-F) non-decellularised and (G-R) decellularised porcine coronary arteries. 
Elastin stains blue-black to black, collagen stains red. i: intima, m: media,            
a: adventitia, IEL: internal elastic lamina, l: luminal surface, ab: abluminal 
surface. Magnification: (A, D, G, J, M, P) 10x, (B-C, E-F, H-I, K-L,                     
N-O, Q-R) 20x. 
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Figure 3.11: Masson’s Trichrome staining of the cross-sections of                       
(A-F) non-decellularised and (G-R) decellularised porcine coronary arteries. 
Collagen stains blue, muscle fibres and cytoplasm stain red. i: intima, m: media,  
a: adventitia, l: luminal surface, ab: abluminal surface. Magnification: (A, D, G, 
J, M, P) 10x, (B-C, E-F, H-I, K-L, N-O, Q-R) 20x. 
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sections, there is partial removal after 6 hours treatment and total removal after         
9 hours of treatment onwards. The denser collagen network of the adventitia is 
visible compared to the delicate collagen matrix of the media. This is also seen in the 
Modified Verhoeff Van Gieson elastic stain where collagen stains red. 
The combination of these stains demonstrates that 9 hours decellularisation is an 
appropriate time period to effectively disrupt all the cells of the vascular wall 
producing a decellularised matrix. Additionally, perfusion decellularisation results in 
a process which is independent of the thickness of the artery, see Figure 3.12. 
 
Figure 3.12: Thickness independence by perfusion decellularisation. H&E 
staining of the cross-section of six porcine coronary arteries of different 
thicknesses decellularised by perfusion for 9 hours. l: luminal surface, m: media, 
ab: abluminal surface. Magnification: 10x. 
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Following 9 hours decellularisation, the artery is translucent compared to             
non-decellularised tissue, however it maintains its form, see Figure 3.13. 
3.3 Discussion 
Due to the wide range of species, blood vessels, timescales, and decellularisation 
protocols used it is difficult to determine the optimum approach to achieve a 
decellularised scaffold suitable for a TEBV. The overall aim is the development of a 
small-diameter TEBV with appropriate biomechanical and structural properties for 
procedures such as coronary artery bypass grafting (CABG). The aorta [10,100], 
carotid artery [92,99], femoral artery [91,102], and umbilical vein [55,108] among 
others have all been decellularised using various methods, yet these vessels are not 
structurally equivalent to the coronary arteries. While the structural characteristics of 
the coronary arteries are well documented [19], they have not previously been 
decellularised to achieve the coronary artery natural matrix scaffold. This is possibly 
due to their location in the cardiovascular system and the numerous branches 
extending from the main conduits, yet their potential as structurally equivalent 
vessels to act as bypass grafts for CABG is significant. In this study, an extensive 
and careful excision method was required to remove significant lengths of porcine 
 
Figure 3.13: (A) Non-decellularised and (B) 9 hour decellularised porcine 
coronary arteries. 
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coronary arteries, up to 60 mm, with all branches ligated. The use of porcine vessels 
is justified due to the almost identical nature of porcine and human coronary 
circulation [33,34]. Some studies [65,91,92] remove the adventitial layer to aid the 
decellularisation process by providing direct reagent contact with the medial layer. 
These studies did not assess the effect of adventitial removal on the biomechanical 
properties of the vessels. However, the adventitia contains type I collagen bundles 
which offer structural support to the blood vessel. Removal of this layer would 
compromise the biomechanical properties of the resulting scaffold. Holzapfel et      
al. [20] performed uniaxial tensile tests on the three individual layers of human 
coronary arteries and determined the stress-stretch response of adventitia was stiffer 
than the media in the longitudinal direction while a similar response was found in the 
circumferential direction, see Figure 2.5 (page 12). This suggests that the removal of 
the stiffer adventitia could result in a more compliant vessel. As porcine coronary 
arteries have been found to be three times more elastic than human coronary arteries 
[13], a further increase in elasticity due to removal of the adventitia would be 
undesirable. The native architecture of the coronary arteries, consisting of the intima, 
media, and adventitia, is maintained in this study. 
Short-term storage of soft tissue has demonstrated the natural degradation of tissue 
post mortem which results in an alteration of the biomechanical response [22,93]. 
After 48 hours storage at 4 °C, the initial slope of the stress-strain response of 
thoracic aortae significantly decreased (fresh vs. stored, 149.7 ± 19.7 kPa vs.      
103.4 ± 13.2 kPa [93]) and the final slope significantly increased (fresh vs. stored, 
925.5 ± 396.4 kPa vs. 1019.9 ± 445.1 kPa [93]). This highlights the need to minimise 
overall decellularisation time, even within 48 hours of harvesting, to maintain native 
biomechanical properties. However, the preservation of the extracellular matrix 
should not be compromised by more rapid decellularisation. The shortest 
decellularisation method described in the literature is of mouse aorta [103], 
significantly smaller than the coronary arteries used in this study. Tsai et al. agitated 
the tissue in 0.075% SDS for 2 hours followed by 100 minutes in PBS. However, 
significant degradation of the tissue as a result of the treatment is evident by 
delamination of the layers and high porosity of the matrix, see Figure 3.14. Liu et   
al. [76] achieved decellularisation of flat sections of rat aorta by agitation using 0.1ᴍ 
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NaOH and PBS over 4 hours without significantly disrupting the extracellular 
matrix. The tubular lengths of PCA natural matrix scaffold obtained in this study 
after 9 hours by perfusion is a considerable improvement compared to 
decellularisation of vessels of similar sizes [55,65,98].  
The majority of decellularisation techniques use agitation to aid reagent infiltration 
of the vessel [10,29,36,55,91,95,100]. It is possible to decellularise short cylindrical 
and flat sections of the coronary arteries by agitation, see Figure 3.5, however, 
treatment by perfusion is necessary for decellularisation of full tubular lengths of 
arteries, with all branches ligated. Increased agitation treatment time may improve 
this outcome, although, as shown in Figure 3.4 (D), extended treatment causes 
significant damage to the remaining matrix. Additionally, Goissis et al. [94] found 
that increasing treatment time to improve cell removal had a significant impact on 
the collagen content of alkaline treated veins. Treatment by perfusion provided the 
most effective method for decellularisation of lengths of cylindrical segments, see 
Figure 3.5 and Figure 3.15. A study by Villegas Montoya and McFetridge [108] 
highlighted the improved decellularisation achieved by convective flow with 
transmural pressure removing cellular debris from the tissue. SEM analysis showed 
that cells remained in the medial layer of agitated sections but not of perfused 
sections.  
 
Figure 3.14: H&E staining of the cross-section of murine thoracic aorta 
decellularised with SDS for 2 hours and washed in PBS for 100 minutes (adapted 
from [103]). 
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A summary of the histological and immunohistochemical analysis used to verify 
decellularisation of PCA is shown in Figure 3.15. Non-decellularised segments of 
PCA stained with H&E and DAPI clearly show the presence of cell nuclei 
throughout the vascular wall, see Figure 3.15 (A, D-E, H). H&E, DAPI, and 
 
Figure 3.15: Summary of the effect of NaOH treatment on porcine coronary 
arteries. (A, E, I, M, Q, U) H&E, (B, F, J, N, R, V) Verhoeff van Gieson Elastic, 
(C, G, K, O, S, W) Masson’s Trichrome, and (D, H, L, P, T, X) DAPI staining the 
cross-sections of (A-D) non-decellularised PCA, (E-H) 9 hour non-decellularised 
PCA, and PCA decellularised for (I-L) 6 hours, (M-P) 9 hours, (Q-T) 12 hours, 
and (U-X) 15 hours. i: intima, m: media, a: adventitia, l: luminal surface,           
ab: abluminal surface. Scale bar: 200 µm.  
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Masson’s Trichrome staining of 6 hour decellularised sections all indicate that intact 
cells remain in the outer portion of the medial layer, see Figure 3.15 (I, K-L). 
Following 9 hour decellularisation no intact cell nuclei or smooth muscle content 
was visible throughout the vascular wall, see Figure 3.15 (M, O-P). Further treatment 
resulted in scaffolds with increased porosity which could aid in the repopulation of 
the scaffold. Modified Verhoeff Van Gieson Elastic stain and Masson’s Trichrome 
stain show the collagen and elastin matrices in the medial and adventitial layers. The 
media of muscular arteries consists mainly of vSMCs with a delicate interlaced 
matrix of collagen and elastin [19]. The adventitia on the other hand consists of thick 
collagen bundles and elastic fibres. These differing compositions are demonstrated 
by darker staining of the adventitia compared to the media for both Modified 
Verhoeff Van Gieson Elastic stain and Masson’s Trichrome stain, see Figure 3.15 
(B-C, F-G, J-K, N-O, R-S, V-W). Staining of decellularised sections does not 
indicate a degradation of the collagen and elastin matrix, however, there appears to 
be a loosening of the fibres, in particular in the elastic fibres in the adventitia of 15 
hour decellularised sections, see Figure 3.10 (P, R). The internal elastic lamina has 
been preserved in all decellularised sections which is vital for this scaffold to 
perform as a TEBV scaffold or graft. The internal elastic lamina exhibits 
inflammation- and thrombosis-resistant properties compared to collagen-based blood 
contacting materials [76]. Additionally, the internal elastic lamina acts as a barrier to 
prevent smooth muscle cells migrating to the intima resulting in intimal hyperplasia 
as well as providing an appropriate surface for endothelial cell attachment [107].  
Degradation of the collagen content of decellularised tissue with NaOH has been 
used to increase the porosity of decellularised tissue for improved cell infiltration 
[92]. In that study, an enzymatic/detergent decellularisation treatment, which 
successfully removed all vascular cells, caused a degree of disruption to the 
extracellular matrix. NaOH (0.5ᴍ) was used to further degrade the matrix of porcine 
carotid arteries over 2 hours, removing small collagen fibres. An additional treatment 
of 0.1ᴍ NaOH for 24 hours further disrupted the collagen network, in particular the 
collagen fibres bundles, resulting in a highly porous matrix. In this current study, the 
use of a lower concentration of NaOH (0.1ᴍ) in isolation for a shorter overall time 
has resulted in a matrix which, based on histological analysis, maintains its collagen 
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content, see Figure 3.10 and Figure 3.11. The preservation of collagen will be further 
investigated in Chapter 4 by an examination of the biomechanical properties. 
Muscular porcine coronary arteries, structurally equivalent to human coronary 
arteries, have been successfully decellularised within 9 hours limiting the natural 
degradation of the tissue and maintaining the gross extracellular matrix 
characteristics. This short-term decellularisation method achieving the natural matrix 
scaffold is considerably shorter than other decellularisation methods in the literature 
for vessels of its size. A short-term decellularisation method is clearly more 
commercially viable than longer term decellularisation protocols. Additionally, 
through the use of perfusion decellularisation, appropriate lengths of PCA scaffold 
suitable for use as grafts have been obtained. Through biomechanical analysis of 
non-decellularised and decellularised arteries, in Chapter 4 it will be determined 
whether NaOH results purely in the removal of vascular cells or additionally disrupts 
extracellular matrix components. While complete decellularisation has been achieved 
after 9 hours treatment, the increased porosity observed in sections with extended 
treatment times may aid in the repopulation of the scaffold, however, this may also 
compromise the biomechanical properties. In addition, achieving the natural matrix 
scaffold of coronary arteries could provide vital benchmarking information on the 
development of other grafts for use in CABG in terms of structural and 
biomechanical properties.  
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Chapter 4 Biomechanical Evaluation of 
Non-decellularised and Decellularised 
Porcine Coronary Arteries 
Despite the prevalence of coronary artery disease and the requirement for surgical 
interventions such as balloon angioplasty, stenting, and coronary artery bypass 
grafting (CABG) there is limited analysis of the biomechanical properties of the 
small-diameter muscular coronary arteries [13,20,21,30,126]. Furthermore, there are 
no studies of the biomechanical properties of the coronary artery natural matrix 
scaffold. As described in Chapter 3, a short-term decellularisation method was 
developed to successfully obtain the natural matrix scaffold of porcine coronary 
arteries (PCA). Histological analysis confirmed the removal of vascular cells and the 
preservation of elastin and collagen in the decellularised matrix. To determine 
whether the elastin and collagen content has been affected as a result of the 
decellularisation procedure the biomechanical properties of non-decellularised and 
decellularised PCAs are evaluated. The short-term (< 48 hours) alteration in 
mechanical properties of arterial tissue has previously been reported [22,93]. 
Therefore, to evaluate the short-term natural degradation as a result of harvesting,     
9 hour non-decellularised PCAs are also analysed. Additionally, the capability of the 
natural matrix scaffold to act as a TEBV graft or scaffold is assessed. A 
comprehensive understanding of both the native blood vessel and natural matrix 
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scaffold can inform the development of other synthetic and natural grafts for TEBV 
scaffolds.  
By conducting uniaxial tensile, inflation, and permeability tests and a dimensional 
analysis this chapter aims to: 
 Characterise the biomechanical properties of non-decellularised PCA 
immediately upon excision;  
 Determine the effect of 0.1ᴍ NaOH treatment on the biomechanical 
properties of decellularised PCA;  
 Determine the short-term natural degradation of non-decellularised PCA 
corresponding to decellularisation time; 
 Evaluate the potential of the natural matrix scaffold to act as a 
biomechanically viable graft or vascular tissue engineering scaffold. 
4.1 Materials and Methods 
4.1.1 Tissue Harvesting and Preparation 
Forty-five porcine hearts, weighing an average of 390 g, were obtained for 
biomechanical tests. Arteries were prepared and excised from porcine hearts as 
described in Section 3.1.1 (pg. 44). Additional lengths of PCA were excised without 
the branches ligated for non-decellularised permeability and uniaxial tensile tests. 
The breakdown of biomechanical tests performed on individual PCAs is shown in 
Figure 4.1. The variability in the mechanical response of the main coronary arteries 
from the same heart was found to be lower than the variability between      
individuals [13]. Therefore, right coronary arteries (RCA), left anterior descending 
coronary arteries (LAD), and left circumflex coronary arteries (LCX) were obtained 
for uniaxial tensile, inflation, and permeability tests, respectively. A dimensional 
analysis was carried out on all three blood vessels. PCAs were decellularised by 
perfusion for either 9 hours or 15 hours as described in Section 3.1.2 (pg. 45). Test 
segments were stored in 0.9% saline at room temperature prior to testing. All tests 
were performed within 24 hours of slaughter to minimise the effect of degradation as 
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a result of harvesting. Unsuccessful tests were a result of unsuitable diameters or 
lengths of PCA or branches located in the test region. 
 
 
 
Figure 4.1: Biomechanical tests performed on each porcine coronary artery.      
(A) Flow chart and (B) illustration detailing the biomechanical tests performed on 
segments of the three main coronary vessels. 
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4.1.2 Uniaxial Tensile Tests 
Uniaxial tensile tests in the longitudinal direction were performed to determine the 
stress-strain response of non-decellularised PCAs and the corresponding alteration as 
a result of decellularisation. Twenty-six RCAs were divided into segments 20 mm in 
length. Depending on appropriate lengths and diameters, where possible, up to three 
segments were obtained from each RCA, see Figure 4.1 (B). Non-decellularised (N0, 
n=25), 9 hour non-decellularised (N9, n=18), and 9 hour decellularised (D9, n=19) 
sections were tested.  
Segments were opened in the longitudinal direction and dog-bone shaped sections, 
with dimensions of 3.7 mm width and 12 mm gauge length, were obtained using a 
custom-made die, see Figure 4.2 (A). Sections containing branches within the gauge 
length were discarded. The sections were mounted into custom-made grips and 
attached to a 20 N load cell within a Zwick Z005 displacement controlled tensile 
testing machine (Zwick GmbH, Ulm, Germany), see Figure 4.2 (B). The grip faces 
were lined with sand paper to prevent tissue slippage during loading. The sections 
were pre-conditioned to reach a steady state and allow for comparison [25]. This was 
performed at a strain rate of 60 %/min of the initial gauge length measured at a     
pre-load of 0.001 N and to a maximum force of 1 N over 5 cycles, see Figure 4.2 (C). 
Sections were irrigated during pre-conditioning with 0.9% saline. Sections were then 
tested to failure at a strain rate of 60 %/min of the initial gauge length. Failure 
occurred when the section began to tear at either grip or along its length. 
The force-extension data recorded by the Zwick Z005 was converted to stress-strain 
for comparison of the sections. Stress was calculated as: 
 
  
 
  
     MPa (Equation 4.1) 
where,  F is the instantaneous force (N) and Ao is the original cross-sectional        
area (m
2
). The gauge length thickness was required to calculate the cross-sectional 
area. Sections of RCA directly adjacent to the test section were obtained and the 
thickness was measured using a microscope with an integrated linear micrometer 
(Mitutoya), see Figure 4.2 (D). An average of six measurements was taken as the 
section thickness.  
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Figure 4.2: Uniaxial tensile test set-up. (A) Dog-bone shaped die to obtain 
sections; (B) right coronary artery section mounted in custom-made grips within 
the Zwick Z005 displacement controlled tensile testing machine; (C) typical       
pre-conditioning curve over 5 cycles to a maximum force of 1 N; and                  
(D) slide-mounted section to measure thickness. 
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Strain was calculated as: 
 
  
  
  
 (Equation 4.2) 
where, ∆l is the change in length (m) and lo is the original length (m) taken at a    
pre-load of  0.001 N after pre-conditioning. 
Further uniaxial tensile tests were performed on sections decellularised for 15 hours 
(D15, n=6) to investigate the effect of increased treatment time on the biomechanical 
properties. The tests were performed as described above.   
4.1.3 Inflation Tests 
Inflation tests were performed to determine the response of intact PCA under 
physiological pressures and the corresponding change as a result of decellularisation. 
Seven segments of LAD, approximately 40 mm in length and with all branches 
ligated, were obtained, see Figure 4.1 (B). Each vessel was cannulated at both ends 
with natural polypropylene barbs (MTLL004-6, Value Plastics, CO, USA) and 
mounted horizontally into a custom-made flow chamber, see Figure 4.3 (A). A     
pre-stretch of 30% was applied to the artery using a linear micrometer attached to the 
flow chamber to imitate in vivo conditions [13,36]. The flow chamber was connected 
to a pressure head of 0.9% saline, the height of which was altered using a pulley 
system to achieve pressures of between 10 mmHg and 200 mmHg, see              
Figure 4.3 (B). The luminal pressure was measured using a paediatric pressure 
catheter (Abbott, IL, USA) connected to a pressure transducer (DTXPlus, BD 
Medical Systems, NJ, USA), amplifier and monitoring device (TA-100, CWE Inc., 
PA, USA). Five pre-conditioning cycles of 10 - 200 mmHg were applied to remove 
the effect of hysteresis and allow for repeatability across the test segments, see 
Figure 4.4. The LAD was then inflated from 10 - 200 mmHg in increments of         
10 mmHg. At each step a video extensometer (MESSPHYSIK Material Testing, 
Austria) immediately recorded an image. The vessel was discarded if substantial 
leaks developed during the test. The flow chamber was interchangeable between the 
inflation and the perfusion decellularisation set-ups. The LAD was decellularised for 
9 hours after which it was immersed in 0.9% saline for 30 minutes to allow it recover 
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Figure 4.3: Inflation test set-up. (A) Flow chamber where a precise pre-stretch is 
applied to the horizontally mounted artery using the linear micrometer.               
(B) Schematic of the inflation test set-up where the height of the reservoir is 
controlled by a pulley system and the mounted artery is monitored by a pressure 
sensor and video extensometer. 
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its relaxed state. The inflation test was then repeated under identical conditions to 
those outlined above. Image analysis of the video extensometer images at each time 
step resulted in multiple measurements of the external diameter along the length of 
the LAD. Combined with the data obtained from the pressure sensor, external 
diameter-pressure curves and pressure-diametrical stretch curves were obtained. 
Diametrical stretch was calculated as: 
                     
 
  
    (Equation 4.3) 
where, ø is the instantaneous diameter (mm) and øo is the original diameter (mm) at 
10 mmHg.  
4.1.4 Permeability Tests 
Permeability tests were performed to determine the alteration as a result of 
decellularisation, and also to determine whether decellularised PCA can maintain the 
ability to withstand high pressures. Twenty-one LCXs were divided into segments, 
each 15 mm in length, and were tested non-decellularised (N0, n=17), 9 hour        
non-decellularised (N9, n=10) or 9 hour decellularised (D9, n=11), see Figure 4.1 (B). 
 
Figure 4.4: Pre-conditioning for inflation tests of the left anterior descending 
coronary artery over 5 cycles to reduce the effect of hysteresis. 
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The segments were opened in the longitudinal direction and 8 mm circular sections 
were obtained using a custom-made die. Sections containing branches were 
discarded.  
The permeability rig consists of two plates with a 4 mm hole through the centre of 
both. The top plate secures to a bottom plate by four screws, see Figure 4.5. There is 
a counterbore in the facing surfaces of each plate, 8 mm in diameter and 5 mm deep. 
A spacer with an external diameter of 8 mm and an internal diameter of 4 mm sits in 
the top well. The LCX section was placed in the well of the bottom plate obstructing 
the 4 mm central hole. A water-filled inflation device (Basix 25, Merit Medical 
 
Figure 4.5: Permeability test set-up. (A) Inflation device attached to permeability 
rig; and (B) close-up of device. 
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Systems, UT, USA), connected to the top plate through a luer connection, increased 
the pressure to 1500 mmHg for 60 minutes. A petri dish under the bottom plate 
collected fluid perfused through the section for the duration of the test. The petri dish 
was weighed before and after the test using a digital Mettler AE50 balance, accurate 
to 0.1 mg. The difference in mass was that of the fluid which passed through the       
4 mm diameter section of PCA exposed to the pressurised water over the course of 
60 minutes. Permeability was calculated using Darcy’s Law: 
 
  
   
   
 m
2
 (Equation 4.4) 
where,  k is the permeability coefficient (m
2
), Q is flow rate (m
3
/s), L is tissue 
thickness (m), µ is viscosity of water (Pa.s), A is surface area (m
2
), and ∆P is 
pressure drop across the material. The thickness was measured from sections of LCX 
directly adjacent to the test section using a microscope with an integrated linear 
micrometer. An average of six measurements was obtained.   
4.1.5 Dimensional Analysis 
The removal of cells from the vascular wall and the potential damage to the 
extracellular matrix (ECM) may alter the dimensions of the vessel. Fourteen        
non-decellularised sections of PCA and fourteen corresponding 9 hour decellularised 
sections of PCA were obtained, each 2 mm in length. The sections were taken from 
regions of PCA as close together as possible. Images were taken of the intact        
(no-load state) cross-section under a microscope with an integrated camera, see 
Figure 4.6 (A). The sections were cut in the longitudinal direction (zero-stress state) 
and a second image was immediately taken, see Figure 4.6 (B). The images were 
analysed for measurements of thickness, internal and external circumference, and 
opening angle using ImageJ 1.42 software (National Institutes of Health, MD, USA), 
see Figure 4.6 (C-D). The opening angle (ϴ) was calculated by measuring the angle 
from the centre of the internal circumference to the outer edges of open sections 
[29,30], see Figure 4.6 (D).  
Additionally, the pre-stretch of ten LADs was measured. The artery was marked in 
two locations in situ and the length measured using a vernier callipers. Upon excision 
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and arterial recoil, the length was measured again and the pre-stretch was calculated 
as: 
 
  
  
  
  (Equation 4.5) 
where, Li is the in situ length and Le is the ex situ length. 
4.1.6 Statistics 
All data is presented as mean ± standard deviation (SD). Error bars indicate one 
standard deviation unless otherwise stated. D’Agostino and Pearson omnibus K2 
normality tests were performed using GraphPad Prism version 5 for Windows 
(GraphPad Software, CA, USA). In some instances the removal of outliers was 
required to achieve normality. Outliers were defined as data points outside the    
mean ± 2SD. Using Microsoft Excel (2010, Microsoft, WA, USA), F-tests were 
performed on data sets to determine equal or unequal variance prior to t-tests to 
ascertain whether the means of two data sets are statistically different from each 
other. A p value < 0.05 was considered significant.  
 
Figure 4.6: Dimensional analysis. Microscope images of sections of                  
non-decellularised PCA in the (A) no-load and (B) zero-stress state with precision 
ruler for calibration; and measurement of (C) intact internal and external 
circumferences and (D) open internal and external circumferences and opening 
angle. 
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4.2 Results 
4.2.1 Uniaxial Tensile Tests 
All sections exhibited the typical non-linear J-shaped curve associated with soft 
tissues for representative stress-strain responses, see Figure 4.7. The variability in the 
elastic behaviour was evident for all groupings. The slope of the curve was analysed 
in three regions; the initial slope, the pre-conditioned slope, and the final slope; by a 
linear fit of the data in that region, see Figure 4.8 (B). Additionally, the x-intercepts 
for the pre-conditioned and final slopes were also analysed as a measure of the 
distensibility of the artery.  
The 9 hour decellularised sections exhibited less stiff behaviour in the initial linear 
region but statistically significant stiffer behaviour in both the pre-conditioned and 
final regions of the curve when compared to non-decellularised and 9 hour           
non-decellularised sections, see Figure 4.9 and Table 4.1. The x-intercepts for the 
pre-conditioned and final slopes occur at a statistically significant higher strain for    
9 hour decellularised sections than for non-decellularised or 9 hour                       
non-decellularised sections, see Figure 4.9 and Table 4.1. The gauge length of all 
sections prior to pre-conditioning are similar; however, after pre-conditioning the 
gauge length of the decellularised sections does not extend to the same degree as the 
non-decellularised and 9 hour non-decellularised sections. Finally, the thickness of 
the non-decellularised and 9 hour non-decellularised sections are equivalent, 
however, the 9 hour decellularised sections exhibit a statistically significant decrease 
by comparison. 
The non-decellularised and 9 hour non-decellularised sections exhibit no significant 
difference at any stage of the stress-strain response. After 15 hours decellularisation 
the same trends were exhibited in comparison to non-decellularised sections. 
However, there was no significant increase in the alteration in biomechanical 
properties found as a result of a prolonged treatment time when compared to 9 hour 
decellularised sections, see Figure 4.9 and Table 4.1.  
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Figure 4.7: Uniaxial stress-strain response for porcine right coronary arteries; 
non-decellularised (N0, n=25), 9 hour non-decellularised (N9, n=18), 9 hour 
decellularised (D9, n=19) and 15 hour decellularised (D15, n=6). 
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Figure 4.8: Uniaxial stress-strain response of porcine coronary arteries.             
(A) Representative uniaxial stress-strain curves for non-decellularised, 9 hour 
non-decellularised and 9 hour decellularised right coronary artery sections.        
(B) Determination of initial slope, mi, pre-conditioned slope, mp, final slope, mf, 
and x-intercepts for mp and mf.  
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Figure 4.9: Uniaxial tensile data for non-decellularised, 9 hour                         
non-decellularised, 9 hour decellularised and 15 hour decellularised sections of 
right coronary arteries. Significance, * p < 0.05. 
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4.2.2 Inflation Tests 
The pressure-external diameter and pressure-diametrical stretch curves for inflation 
tests were analysed as shown in Figure 4.10. A linear fit of the data resulted in 
measurements of the initial slope, mi, the physiological slope between 80 mmHg and 
120 mmHg, mphy, and the final slope, mf.  
The external diameter-pressure curves for each LAD demonstrate that                  
non-decellularised and decellularised arteries exhibit initial and final linear regions 
linked by a non-linear region, see Figure 4.11. The external diameter at the initial 
reading of 10 mmHg increased from 3.80 ± 0.47 mm to 4.33 ± 0.57 mm after 9 hour 
decellularisation however this was not statistically significant. 9 hour decellularised 
LADs experience a larger external diameter at all recorded pressures compared to 
non-decellularised LADs. Statistical significance was found in the slopes for 9 hour 
decellularised LADs in comparison to non-decellularised LADs at all stages of the 
external diameter-pressure curves, see Table 4.2.  
The pressure-diametrical stretch curves show that 9 hour decellularised LADs are 
initially less stiff when compared to non-decellularised LADs, see Table 4.3 and 
Figure 4.12. However in all but one instance, as the pressure increased the 9 hour 
decellularised LADs exhibited stiffer behaviour than non-decellularised LADs.  
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Figure 4.10: Analysis of inflation test data. (A) Determination of initial slope, mi, 
physiological slope, mphy, and final slope, mf, of the pressure-external diameter 
response, and (B) determination of the  initial (mi) and final slopes (mf) of the 
pressure-diametrical stretch response for inflation tests of porcine left anterior 
descending coronary arteries.  
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Figure 4.11: Pressure-external diameter response for inflation tests of              
non-decellularised (♦) and corresponding 9 hour decellularised (▲) left anterior 
descending porcine coronary arteries. Markers and error bars indicate mean + one 
standard deviation. 
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Table 4.2: Non-decellularised (N0) and 9 hour decellularised (D9)              
pressure-external diameter data analysis from inflation tests of porcine left 
anterior descending porcine coronary arteries. 
 
 
Table 4.3: Non-decellularised (N0) and 9 hour decellularised (D9)              
pressure-diametrical stretch data analysis from inflation tests of porcine left 
anterior descending porcine coronary arteries. 
  
Initial Slope,  
mi 
(mmHg) 
Physiological 
Slope, mphy 
(mm/mmHg) 
Final Slope, 
 mf 
(mmHg) 
Initial External 
Diameter 
(mm) 
N0, n=7 0.0244 ± 0.0099 0.0032 ± 0.0006 0.0017 ± 0.0008 3.80 ± 0.47 
D9, n=7 0.0423 ± 0.0083* 0.0013 ± 0.0007* 0.0007 ± 0.0003* 4.33 ± 0.57 
Significance, * p < 0.05    
  
Initial Slope,  
mi  
(mmHg) 
Final Slope,  
mf   
(mmHg) 
N0, n=7 167.49 ± 45.66 2087.99 ± 584.37 
D9, n=7 100.77 ± 22.82* 5769.38 ± 1187.68* 
Significance, * p < 0.05  
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Figure 4.12: Pressure-diametrical stretch response for inflation tests of               
(A) non-decellularised and (B) corresponding 9 hour decellularised left anterior 
descending porcine coronary arteries. (C) Response of LAD # 4 before and after 
decellularisation. 
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4.2.3 Permeability Tests 
A statistically significant increase in the permeability of 9 hour decellularised 
sections was exhibited in comparison to both non-decellularised and 9 hour          
non-decellularised sections, see Figure 4.13. The permeability increased from                
3.5 x 10
-13
 m
2
 to 2.8 x 10
-12
 m
2
 following 9 hour decellularisation. There was no 
statistically significant difference in the permeability of non-decellularised LCX and 
9 hour non-decellularised LCX. The permeability of the 9 hour decellularised 
sections displayed a large variability which was not present in the non-decellularised 
sections. All test groups withstood pressures up to 1,500 mmHg. The thickness of     
9 hour decellularised sections of LCX, 0.43 ± 0.10 mm, was a statistically significant 
reduction compared to non-decellularised and 9 hour non-decellularised sections, 
0.74 ± 0.14 mm and 0.74 ± 0.12 mm, respectively.  
 
 
Figure 4.13: Permeability of non-decellularised (N0), 9 hour non-decellularised 
(N9) and 9 hour decellularised (D9) sections of porcine left anterior descending 
coronary arteries. Significance, * p < 0.05.  
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4.2.4 Dimensional Analysis 
Representative images of ring segments in the no-load and zero-stress state for    
non-decellularised and 9 hour decellularised PCAs are shown in Figure 4.14. 
Thickness, internal circumference, external circumference, and opening angle data 
are presented in Table 4.4. Upon opening, the non-decellularised section increased in 
thickness and internal circumference and decreased in external circumference 
although there is no statistical significance. 9 hour decellularised sections also 
exhibit a decrease in external circumference upon opening but to a lesser extent. 
However, there is no change in thickness or internal circumference. There is a 
statistically significant decrease in the thickness of 9 hour decellularised PCAs in 
comparison to non-decellularised sections for both no-load and zero-state 
configurations. The radial stretch ratio, calculated as λ = Tn / Tz, where Tn is the    
no-load wall thickness and Tz is the zero-stress wall thickness, was 0.91 for         
non-decellularised sections and 1.01 for 9 hour decellularised sections. The internal 
diameter of 9 hour decellularised PCA increased in comparison to non-decellularised 
PCA however no trend was found for the external circumference. The 
circumferential stretch ratio was calculated as λ = Cn/Cz, where Cn is the no-load 
Table 4.4: Dimensional analysis of corresponding sections of non-decellularised 
(N0) and 9 hour decellularised (D9) porcine coronary arteries. 
 
State 
Thickness 
 
(mm) 
Internal 
Circumference 
(mm) 
External 
Circumference 
(mm) 
Opening 
Angle  
(°) 
N0, 
n=14 
No-load 0.63 ± 0.18 6.24 ± 1.48 10.19 ± 2.06 - 
Zero-stress 0.70 ± 0.21 6.82 ± 1.34 9.01 ± 2.09 72.22 ± 26.42 
D9, 
n=14 
No-load 0.46 ± 0.11
1
 7.20 ± 1.44 9.93 ± 1.72 - 
Zero-stress 0.46 ± 0.15
 2
 7.21 ± 1.51 9.63 ± 1.72 18.59 ± 27.52
2
 
Significance, 
1
 p < 0.05, from corresponding no-load non-decellularised sections 
     
2
 p < 0.05, from corresponding zero-stress non-decellularised sections 
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circumference and Cz is the zero-stress circumference. The internal and external 
circumferential stretch ratios for non-decellularised sections were 0.91 and 1.13, 
respectively. The corresponding internal and external circumferential stretch ratios 
for 9 hour decellularised sections were 1 and 1.03, respectively. There was a 
statistically significant decrease in the opening angle for 9 hour decellularised PCAs 
compared to non-decellularised PCAs. The in situ longitudinal pre-stretch of ten 
LADs was measured as 28.9% ± 4.2%.  
4.3 Discussion 
There is limited data on the biomechanical properties of human and porcine coronary 
arteries in terms of uniaxial tensile, biaxial tensile and inflation tests [13,20,21]. This 
study characterises the biomechanical properties of small-diameter muscular porcine 
coronary arteries and is the first to provide an insight into the corresponding    
coronary artery natural matrix scaffold.  
Due to their anisotropic nature, the non-linear response of arteries to an applied load 
is direction-dependent. In this study uniaxial tensile tests were performed in the 
 
Figure 4.14: Dimensional analysis of (A, C) intact and (B, D) open sections of   
(A-B) non-decellularised and (C-D) 9 hour decellularised porcine coronary 
arteries. 
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longitudinal direction only due to limitations relating to the dimensions of PCAs. 
However, this provides sufficient information on the stress-strain response of PCAs 
and the corresponding alteration due to decellularisation. Although statistically 
significant changes in the stress-strain response occur as a result of the short-term 
decellularisation method, the natural matrix scaffold maintains the highly non-linear 
response of non-decellularised arteries. This indicates a gross preservation of the 
collagen and elastin matrix. An initial linear region due to the extension of elastin 
fibres is followed by a highly non-linear region as collagen fibres straighten out and 
a final linear region once all the collagen fibres are recruited. Similar to other studies 
of decellularised arteries, the natural matrix scaffold of PCA is initially less stiff and 
more distensible in the low load range compared to non-decellularised sections 
[90,100], see Figure 4.9 and Table 4.1. Subsequently, as undulated collagen 
straightens out and is recruited, the decellularised arteries become stiffer than      
non-decellularised arteries [64,90,92]. The absence of smooth muscle cells results in 
a more pronounced response from the collagen and elastin content; an increased 
elasticity in the low-load range due to the elastin and an increase in stiffness in the 
latter stages from the contribution of collagen fibres. Uniaxial tensile tests performed 
after 15 hours decellularisation demonstrate that there is no further significant 
alteration in the biomechanical properties of the scaffold despite the increased 
porosity observed in Chapter 3. This verifies its ability to withstand loads despite the 
extended treatment time.  
Inflation tests exhibit similar trends in the radial direction to longitudinal uniaxial 
tensile tests where the initially less stiff decellularised PCA becomes increasingly 
stiffer in comparison to the non-decellularised segments, see Figure 4.12 and     
Table 4.3, similar to the findings of Conklin et al. [8]. In contrast to other studies 
which test different vessels [8,36,65,104], the inflation tests were performed on the 
same LAD vessel before and after decellularisation, therefore, eliminating the 
variability associated with soft tissue testing. The initial compliant region of the             
pressure-external diameter curves where the diameter increases dramatically with 
increasing pressure is due to the contribution of elastin. A stiffer response is 
exhibited once the collagen fibres are recruited, see Figure 4.11. Decellularised 
PCAs reach a plateau after 60 mmHg as the collagen fibres are fully recruited and 
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resist further radial expansion. This is further demonstrated by the physiological and 
final slopes of decellularised arteries which were not significantly different. 
However, there is a statistically significant decrease in the final slope of               
non-decellularised arteries in comparison to the physiological slope indicating the 
continuing recruitment of collagen fibres and further expansion of the vessel. The 
physiological and final slopes of the 9 hour decellularised arteries are significantly 
less than that of non-decellularised arteries. Similar to other inflation studies, the 
initial diameter of decellularised arteries at 10 mmHg is larger than that of           
non-decellularised arteries [8,36,104]. With the exception of specimen 3, the external 
diameter of non-decellularised arteries does not expand to the same diameter as the 
corresponding decellularised vessel, see Figure 4.11.  
Van Andel et al. [13] showed that young PCA is approximately three times more 
elastic than aged (61 to 85 years) human coronary arteries, see Figure 4.15. A 
circumferential strain of between 60% and 70% was achieved for porcine coronary 
arteries, however, a value of approximately 20% circumferential strain was achieved 
for human coronary arteries, see Figure 4.15 (B). The expansion of the external 
diameter of non-decellularised PCA in the range of 10 to 100 mmHg in this current 
study, see Figure 4.11, follows a similar trend to that seen by van Andel, see Figure 
4.15 (A). However, van Andel shows the expansion of human coronary arteries from 
0 to 100 mmHg is much less than that of PCAs. Additionally, circumferential stress 
in PCAs was lower at a given circumferential strain compared to human coronary 
arteries, see Figure 4.15 (B).  
A key factor for vascular substitutes is burst pressure or ultimate strength since an 
inadequate burst pressure could lead to acute rupture and anastomotic     
degeneration [55]. In this current study, burst pressure tests have not been explicitly 
performed however inflation tests confirm that 9 hour decellularised tubular sections 
can withstand luminal pressures up to 200 mmHg. The permeability tests indicate 
that flat sections of 9 hour decellularised matrix can withstand pressures up to            
1500 mmHg, well above the physiological range of an artery. Since this pressure 
only indicates the normal radial pressure that the tissue can withstand, without 
explicit consideration of circumferential stress, it can therefore not be used as a true 
measure of burst pressure but it does show that the tissue retains considerable 
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integrity and strength following decellularisation. The burst pressure of coronary 
arteries has not been previously tested, however the burst pressures of human 
saphenous veins and internal mammary arteries are reported to be                       
1,599 ± 877 mmHg and 3,196 ± 164 mmHg respectively [66]. Other studies of 
decellularised vessels were unable to maintain pressures up to 200 mmHg [29,104] 
and, therefore, would be unsuitable for implantation as a vascular graft. Williams et 
al. [29] was unable to perform inflation tests on decellularised sections of rabbit 
carotid artery as the tissue was too porous following decellularisation and could not 
maintain a steady pressure. Decellularised porcine carotid arteries tested by Heine et 
al. [104] failed between pressures of 120 and 200 mmHg.  
 
Figure 4.15: Comparison of inflation tests of porcine and human coronary 
arteries. (A) External diameter-transmural pressure curves and                            
(B) circumferential stress-circumferential strain curves of young porcine and aged 
human left anterior descending coronary arteries (adapted from [13]). 
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Additionally, permeability tests show flat sections of decellularised PCA can 
withstand pressures of up to 1,500 mm Hg. Permeability tests have not previously 
been performed on non-decellularised blood vessels. The permeability of human 
umbilical vein (HUV) has been measured over the course of a perfusion 
decellularisation procedure [108]. The transmural flow across a segment of HUV,   
85 mm in length, was measured over 72 hours resulting in an average permeability of 
2.3 x 10
-16
 m
2
 at 150 mmHg. This is considerably lower in comparison to the       
non-decellularised and decellularised values in this current study, see Figure 4.13. A 
significant increase in permeability of the tissue results following 9 hour 
decellularisation. The removal of material from the vascular wall can be linked to 
this 8-fold increase in permeability. This provides key information on the 
permeability of the natural matrix scaffold and therefore the optimum environment 
for vascular smooth muscle cells seeded in tissue engineered scaffolds. Additionally, 
the significant increase in permeability may encourage cell infiltration aiding in the 
repopulation of the scaffold. 
Residual stresses are present in non-decellularised arteries in the no-load state, 
demonstrated by the springing open of the artery when a ring section is cut in the 
longitudinal direction, releasing the internal stresses. This implies that the internal 
surface, the intima, is undergoing compression and the outer surface, the adventitia, 
is undergoing tension in the no-load state [16]. The opening angle has been reported 
to significantly decrease as a result of the removal of vascular smooth muscle cells 
from the arterial wall [29,36]. Williams et al. [29] found a decrease from an average 
of 107° to 67° in the opening angles of non-decellularised and enzymatically 
decellularised rabbit common carotid arteries. Histological analysis confirmed that 
the elastic laminae remained intact indicating that increased porosity and disrupted 
cell-fibre interactions led to the relaxation in residual stresses. A reduction in 
opening angle from 69° for non-decellularised porcine carotid arteries to 26° for 
detergent-enzymatically treated vessels was found by Roy et al. [36]. They 
determined this was due to the release of compressive residual stress existing in the 
elastin fibre network as a result of the removal of vascular smooth muscle cells. In 
this current study, the opening angle of non-decellularised PCAs decreased from an 
average of 72° to 19° after decellularisation. The non-decellularised opening angle is 
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similar to that of Carboni et al. [35] who reported the opening angle of porcine left 
circumflex coronary artery as 75° ± 29°. The loss of residual stresses in the arterial 
wall can also account for the increase in initial external diameter of decellularised 
vessels compared to non-decellularised vessels in inflation tests, see Figure 4.11 and 
Table 4.2. Holzapfel et al. [127] demonstrated the residual stretches in the individual 
layers of human aorta in both the circumferential and longitudinal directions. When 
cut open to release residual stresses, the adventitia and media shortened while the 
intima elongated. Consequently, in this current study, the external circumference 
decreased and internal circumference increased in non-decellularised sections when 
opened, see Table 4.4. However, there was almost no change in these measured 
values for non-decellularised sections, further indicating the loss of residual stresses 
as a result of decellularisation.  
Intuitively, the thickness of a blood vessel should decrease as a result of the removal 
of vascular cells. Similar to other decellularisation studies [36,65,114], decellularised 
PCAs experienced a decrease in wall thickness in comparison to non-decellularised 
PCAs, see Table 4.4. This is further supported by the thickness measurements of the 
tensile and permeability tests, see Figure 4.9 and Section 4.2.3.  
The pre-stretch of human coronary arteries has been reported as 4.4% by Holzapfel 
et al. [127] and 10% by van Andel et al. [13]. In this current study, a standard         
pre-stretch of 30% was applied to LADs for inflation tests based on previous reports 
on the longitudinal stretch of porcine coronary arteries [13,36]. The use of this      
pre-stretch was validated by an average measurement of 29% pre-stretch PCAs in 
this study. Measuring and applying the unique pre-stretch of each individual artery 
may decrease the variability observed between arteries. Additionally, Roy et al. [36] 
reported a mean increase of 12% in the length of the elastic porcine carotid artery 
following detergent/enzymatic decellularisation. This was not accounted for in this 
study so further work could be completed to determine if there is any increase in 
length following 0.1ᴍ NaOH decellularisation.  
The alteration in the biomechanical properties of non-decellularised and 
decellularised sections of PCA presented is due to the effects of the decellularisation 
method rather than a natural degradation of the tissue. This is verified by the 
comparison of the non-decellularised and 9 hour non-decellularised uniaxial tensile 
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test data and the permeability data where there is no statistically significant 
difference, see Figure 4.9 and Figure 4.13.  
The biomechanical tests performed in this study provide an insight into the alteration 
of biomechanical properties of the PCA as a result of short-term decellularisation. 
Although changes in the biomechanical properties occur, the scaffold maintains the 
highly non-linear response present in non-decellularised arteries. Uniaxial tensile and 
inflation tests confirmed decellularisation resulted in a less stiff, more distensible 
low-load response and stiffer high-load response compared to non-decellularised 
sections. Additionally, extending the decellularisation treatment time yielded no 
significant increase in the changes already observed in the 9 hour decellularised 
sections. Chapter 5 will determine whether the increased permeability due to the 
removal of vascular cells is favourable for repopulation of the natural matrix 
scaffold. The natural matrix scaffold exhibited encouraging behaviour to perform as 
graft, withstanding pressures of 200 mmHg. Furthermore, the natural matrix scaffold 
obtained should also provide a suitable benchmark for the biomechanical properties 
of other scaffolds suitable for use as TEBV scaffolds.  
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Chapter 5 Repopulation Study and 
Biomechanical Evaluation of Decellularised 
Porcine Coronary Arteries 
The previous chapters have demonstrated a short-term decellularisation method to 
achieve the natural matrix scaffold of porcine coronary arteries (PCA), maintaining 
the biomechanical and structural integrity of the tissue. However, for the PCA 
scaffold to perform as a tissue engineered blood vessel (TEBV), the ability to support 
xenogeneic vascular cell growth and withstand physiological pulsatile flow is vital. 
Vascular smooth muscle cells (vSMCs) are required to repopulate the medial layer of 
the natural matrix scaffold for extracellular matrix (ECM) production and smooth 
muscle tone. Endothelial cells (ECs) are necessary to form a confluent layer on the 
luminal surface of the scaffold to act as a smooth, non-thrombogenic lining.   
To demonstrate the ability of the short-term decellularised PCA to maintain viable 
cells, the majority of tests were completed under static conditions using bovine 
smooth muscle cells, thereby confirming the ability of the scaffold to maintain 
xenogeneic cells. To determine the capability of cells to form a confluent layer on the 
abluminal surface, bovine aortic endothelial cells were seeded on the internal elastic 
lamina (IEL). Mesenchymal stem cells (MSCs) have demonstrated an ability to 
differentiate into vascular cells and are, therefore, a potential source of autologous 
cells. Consequently, in a preliminary study, MSCs were seeded to the PCA natural 
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matrix scaffold to assess the suitability for stem cell growth. Additionally, to validate 
PCA natural matrix scaffold for human applications an additional seeding test using 
human coronary artery smooth muscle cells was performed. To determine its ability 
to perform as a TEBV tubular lengths of the PCA scaffold were maintained in a 
bioreactor under pulsatile flow at physiological pressures. There is limited research 
completed to-date on the effect of cell seeding of decellularised scaffolds on the 
biomechanical properties. Therefore, to establish the influence of cell attachment and 
infiltration a biomechanical analysis of the seeded scaffold was completed using 
uniaxial tensile tests.  
To investigate the potential of the natural matrix scaffold of PCA to act as a vascular 
graft or scaffold the following criteria were assessed:  
 The ability of the PCA natural matrix scaffold as a suitable environment for 
xenogeneic cell attachment; 
 The most appropriate surface of the scaffold to achieve cell infiltration; 
 The maintenance of internal elastic lamina on the luminal surface of the 
scaffold as a barrier to cell infiltration; 
 The capability of endothelial cells to adhere to and form a smooth, confluent 
lining on the luminal surface of the scaffold; 
 The effect of cell infiltration on the biomechanical properties of the scaffold; 
 The effect of a dynamic uniaxial strain environment on the growth of cells 
seeded to the scaffold; 
 The viability of the scaffold to act as a graft by maintaining physiological 
pressure in the long-term; 
 The ability of the scaffold to support human coronary artery smooth muscle 
cells.  
5.1 Materials and Methods 
All cell culture techniques were performed under sterile conditions in a Bio Air 2000 
MAC laminar flow cabinet using sterile equipment. Cells were visualized using an 
Olympus CK30 phase contrast microscope. Cells and cell-seeded scaffolds were 
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maintained in a Nuaire CO2 water-jacketed incubator in a humidified atmosphere of 
95% air and 5% CO2 at 37 °C. 
5.1.1 Cell Culture 
Cells were cultured in 25 cm
2
, 75 cm
2
, and 175 cm
2
 tissue culture flasks under 
normal conditions and were routinely fed every 2 - 4 days. Cells were sub-cultured at 
80 - 90% confluency by trypsinisation.  
5.1.1.1 Bovine Aortic Smooth Muscle Cell and Bovine Aortic Endothelial Cell 
Culture 
The main cell line used in this study was bovine aortic smooth muscle cells 
(BASMC, AG08504, Coriell, NJ, USA). Experiments were conducted between 
passages 8 - 18. Additionally, bovine aortic endothelial cells (BAEC, AG08500, 
Coriell, NJ, USA) were obtained and experiments were conducted between   
passages 14 - 18.  
BASMC and BAEC were maintained in RPMI-1640 media (R8758, Sigma-Aldrich) 
supplemented with 10% fetal bovine serum (FBS, F9665, Sigma-Aldrich) and       
1% Penicillin-Streptomycin (P/S, P4333, Sigma-Aldrich) under normal conditions. 
To achieve sub-culture, the cells were washed twice in 1x phosphate-buffered saline 
(PBS, P5493, Sigma-Aldrich). Cells were removed from the bottom of the flask by 
incubating at 37 °C for 5 minutes in 2x Trypsin-EDTA (T4174, Sigma-Aldrich) 
diluted from a 10x stock solution. RPMI-1640 medium containing 10% FBS and   
1% P/S was added to deactivate the trypsinisation process and the cell suspension 
was centrifuged at 1,500 RPM for 5 minutes to form a pellet. Cells were resuspended 
in culture medium and typically diluted 1:4 into culture flasks.   
5.1.1.2 Rat Mesenchymal Stem Cell Culture 
Rat mesenchymal stem cells (rMSCs, 009, REMEDI, Galway) were cultured 
between passages 7 - 14 under normal conditions. Cells were maintained in        
50:50 Minimum Essential Medium Eagle Alpha Modified (α-MEM, M0644,             
Sigma-Aldrich) and Ham’s Nutrient Mixture F12 (Ham’s, 51651C, Sigma-Aldrich) 
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supplemented with 10% FBS and 1% P/S under normal conditions. Sub-culturing 
was performed as described in Section 5.1.1.1, using a concentration of              
0.25x Trypsin-EDTA solution and appropriate media. 
5.1.1.3 Human Coronary Artery Smooth Muscle Cell Culture 
Human coronary artery smooth muscle cells (HCASMC, CC-2583, Lonza, 
Switzerland) were cultured between passages 2 - 5. HCASMC were maintained in 
smooth muscle cell growth medium 2 and Supplement Mix (C-22062, PromoCell) 
supplemented with 10% FBS and 1% P/S under normal conditions. The supplement 
mix contained 0.05 ml/ml fetal calf serum, 0.5 ng/ml epidermal growth factor,          
2 ng/ml basic fibroblast growth factor, and 5 μg/ml insulin. Sub-culturing was 
performed as described in Section 5.1.1.1, using a concentration of                      
0.25x Trypsin-EDTA solution and appropriate media. 
5.1.2 Cryogenic Cell Storage and Recovery 
For long-term cell storage, cells were maintained in liquid nitrogen in a cryofreezer 
unit. Briefly, cells were washed in 1x PBS, trypsinised for 5 minutes at 37 °C, 
centrifuged at 1,500 RPM for 5 minutes to form a pellet, and re-suspended in cell 
freezing media containing 10% dimetylsulphoxide (cell freezing media-DMSO, 
C6164, Sigma-Aldrich). 1 ml aliquots were transferred to cryovials and frozen to        
-80 °C at a rate of 1 °C/minute in a Nalgene cryofreezing container. The cryovials 
were then transferred to liquid nitrogen.  
To recover cells from long-term storage cryovials were rapidly thawed by gentle 
agitation in a waterbath at 37 °C. The cells were re-suspended in fresh growth 
medium in a 75 cm
2
 tissue culture flask. The following day the cells were washed in 
PBS and fresh growth medium was added. 
5.1.3 Tissue Preparation 
PCA were excised from hearts as described in Section 3.1.1 (pg. 44). PCA were 
decellularised by perfusion for 9, 12, and 15 hours. Non-decellularised PCA were 
stored in 0.9% saline at room temperature for use as controls. To sterilize the tissue 
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suitable for cell culture, it was thoroughly washed in sterile PBS and placed in     
70% ethanol (EtOH) for 1 hour in a laminar flow cabinet. The tissue was then 
washed three times in sterile PBS and placed in fresh PBS for 1 hour to rehydrate 
prior to cell seeding.  
All equipment for cell seeding tests was obtained in pre-sterilised packaging or 
autoclaved prior to introduction into the laminar flow cabinet. No adhesion 
molecules were used in any experiment.  
5.1.4 Static Cell Seeding of Scaffold 
For static experiments, ligated branches were removed from tubular segments of 
PCA. The segments were opened in the longitudinal direction, divided into 5 x 5 mm 
sections, and placed in individual wells of culture plates using sterile tweezers. 
Sections containing branches were discarded. Sections of non-decellularised PCA 
and non-seeded decellularised PCA were maintained as controls and to determine the 
natural degradation of PCA and PCA scaffold with time. Seeded scaffolds and 
controls were maintained in an incubator under normal conditions for the duration of 
experiments. 
5.1.4.1 Cell Attachment Study 
To evaluate the suitability of decellularised PCA for cell attachment, BASMC were 
seeded to the luminal or abluminal sides of 5 x 5 mm sections of 9 hour 
decellularised PCA in a 24-well plate. BASMC were seeded at a concentration of     
1 x 10
5
 cells/cm
2
. The cell-seeded scaffolds were maintained in RPMI-1640 media 
supplemented with 10% FBS and 0.2% Primocin (ant-pm-1, CAYLA-InvivoGen, 
France). To determine cell attachment after 24 hours, the luminal and abluminal 
surfaces were analysed by DAPI staining. Further sections were maintained for       
72 hours and were processed for H&E staining to observe cell attachment to the 
abluminal and luminal surfaces. 
 101 
 
5.1.4.2 Cell Infiltration Study 
To determine the capability of cells to infiltrate PCA scaffolds, PCAs were 
decellularised for 9, 12, and 15 hours. 5 x 5 mm sections, abluminal surface facing 
upwards, were placed in 24-well plates using sterile tweezers. BASMC were seeded 
at a concentration of 5 x 10
4
 cells/cm
2
 in RPMI-1640 media supplemented with 10% 
FBS and 0.2% Primocin. Sections were removed from the experiment after 5, 10, 15, 
30, and 45 days and processed for histological and immunocytochemical analysis. 
To encourage the infiltration of cells into the scaffold, tubular segments of 15 hour 
decellularised PCA were perfused and soaked in 100% FBS for 1 hour, respectively. 
Additionally, the effect of increasing the cell seeding density was analysed. Eighteen 
5 x 5 mm sections, abluminal side up, were placed in 24-well plates. BASMC were 
seeded at a concentration of 5 x 10
4
 cells/cm
2
 to 9 sections and at a concentration of 
2 x 10
5
 cells/cm
2
 to a further 9 sections, see Figure 5.1. Three sections for each cell 
concentration were removed after 5, 10, and 15 days and processed for histological 
and immunocytochemical analysis. 
 
Figure 5.1: Experimental set-up for BASMC-seeding of 15 hour decellularised 
PCA at high (2 x 10
5
 cells/cm
2
) and low (5 x 10
4
 cells/cm
2
) cell-seeding 
concentrations for periods of 5, 10, and 15 days. x: 5 x 5 mm section of 
decellularised PCA, abluminal side up. 
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5.1.4.3 Assessment of Endothelial Layer Formation 
BAEC were seeded to the luminal surface of six 5 x 5 mm sections of 15 hour 
decellularised PCA at a concentration of 2 x 10
4
 cells/cm
2
 and incubated in      
RPMI-1640 media supplemented with 10% FBS and 0.2% Primocin. Three sections 
were removed after 24 hours and 10 days of culture, respectively, and prepared for 
histology and immunocytochemical analysis. 
5.1.5 Cell Seeding of Tubular Scaffold  
To show attachment by circulating cells, a 40 mm section of 15 hour decellularised 
PCA was placed in a test tube with BASMC-containing RPMI-1640 media 
supplemented with 10% FBS, 0.2% Primocin and 1.15g/500ml 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES, H4034, Sigma-Aldrich). The BASMC 
concentration was 2 x 10
4
 cells/cm
2
. The test tube was attached to a rotator (Rotator 
Drive STR4, Stuart Scientific) which revolved at a speed of 1 RPM in an incubator 
under normal conditions. The media was replaced with fresh BASMC-containing 
media (concentration of 2 x 10
4
 cells/cm
2
) every 24 hours for 7 days. After 8 days the 
section was removed, washed in sterile PBS, divided into seven equal sections, and 
prepared for histological and immunocytochemical analysis.  
5.1.6 Effect of Uniaxial Cyclic Strain on BASMC-seeded Scaffold 
The FX-4000
TM
 Flexercell® Tension Plus
TM
 system (Flexcell International Corp, 
McKeesport, PA, USA) consists of an electronic control unit, a vacuum pump, and a 
baseplate containing BioFlex® 6-well plates (Dunn Labortechnik GmbH, Asbach, 
Germany), see Figure 5.2 (A). A vacuum deforms the compliant silicone membranes 
of the BioFlex® plates over the loading posts of the baseplate, see Figure 5.2 (C), 
thereby applying a controlled strain to cells seeded to the membrane. A method was 
developed to attach PCA sections to the silicone membrane of the BioFlex® 6-well 
plates. 15 x 5 mm sections of PCA were obtained using a custom-made die. PCA 
sections were sutured to 15 x 5 mm sections of silicone using sterile needle and 
thread (Johnson and Johnson, Mersilk W622H) with the aid of a custom-made die for 
uniformity, see Figure 5.3. The die consists of three plates which slot together. The 
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middle plate has an opening for two silicone sections and one section of PCA. The 
top and bottom plates have guides for the needle and thread. The silicone sections, 
with PCA attached, were then located in a well of the BioFlex® plate using a custom 
die, see Figure 5.4. The silicone sections were glued (Momentive Silicone Rubber 
Adhesive Sealant) to the silicone membrane of the plate. 200 μL of PBS was pipetted 
onto PCA to maintain hydration for 1 hour while the glue dried. A mean strain of 
5%, with an amplitude of ± 2.5% and at a frequency of 1 Hz, was achieved by 
calibration using a video extensometer. This loading regime was chosen to represent 
the approximate strains induced in an artery under physiological conditions [128]. 
The sutures on the PCA scaffold were used as markers to calibrate the system. 
Eight sections, 15 x 5 mm, of 9 hour decellularised PCA were attached to two 
BioFlex® plates, luminal surface facing upwards. Following calibration, two 
scaffolds on each plate were seeded with BASMC at a concentration of                
1.25 x 10
5
 cm
2
 in RPMI-1640 media supplemented with 10% FBS and                
0.2% Primocin. The BioFlex® plates were incubated under normal conditions for   
24 hours to allow for cell attachment. Strain was applied to one plate for a further   
72 hours whilst the other plate remained unstrained as a control. The sections were 
then removed from the silicone membranes and processed for immunocytochemical 
analysis.  
  
 104 
 
 
 
 
Figure 5.2: Application of uniaxial strain to porcine coronary artery section.      
(A) FX-4000
TM
 Flexercell® Tension Plus
TM
 system; (B) schematic of porcine 
coronary artery section attached to the silicone membrane of a BioFlex® Well via 
silicone sections glued to the surface; and (C) application of uniaxial strain to 
BASMC-seeded scaffold.  
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Figure 5.3: Attachment of porcine coronary artery sections to silicone sections.  
(A-B) Custom die to uniformly suture tissue to silicone sections; and (C) completed 
section.  
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Figure 5.4: Attachment of porcine coronary artery sections to BioFlex® Well.    
(A) Custom die for uniform placement of sections; (B-C) alignment of die and 
sutured section in BioFlex® Well. 
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5.1.7 Biomechanical Analysis of BASMC-seeded Scaffold 
Nine PCAs were obtained to determine of the effect of cell seeding and infiltration 
on the biomechanical properties of PCA scaffolds. Six PCAs were decellularised for 
15 hours and three were maintained in 0.9% saline as non-decellularised controls. 
Where possible, lengths of PCA where divided into two consecutive sections, see 
Figure 5.5, resulting in ten 15 x 5 mm decellularised sections and three 15 x 5 mm 
non-decellularised sections. All sections were placed in 24-well plates, abluminal 
surface facing upwards, and incubated in RPMI-1640 media supplemented with  
10% FBS and 0.2% Primocin under normal conditions. Five decellularised sections 
were seeded with BASMC at a concentration of 2 x 10
4
 cells/cm
2
 every day for         
7 days. All sections were removed after 30 days. Uniaxial tensile tests were 
performed using a similar protocol to Section 4.1.2 (pg. 69). Each section was 
divided in the longitudinal direction, each 15 x 2.5 mm, see Figure 5.5.                 
Pre-conditioning was performed to 0.5 N over 5 cycles and sections were then tested 
to failure. Sections were fixed in 10% formalin for histological analysis. 
 
Figure 5.5: Division of porcine coronary artery for uniaxial tensile tests. Cut 1 was 
made prior to placement in 24-well plates, dividing the artery into two consecutive 
sections. Cut 2 was made upon completion of the experiment, enabling uniaxial 
tensile tests of up to 4 sections from the same artery. 
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5.1.8 Effect of Pulsatile Flow on PCA Scaffold 
A novel vascular bioreactor system, developed to allow strain and shear stress to be 
applied to cells cultured on mock coronary arteries [129], was adapted for tubular 
lengths of the natural matrix scaffold of PCA. Four lengths of PCA, approximately 
30 mm, were obtained. Two were decellularised for 15 hours and two were 
maintained in 0.9% saline as non-decellularised controls. Following sterilisation, the 
vessels were mounted and sealed in individual bioreactor chambers, see Figure 5.6. 
The system consists of a CellMax® Bioreactor tubing system with serial pump 
which circulates culture medium from a reservoir to the bioreactor chamber. The 
reservoir maintains a mean pressure of 100 mmHg. The system was calibrated using 
a series of clamps to obtain a pulsatile flow of 120/80 mmHg. The luminal pressure 
was measured using a paediatric pressure catheter (Abbott, IL, USA) which was 
withdrawn after calibration to maintain system sterility. A filter on each bioreactor 
chamber allowed for gaseous exchange. Each reservoir contained 125 ml RPMI-1640 
media supplemented with 10% FBS and 0.2% Primocin. Prior to connecting the 
reservoir, media was syringed through the tubing system to remove airlocks. The 
extraluminal space of the bioreactor chamber was filled with media and the entire 
system was placed in an incubator under normal conditions. The media was 
circulated from the reservoir by the bioreactor at a flow rate of 14 ml/min and at a 
pulse rate of 88 beats/min. 
Images were recorded using a video extensometer every 5 days to obtain a measure 
of the external diameters. Additionally, diametrical compliance, C, was calculated 
using the inverse of Peterson’s elastic modulus: 
 
   
      
           
    %mmHg
-1
 x 10
-2
 (Equation 5.1) 
where, Ds and Dd are systolic and diastolic external diameters, and Ps and Pd are the 
systolic, 80 mmHg, and diastolic pressures, 120 mmHg.  
The reservoir, tubing and extraluminal media was replaced every 5 days. The vessels 
were removed after 30 days and 2 mm sections were embedded in paraffin for 
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histological analysis. Additionally, tensile tests were performed on 15 x 2.5 mm 
sections from each vessel according to the protocol in Section 4.1.2 (pg. 69).   
5.1.9 Attachment of Other Cell Types 
5.1.9.1 Mesenchymal Stem Cell Seeding 
rMSCs were seeded to the abluminal surface of six 5 x 5 mm sections of 15 hour 
decellularised PCA in a 24-well plate. Sections were pretreated with 100% FBS by 
perfusion and soakage for 1 hour, respectively. rMSCs were seeded at a 
concentration of 5 x 10
4
 cells/cm
2
 to three sections and at a concentration of              
2 x 10
5
 cells/cm
2
 to a further three sections. The sections were incubated in        
50:50 Ham’s and α-MEM media supplemented with 10% FBS and 0.2% Primocin. 
All sections were removed after 15 days and processed for histological and 
immunocytochemical analysis.  
 
Figure 5.6: Bioreactor flow chamber. Tubular porcine coronary artery, with all 
branches ligated, mounted and sealed in bioreactor chamber and immersed in 
RPMI-1640 media. 
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5.1.9.2 Human Coronary Artery Smooth Muscle Cell Seeding  
HCASMC were seeded to the abluminal surface of six 5 x 5 mm sections of 15 hour 
decellularised PCA at a concentration of 2 x 10
4
 cells/cm
2
 in a 24-well plate. The 
cell-seeded sections were incubated in smooth muscle cell growth medium 2 and 
Supplement Mix with 10% FBS and 0.2% Primocin. Three sections were removed 
after 24 hours and 15 days of culture, respectively, and prepared for 
immunocytochemical analysis. 
5.1.10 Histological and Immunohistochemical Analysis 
Upon completion of each test, sections were repeatedly washed in sterile PBS to 
ensure any non-adhering cells were removed from the scaffold prior to fixing in  
10% formalin for analysis. 
4’,6-diamidino-2-phenylindole (DAPI) analysis of the scaffold surface was used to 
determine the attachment of cells to the luminal and abluminal surfaces of 
decellularised PCA. Hematoxylin and Eosin (H&E) staining and DAPI staining of 
slide-mounted cross-sections of PCA established the degree of cell infiltration into 
the scaffold. Masson’s Trichrome stain highlighted the presence of smooth muscle 
within the scaffold as a result of infiltrated cells. Modified Verhoeff Van Gieson 
Elastic stain determined the quality of elastin remaining in the sections. Sections 
were prepared and stained as described in Section 3.1.3 (pg. 47) and Section 3.1.4 
(pg. 50).  
5.1.11 Immunocytochemical Analysis 
Cells were washed in PBS and fixed in 0.3% formaldehyde for 15 minutes at room 
temperature. Cells were washed twice in PBS and permeabilised in PBS containing 
0.025% Triton X-100 (X100, Sigma-Aldrich) for 10 minutes. Cells were washed 
twice in PBS and were blocked in 5% bovine serum albumin (BSA)-PBS- 1% Tween 
(P5927 Sigma-Aldrich) for 2 hours at room temperature. Cells were incubated 
overnight at 4 °C in the appropriate primary antibody. Cells were washed in           
1% Tween-PBS for 10 minutes. Cells were incubated for 1 hour at room temperature 
in the appropriate secondary antibody in the dark. Cells were rinsed three times in 
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PBS for 5 minutes and were stained with DAPI for 4 minutes. Cells were washed 
twice in PBS prior to mounting and imaging.  
The primary antibody used for staining BAEC was endothelial Nitric Oxide Synthase 
3 (eNOS, PA1-037, Thermo Scientific) and the secondary antibody was anti-rabbit 
IgG FITC conjugate (Invitrogen, Groningen, Netherlands). The primary antibody for 
staining BASMC was anti α-smooth muscle cell specific actin (α-SM actin, A5228, 
Sigma-Aldrich) and the secondary antibody was Alexa Fluor 546 conjugate 
(Invitrogen, Groningen, Netherlands). 
5.1.11.1 FITC-Phalloidin Stain 
Fluorescein Isothiocyanate Labeled Phalloidin (FITC-Phalloidin, P5282,          
Sigma-Aldrich) stains the actin filaments of smooth muscle cells. Briefly, PCA 
sections were washed three times in PBS for 5 minutes, fixed in 10% formalin for     
5 minutes, washed extensively in PBS, permeabilised with 0.1% Triton X-100 in 
PBS, and washed three times in PBS for 5 minutes. Sections were then stained with 
50 μg/ml fluorescent phalloidin conjugate solution in PBS (containing 1% DMSO 
from original stock solution) for 40 minutes at room temperature in the dark. 
Sections were washed three times in PBS for 5 minutes, stained with DAPI for        
15 minutes, and washed again in PBS prior to imaging. 
5.1.12 Cell Count and Statistics  
Cell counts were performed on sections of DAPI-stained cell-seeded decellularised 
PCA. This was performed using ImageJ 1.42 software (National Institutes of Health, 
MD, USA). The number of nuclei in a 300 x 300 μm representative area of a section 
from a microscopic image was counted. The average cell count from three 
representative areas of each section was taken. A t-test was performed on the data 
sets to determine the p-value, where p < 0.05 was considered significant.   
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5.2 Results 
Non-seeded decellularised tissue sections were used as controls for all experiments. 
There was no evidence of cells present in those sections by H&E analysis. The 
images presented are representative of all sections viewed. 
5.2.1 BASMC Attachment and Infiltration of Scaffold 
BASMC stain positively for the contractile protein α-SM actin, see Figure 5.7. 
BASMC were seeded to the luminal and abluminal surfaces of 9 hour decellularised 
PCAs to determine the suitability of the scaffold for cell attachment. BASMC were 
seeded at a concentration of 1 x 10
5
 cells/cm
2
. H&E and DAPI staining confirmed a 
confluent layer of cells attached to the luminal and abluminal surfaces of 9 hour 
decellularised PCA after 24 and 72 hours, respectively, see Figure 5.8. The internal 
elastic lamina, lining the luminal surface, acted as a barrier to cell infiltration. A 
minor degree of cell infiltration was observed on the abluminal surface after this 
short period of cell seeding.  
BASMC were seeded to sections of PCA decellularised for 9, 12, and 15 hours to 
determine the decellularisation time which maximises cell infiltration. As the 
previous study indicated that cells would not infiltrate through the luminal surface, 
BASMC were seeded to the abluminal surface of decellularised PCA at a 
concentration of 5 x 10
4
 cells/cm
2
, see Figure 5.9. Cells are clearly visible throughout 
the medial and adventitial layers of H&E stained non-decellularised PCA after days 
0, 5, and 10, see Figure 5.9 (A-C). However, with increasing culture time, cells near 
the lateral edges of the scaffold began to migrate from the scaffold, see Figure 5.9 
(D-E). This was further evidenced by DAPI and Masson’s Trichrome staining of 
cross-sections of non-decellularised PCA after 30 days, see Figure 5.10. The number 
of cell nuclei in media and adventitia of lateral edges of PCA areas was substantially 
reduced compared to central areas. Additionally, the quantity of smooth muscle in 
lateral edges of the sections was reduced as observed by Masson’s Trichrome 
staining smooth muscle red. Pores appeared in the medial and adventitial layers of 
non-decellularised sections after 10 days and in some areas the media separated from 
the adventitia highlighting the degradation of the tissue with time, see Figure 5.9 (A-E).              
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Figure 5.7: α-SM actin in bovine aortic smooth muscle cells. (A) Primary control 
and (B) no primary control. Magnification: 20x. 
 
Figure 5.8: Luminal and abluminal BASMC-seeding of 9 hour decellularised 
porcine coronary arteries. DAPI staining of the (A) luminal and (B) abluminal 
surfaces after 24 hours and (C-D) H&E staining of the cross-sections after          
72 hours. BASMC-seeding concentration of 1 x 10
5
 cells/cm
2
. l: luminal surface, 
ab: abluminal surface. Scale bar: 200μm, magnification: 10x. 
 114 
 
After 15 days, the non-seeded decellularised scaffolds, acting as controls, showed no 
significant degradation of the scaffold, see Figure 5.11. 
There were no intact cell nuclei visible in 9, 12, and 15 hour decellularised sections 
at day 0, see Figure 5.9 (F, K, P). BASMC infiltration occurred on the abluminal and 
lateral edges of the scaffolds, increasing in number and distance infiltrated with 
increased culture time. After 5 days of culture a layer of BASMC was visible on the 
abluminal surface of all decellularised sections, see Figure 5.9 (G, L, Q). A degree of  
 
Figure 5.9: BASMC-seeding of the abluminal surfaces of decellularised porcine 
coronary arteries. H&E staining after 0, 5, 10, 15, and 30 days of the              
cross-sections of (A-E) non-decellularised porcine coronary arteries, and            
(F-J) 9 hour, (K-O) 12 hour, and (P-T) 15 hour decellularised porcine coronary 
arteries. BASMC-seeding concentration of 5 x 10
4
 cells/cm
2
. i: intima, m: media,                
a: adventitia, l: luminal surface, ab: abluminal surface. Magnification: 10x. 
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infiltration into the abluminal surface was observed after 10 days, see Figure 5.9 (H, 
M, R). After 15 days of culture, BASMC infiltrated the lateral edges of the scaffolds 
and there was increased infiltration of the abluminal surfaces, see Figure 5.9 (I, N, 
S). After 45 days of culture, there was excellent infiltration along the length of the 
scaffolds in both the medial and the adventitial layers for all decellularisation times 
as evidenced by both H&E and DAPI staining, see Figure 5.12 (A-O). The greatest 
infiltration occurred in 15 hour decellularised sections. Additionally, Masson’s 
 
Figure 5.10: Migration of cells from non-decellularised sections after 30 days.   
(A-D) DAPI and (E-F) Masson’s Trichrome staining of (A, C, E) central and     
(B, D, F) lateral cross-sections of non-decellularised porcine coronary arteries.     
i: intima, m: media, a: adventitia. Magnification: 10x. 
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Trichrome staining highlighted the presence of smooth muscle within the medial 
layer as a result of BASMC infiltration, see Figure 5.12 (P-R). 
15 hour decellularised sections showed the greatest degree of BASMC infiltration, 
therefore, further cell seeding and biomechanical experiments were performed using 
this scaffold. The effect of increasing the cell concentration was examined. DAPI 
staining showed an increase from day 5 to day 15 in the number of BASMC on the 
abluminal surface for both high (2 x 10
5
 cells/cm
2
) and low (5 x 10
4
 cells/cm
2
)     
cell-seeding concentrations, see Figure 5.13. The 5 x 5 mm sections were not fixed to 
the base of the 24-well plates. Therefore, in some instances they did not remain flat 
for the duration of the test. As a result, for these sections a non-uniform dispersion of 
cells on the abluminal surface, where the cells were initially seeded, was observed. 
Additionally, cells attached to the luminal surface due to the curling of these 
sections. However, for sections that remained flat for the duration of the test, after 
day 5 there were no cells in central sections of the luminal surface, yet there were 
clusters of BASMC at the lateral edges, see Figure 5.14 (A - D). By day 15 BASMC 
had migrated onto and across the luminal surface and were observed in central areas 
although no infiltration occurred through the luminal surface, see Figure 5.14 (E, G).  
 
 
Figure 5.11: Decellularised controls after 15 days culture. H&E staining of the 
cross-sections of non-seeded (A) 9 hour, (B) 12 hour and (C) 15 hour 
decellularised PCA. l: luminal surface, m: media, ab: abluminal surface. 
Magnification: 10x. 
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Figure 5.12: Infiltration of BASMC into decellularised porcine coronary arteries 
after 45 days. (A-I) H&E, (J-O) DAPI, and (P-R) Masson’s Trichrome  staining of 
the cross-sections of 9 hour, 12 hour, and 15 hour decellularised porcine coronary 
arteries. l: luminal surface, m: media, ab: abluminal surface.            
Magnification: (A-C) 4x, (D-F, J-R) 10x, (G-I) 20x. 
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H&E staining after 5 days of culture verified a greater number of cells attached to the 
higher concentration-seeded scaffolds in comparison to the lower          
concentration-seeded sections, see Figure 5.15. BASMC attached to the abluminal 
and lateral edges of the scaffolds although there was no infiltration visible at this 
stage. Clusters of cells occurred on the higher seeding concentration sections, in 
particular near the edges of the sections, whilst a confluent layer of cells formed on 
the abluminal surface, see Figure 5.15 (D-F). In some areas the cells were layered as 
also noted in the DAPI analysis. 
 
 
 
Figure 5.13: High (2 x 10
5
 cells/cm
2
) and low (5 x 10
4
 cells/cm
2
) cell-seeding 
concentrations. DAPI staining of the abluminal surface of BASMC-seeded PCA 
after (A, C) 5 days and (B, D) 15 days culture. Scale bar: 200μm. 
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Figure 5.14: Migration of BASMC across the luminal surface of          
abluminally-seeded 15 hour decellularised porcine coronary arteries. DAPI 
staining of (A, C, E, G) central and (B, D, F, H) lateral areas of the luminal 
surface of porcine coronary arteries seeded at (A-B, E-F) a  low concentration of  
5 x 10
4
 cells/cm
2
 and (C-D, G-H) a high concentration of 2 x 10
5
 cells/cm
2
 after     
5 days and 15 days culture. Scale bar: 200μm. 
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Figure 5.15: BASMC attachment and infiltration of 15 hour decellularised porcine 
coronary arteries seeded with low and high cell concentrations after 5 and 15 days. 
Representative images of H&E staining of the cross-sections of different segments 
seeded at concentrations of (A-C, G-I) 5 x 10
4
 cells/cm
2
 and                                  
(D-F, J-L) 2 x 10
5
 cells/cm
2
 after 5 days and 15 days culture. l: luminal surface,  
m: media, ab: abluminal surface. Magnification: (A-B, D-E, G-H, J-K) 10x,             
(C, F, I, L) 20x. 
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5.2.2 Scaffold Endothelialisation 
BAEC stain positively for the enzyme eNOS, see Figure 5.16. BAEC were seeded to 
the luminal surface of 15 hour decellularised scaffolds at a concentration of               
2 x 10
4
 cells/cm
2
 to determine their ability to attach and form a confluent monolayer. 
H&E and DAPI staining confirmed the presence of BAEC on the luminal surface 
after 1 day and the formation of an almost confluent layer after 10 days, see      
Figure 5.17 and Figure 5.18. No cell infiltration was observed through the internal 
elastic lamina. A low number of cells attached to the luminal surface after 1 day 
indicating that more time was required for BAEC to attach to the surface. However, 
after 10 days of culture there was a statistically significant higher concentration of 
BAEC on the luminal surface, see Figure 5.19. H&E staining showed that the 
contact-inhibited BAEC attached to the luminal surface to form a monolayer, see 
Figure 5.18 (A-B). In some areas the endothelial layer appeared to have detached 
from the luminal surface. This was most likely due to the harsh process involved in 
the embedding procedure as the DAPI staining indicated that BAEC adhered to the 
surface.  
 
Figure 5.16: eNOS in bovine aortic endothelial cells. (A) Primary control and    
(B) no primary control. Magnification: 20x. 
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Figure 5.17: Endothelial cell attachment to the luminal surface of PCA scaffold. 
DAPI staining of 15 hour decellularised PCA seeded with BAEC at a 
concentration of 2 x 10
4
 cells/cm
2
 after (A) 24 hours and (B-C) 10 days. Scale   
bar: 200 μm. 
 
 
Figure 5.18: Endothelial cell attachment to the luminal surface of 15 hour 
decellularised scaffold after 10 days. (A-B) H&E and (C-D) DAPI staining of 
BAEC-seeded 15 hour decellularised PCA. l: luminal surface, m: media,             
ab: abluminal surface. Magnification: (A) 10x, (B-D) 20x.  
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5.2.3 Seeding of 3D Tubular Scaffold 
Representative images from distal, central, and proximal sections of the 40 mm 
length of PCA scaffold are shown in Figure 5.20. DAPI staining demonstrated an 
almost confluent layer of BASMC adhered to the luminal and abluminal surfaces of 
the scaffold after 8 days, see Figure 5.20 (A-F). H&E staining of cross-sections of 
the scaffold also indicated the attachment of BASMC on both luminal and abluminal 
surfaces along the 40 mm length, see Figure 5.20 (G-O). By 8 days, although 
infiltration had occurred via the lateral edges of sections 1 and 7, the most distal and 
proximal sections of the arterial segment, see Figure 5.20 (G, I, M, O), it did not 
extend beyond the distal and proximal ends of the scaffold, see Figure 5.20 (H, K, 
N). There was no infiltration through the luminal surface as expected, whilst a degree 
of infiltration from the abluminal surface was observed. 
 
 
Figure 5.19: Endothelial cell count after 1 and 10 days culture on the luminal 
surface of 15 hour decellularised porcine coronary arteries.  
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Figure 5.20: 40 mm length of BASMC-seeded 15 hour decellularised 3D tubular 
porcine coronary artery. (A-F) DAPI and (G-O) H&E staining of                         
(A, D, G, J, M) proximal, (B, E, H, K, N) central and (C, F, I, L, O) distal sections. 
l: luminal surface, m: media, ab: abluminal surface. Scale bar: 200 μm. 
Magnification: (G-I) 4x, (A-F, J-L) 10x, (M-O) 20x. 
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5.2.4 Effect of Uniaxial Cyclic Strain on BASMC-seeded Scaffold  
BASMC were seeded to the luminal surface of 9 hour decellularised PCA at a 
concentration of 1.25 x 10
5
 cm
2
 for a total of 96 hours. To determine if there was cell 
alignment as a result of cyclic uniaxial strain, cells were stained with                 
FITC-Phalloidin and DAPI. Static sections displayed a dispersed distribution of cells 
on the luminal surface, see Figure 5.21 (A, C). An even distribution of BASMC was 
observed on the luminal surface of sections which underwent 72 hours of cyclic 
uniaxial strain, see Figure 5.21 (B, D). Furthermore, the alignment of BASMC actin 
filaments at approximately 45° to the direction of stimulation was evident, see  
Figure 5.21 (B, D). There was no alignment of cells seeded to static sections. There 
were no cells visible on the surface of non-seeded sections, see Figure 5.21 (E-F).  
 
Figure 5.21: DAPI and FITC-Phalloidin staining of the luminal surface of 9 hour 
decellularised porcine coronary arteries following 72 hours in (A, C, E) static and 
(B, D, F) dynamic conditions. Arrows indicate the direction of the applied cyclic 
uniaxial strain. Magnification: (A-B, E- F) 10x, (C-D) 20x. 
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5.2.5 Biomechanical Analysis of BASMC-seeded Scaffold 
Non-decellularised, decellularised, and BASMC-seeded decellularised sections all 
exhibited the typical J-shaped curve associated with soft tissue, see Figure 5.22. The 
variability of soft tissue was evident in the stress-strain response, in particular for 
seeded and non-seeded decellularised sections.  
The final slopes and final x-intercepts of the stress-strain response was analysed for 
all sections using the method described in Section 4.1.2 (pg. 69), see Table 5.1 and 
Figure 5.23. Seeded decellularised sections were less distensible than non-seeded 
decellularised sections. However, the high variability in the stress-strain response of 
both decellularised and seeded decellularised sections resulted in no statistical 
significance. The final x-intercept of non-decellularised sections occurred at a 
significantly higher strain than seeded decellularised sections. The slopes of the final 
curve, associated with collagen recruitment, were equivalent for non-seeded 
decellularised and seeded decellularised sections. Although, these final slopes 
exhibited statistically significant stiffer behaviour compared to non-decellularised 
sections. Additionally, there was no statistical significance between the ultimate 
tensile strength of all three categories. A comparison of seeded and non-seeded 
decellularised sections obtained from the same arteries is shown in Figure 5.24, 
demonstrating, in the majority of cases, the less distensible seeded sections in 
comparison to non-seeded sections.  
When viewed under a microscope during the course of the experiment, cells of the    
5 x 15 mm non-decellularised sections were observed migrating from the tissue after 
9 days. H&E staining of these sections fixed after 30 days confirmed the migration of 
cells from the lateral edges of the tissue while the interior of the tissue remained 
populated, see Figure 5.25 (A, D). While the number of cells observed is low 
compared to non-decellularised tissue, BASMC infiltrated the scaffold of the seeded 
decellularised PCA in both the medial and the adventitial layers, see Figure 5.25 (C, 
F). Sections were embedded and stained following the tensile tests, therefore, pores 
were visible throughout the thickness of all sections due to the sections being tested 
to failure prior to fixing. Modified Verhoeff Van Gieson staining of the sections 
highlight the presence of elastin in the tissue, see Figure 5.25 (G-I). The quality of 
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elastin in the adventitia of non-decellularised sections appeared diminished compared 
to seeded and non-seeded decellularised sections.  
 
Figure 5.22: Uniaxial tensile tests of non-decellularised (N30), 15 hour 
decellularised (D30), and BASMC-seeded 15 hour decellularised (S30) sections of 
porcine coronary arteries after 30 days of static culture. 
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Figure 5.23: Uniaxial tensile data for non-decellularised (N30), 15 hour 
decellularised (D30), and 15 hour BASMC-seeded decellularised (S30) sections of 
porcine coronary arteries after 30 days of static culture. Significance, * p < 0.05. 
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Figure 5.24: Comparison of uniaxial tensile tests performed on consecutive 
sections of non-seeded (N) and seeded (S) decellularised after 30 days of static 
culture.  
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Figure 5.25: Sections of (A, D, G) non-decellularised, (B, E, H) non-seeded 
decellularised, and (C, F, I) seeded decellularised porcine coronary arteries after 
30 days static culture. (A-F) H&E and (G-I) Modified Verhoeff Van Gieson 
stained sections after uniaxial tensile testing. i: intima, m: media, a: adventitia,     
l: luminal surface, ab: abluminal surface. Magnification: (A-C, G-I) 10x,           
(D-E) 20x. 
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5.2.6 Effect of Pulsatile Flow on PCA Scaffold 
Both non-decellularised vessels became contaminated after 5 days and 20 days, 
respectively, and were removed from the experiment. Both decellularised sections 
were removed after 30 days of pulsatile flow at physiological pressure. There were 
minor leakages throughout the course of the experiment for all segments, although all 
branches remained ligated. There was no indication of aneurysm formation in any 
vessel, see Figure 5.26 and Figure 5.27. Due to the design of the bioreactor chambers 
and the luer connectors on which the arteries were mounted, it was not possible to 
apply a known pre-stretch to the vessels. As a result, the pre-stretch applied to 
decellularised artery B was insufficient and caused bending of the vessel upon 
pressurisation. However, the other three vessels remained straight when pressurised. 
The external diameter at 100 mmHg was measured for each vessel. There was a 
significant decrease in the external diameter of non-decellularised artery B at day 20 
which corresponded to contamination of the vessel, see Figure 5.26. Additionally, 
both decellularised vessels also exhibited a decrease in external diameter after day 
15, see Figure 5.27. 
With the exception of the compliance of decellularised vessel A at day 5 and 
decellularised vessel B at day 10, there is a steady increase in the compliance of all 
vessels with time, see Figure 5.28 (A). Large increases occurred after day 15 
corresponding to the decrease in external diameter exhibited in all vessels.  
Uniaxial tensile tests of the decellularised sections were performed following 30 days 
in the bioreactor. The typical J-shaped stress-strain response associated with soft 
tissue was observed for both vessels, see Figure 5.28 (B). Final slopes of 8.53 MPa 
and 6.86 MPa were calculated for decellularised vessel A and decellularised vessel 
B, respectively. 
The decellularised PCA remained intact for the duration of the experiment, see 
Figure 5.29. However, H&E staining indicated loose, porous layers, particularly in 
the adventitia. Additionally, Modified Verhoeff Van Gieson staining indicated a 
breakdown of the internal elastic lamina in regions following 30 days of pulsatile 
flow, see Figure 5.29 (E-F).  
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Figure 5.26: Biomechanical analysis of the effect of pulsatile flow at physiological 
pressures on non-decellularised porcine coronary arteries. External diameter at 
100 mmHg and corresponding images for each time point.  
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Figure 5.27: Biomechanical analysis of the effect of pulsatile flow at physiological 
pressures on 15-hour decellularised porcine coronary arteries. External diameter 
at 100 mmHg and corresponding images for each time point.  
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Figure 5.28: Biomechanical analysis of the effect of pulsatile flow at physiological 
pressures on non-decellularised and decellularised porcine coronary arteries.     
(A) Compliance measurement at 100 mmHg; and (B) uniaxial tensile tests of 
decellularised vessels after 30 days. 
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Figure 5.29: Decellularised porcine coronary arteries after 30 days of pulsatile 
flow at physiological pressures in a bioreactor. (A-D) H&E and (E-F) Modified 
Verhoeff Van Gieson Elastic staining of the arterial cross-sections. l: luminal 
surface, m: media, ab: abluminal surface. Magnification: (A-B, E-F) 10x,          
(C-D) 20x. 
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5.2.7 Attachment of Mesenchymal Stem Cells to Scaffold 
It is clear that rMSCs adhere to the PCA scaffold after 15 days of static culture, see 
Figure 5.30 and Figure 5.31. A uniform distribution of cells was evident for both low 
and high concentrations on the abluminal surfaces, see Figure 5.30 (A, B, D, E). 
DAPI staining showed a low number of cells on the luminal surface mainly clustered 
near the lateral edges of the sections, see Figure 5.30 (C, F), similar to that found in 
BASMC-seeded sections (Figure 5.14). There was a minor degree of infiltration of 
rMSCs in the abluminal and lateral surfaces after 15 days, see Figure 5.31. However, 
the higher cell concentration did not increase the degree of infiltration into the 
scaffold. At the lower cell density a pattern of cells clustering was visible which was 
not apparent in the higher density sections, see Figure 5.31 (A). The intimal barrier, 
the internal elastic lamina, remained intact and resulted in no cell infiltration through 
the luminal surface. 
 
Figure 5.30: Rat mesenchymal stem cell seeding of 15 hour decellularised porcine 
coronary arteries. DAPI staining of the abluminal and luminal surfaces after      
15 days culture at concentrations of (A-C) 5 x 10
4
 cells/cm
2
 and (D-F) 2 x 10
5
 
cells/cm
2
. Scale bar: 200 μm. 
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5.2.8 Attachment of Human Coronary Artery Smooth Muscle Cells 
to Scaffold 
HCASMC were seeded to the abluminal surface of 15 hour decellularised PCA at a 
concentration of 2 x 10
4
 cells/cm
2
. DAPI staining confirmed the adherence of 
HCASMC to the abluminal surfaces after 1 and 15 days, see Figure 5.32. A low 
number of cells adhered overall, however, there was a statistically significant        
3.5-fold increase in the number of cells attached to the abluminal surface after 15 
days, Figure 5.33.  
 
 
Figure 5.31: Rat mesenchymal stem cell seeding of 15 hour decellularised porcine 
coronary arteries. H&E staining of the cross-sections after 15 days culture at 
concentrations of (A-C) 5 x 10
4
 cells/cm
2
 and (D-F) 2 x 10
5
 cells/cm
2
. l: luminal 
surface, m: media, ab: abluminal surface. Magnification: (A-B, D-E) 10x,          
(C, F) 20x. 
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Figure 5.32: Human coronary artery smooth muscle cell attachment to the 
abluminal surface of 15 hour decellularised porcine coronary arteries. DAPI 
staining of the abluminal surface seeded at a concentration of 2 x 10
4
 cells/cm
2
 
after 1 day and 15 days. Scale bar: 200 μm.  
 
Figure 5.33: Human coronary artery smooth muscle cell count after 1 and 15 days 
culture on the abluminal surface of 15 hour decellularised porcine coronary 
arteries.  
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5.3 Discussion 
To perform as a viable tissue engineered blood vessel scaffold, the decellularised 
porcine coronary artery scaffold must be capable of maintaining cells; allowing 
growth, infiltration and migration. This study is the first to seed cells to the natural 
matrix scaffold of PCA. While the tubular structure of decellularised PCA would be 
required for use as a TEBV, in order to determine the capability of the scaffold for 
repopulation, flat sections were initially seeded with cells. The cell studies performed 
demonstrate the suitability of the PCA scaffold for xenogeneic cell growth, 
attachment, and infiltration. Without the use of adhesion molecules to promote cell 
attachment, BASMC adhered to both the luminal and abluminal scaffold surfaces 
after 24 hours of static culture, see Figure 5.8. However, the internal elastic lamina 
proved to be a barrier to cell infiltration from the luminal surface. The exposure of 
vSMCs to blood flow may encourage over proliferation leading to intimal 
hyperplasia as demonstrated in a cyclic strain environment [128].  For a potential 
TEBV, the maintenance of the internal elastic lamina is a positive outcome as an 
intact internal elastic lamina could support endothelial cell seeding without the risk 
of smooth muscle cell neointimal formation. Consequently, the more loosely packed 
adventitial layer appeared the most favourable approach for scaffold repopulation. 
The composition of the natural matrix scaffold is vital as shown by Gui et al. [95]. In 
that study of in vivo repopulation of decellularised umbilical artery, the dense 
collagen matrix resulted in no cellular infiltration after 8 weeks implantation. 
Similarly, the adventitial layer of PCA scaffold is denser towards the media and may 
not support cellular infiltration, see Figure 5.9. Furthermore, as an additional barrier 
to BASMC-repopulation of the media, the external elastic lamina separates the media 
from the adventitia. Similar to the internal elastic lamina preventing cells moving 
into the media from the luminal surface, the external elastic lamina may also prove to 
be a barrier against SMC infiltration of the media from the abluminal surface. 
Consequently, the most encouraging approach for SMC repopulation of the media is 
from the lateral edges of the scaffold. Cells were observed infiltrating the media after 
15 days, see Figure 5.9 (J, P). This is encouraging for in vivo scaffold repopulation 
as an end-to-end or end-to-side anastomosis of the scaffold to the native coronary 
 141 
 
arteries could potentially repopulate the graft without the need for pre-population of 
the medial layer of the scaffold.  
A further indication of cell migration was evidenced on the luminal surface of 
abluminally-seeded sections. The luminal surface remained flat on the base of the 
culture plate for the duration of culture. However, after 5 days, cells were visible 
clustered at the edges of the luminal surfaces, see Figure 5.14 (A-D). There were no 
cells visible in the central areas of the luminal surface at this stage, however, after 15 
days BASMC covered all areas of the luminal surface, see Figure 5.14 (E-H). 
Mesenchymal stem cells seeded under the same conditions showed an equivalent 
pattern, see Figure 5.30; however, in these preliminary MSC experiments the 
phenotype was not assessed. Moreover, this behaviour is promising for in vivo 
repopulation of the scaffold implanted without pre-seeding. 
A degree of scaffold porosity is required to enable cell infiltration of a TEBV, 
however, it should not compromise the structural and biomechanical properties 
required to perform suitably as a TEBV. An increased NaOH decellularisation time 
results in a scaffold with increased porosity without an adverse biomechanical effect, 
see Table 4.1 (pg. 78). Therefore, cell seeding studies were performed on PCA 
decellularised for 9, 12, and 15 hours. An increased cell number and a greater degree 
of infiltration, in particular in the medial layer, was demonstrated by 15 hour 
decellularised PCA as opposed to PCA treated for 9 hours and 12 hours, see     
Figure 5.12.  
PCA scaffolds were pre-treated with fetal bovine serum to encourage cell infiltration; 
however, there was no noticeable improvement in infiltration as a result. In fact, as a 
consequence of perfusing the scaffold with FBS, in some instances there appeared to 
be a degree of damage to the luminal surface thereby fragmenting the internal elastic 
lamina in areas, see Figure 5.15 (E, G). This could potentially lead to cells 
infiltrating through the internal elastic lamina; a negative outcome for a TEBV 
potentially leading to thrombus and neointimal formation.  
In an effort to improve scaffold repopulation, an increased cell seeding concentration 
was applied. However, rather than increasing cell infiltration, the cells preferentially 
attached to each other rather than the scaffold, see Figure 5.15 (D, F). To overcome 
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this behaviour, rather than seed a high concentration of cells simultaneously, cells 
were seeded in low numbers over a period of days. As a result, a higher total number 
of cells were seeded to the scaffold and there was no evidence of cell clustering as 
previously observed, see Figure 5.20 and Figure 5.25. While the cell numbers that 
infiltrate the scaffolds remain low in comparison to non-decellularised PCA this 
approach is promising for future in vitro scaffold repopulation studies.  
Studies of other decellularised vessels have examined the ability of endothelial cells 
to form confluent layers on luminal surfaces. With the aid of fibronectin, Gui et      
al. [95] seeded human umbilical vein endothelial cells to flat segments of 
decellularised human umbilical artery. Liu et al. [96] seeded porcine aortic 
endothelial cells on flat strips of decellularised descending aorta of fetal pigs. Almost 
confluent layers were achieved in static culture within 5 days and 7 days, 
respectively. In this current study, BAEC were seeded to the luminal surface of PCA 
scaffold at a low concentration to observe the development of an endothelial layer 
with time. BAEC formed an almost confluent layer after 10 days of static culture 
without the use of adhesion molecules, see Figure 5.17. There was a 22-fold increase 
in the number of cells attached to the luminal surface at 10 days compared to 1 day. 
Similar to other studies, there was an even distribution of cells across the luminal 
surface due to the contact-inhibiting nature of EC. The ability of a TEBV scaffold to 
support a endothelial cells is vital as demonstrated by the thrombus formation and 
occlusion of decellularised vessels implanted without EC pre-seeding [95,98,114]. 
While it has been shown that NaOH decellularised PCA can support the attachment 
and infiltration of BASMC, verifying its ability to maintain xenogeneic cells, the 
scaffold must also support human cells to function as a TEBV. HCASMC adhered to 
the abluminal surface of PCA scaffold after 15 days. Additionally, the attachment 
and infiltration of mesenchymal stem cells was achieved, see Figure 5.30 and   
Figure 5.31. MSCs have demonstrated the ability to differentiate into smooth muscle 
and endothelial cells [82]. Autologous MSCs are more readily available for use in 
tissue engineering since they can be harvested from bone marrow whilst obtaining 
autologous vascular SMC and EC necessitates the explant of a blood vessel.  
To overcome issues of lack of cell infiltration in decellularised arteries, novel 
techniques other than the standard method of seeding cells directly to the scaffold 
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surfaces, have been proposed by Soletti et al. [130] and more recently by Sheridan et 
al. [92]. Soletti et al. [130] accomplished more uniform scaffold cell seeding using 
combined vacuum pressure, centrifugal force and flow. Sheridan et al. [92] 
embedded micro-needles in the artery during the decellularisation procedure and 
subsequently used the needles to inject cells and re-seed the scaffold. This current 
study maintained the native architecture during both decellularisation and 
repopulation of the scaffold.  
The removal of vascular cells by NaOH results in a less stiff, more distensible low 
load response and a stiffer high load response of PCA as demonstrated in Chapter 4. 
Therefore, uniaxial tensile tests were performed on BASMC-seeded PCA scaffolds 
after 30 days culture to determine if there is a corresponding alteration as a result of 
scaffold repopulation. Additionally, further sections were tested to establish if there 
is degradation of non-decellularised tissue and non-seeded decellularised scaffolds 
with time. In addition to providing a suitable environment for cell attachment and 
growth, the scaffold must have appropriate biomechanical properties to withstand 
physiological blood pressure upon implantation. A number of studies of repopulated 
decellularised scaffolds have indicated an improvement in the scaffold 
biomechanical properties in comparison to the bare scaffold. Schenke-Layland et    
al. [115] reported improved radial and circumferential tensile strength of repopulated 
decellularised porcine pulmonary valves after 16 days of dynamic culture, in line 
with the biomechanical properties of fresh valves. Recently, two studies [90,104] of 
the repopulation of porcine carotid arteries have shown a reversal in the alteration of 
biomechanical properties that occurred as a result of decellularisation. In both cases, 
despite the use of different decellularisation methods, the repopulated arteries 
exhibited reduced elasticity compared to non-seeded decellularised arteries. A 
similar trend is exhibited in this current study after 30 days static culture of  
BASMC-seeded scaffolds, see Figure 5.22 and Table 5.1. The reintroduction of 
smooth muscle into the medial layer of the scaffold, see Figure 5.12 (P-R), has 
potentially established cell-matrix interactions resulting in a reduction in 
distensibility, exhibited by a reduced final x-intercept value, in comparison to 
decellularised sections. Additionally, infiltration of cells may account for the reduced 
variability in the seeded decellularised stress-strain response compared to non-seeded 
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decellularised sections. Conversely, non-decellularised sections have a reduced 
quantity of smooth muscle within the tissue due to the migration of cells from the 
tissue, see Figure 5.10 and Figure 5.25, and exhibit the highest degree of 
distensibility.  
In three instances, non-seeded decellularised sections from artery #9 and non-seeded 
and seeded decellularised sections from artery #7, there is early recruitment of the 
collagen fibres resulting in a low value x-intercept compared to the remaining 
sections, see Figure 5.24. Analysis of the test data revealed that the gauge lengths of 
these particular sections after pre-conditioning were unusually high. This is 
demonstrated by the large standard deviations of the gauge lengths of non-seeded 
decellularised and seeded decellularised sections after pre-conditioning, see       
Table 5.1 and Figure 5.23. Histological analysis of the four sections from artery #9, 
see Figure 5.34, revealed that the section with the high gauge length was 
 
Figure 5.34: H&E sections of the four sections from artery #9 (see Figure 5.24). 
(A-B) Non-seeded decellularised adjacent sections and consecutive (C-D) seeded 
decellularised adjacent sections. l: luminal surface, m: media, ab: abluminal 
surface. Magnification: 10x.  
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significantly more porous than the other sections, see Figure 5.34 (B). Additionally, a 
breakdown of the internal elastic lamina was apparent which may account for the 
early recruitment of collagen fibres.  
SMC subjected to cyclic uniaxial strain have been shown to achieve an almost 
perpendicular orientation to the direction of the applied strain [131]. A Flexercell® 
unit designed to apply biaxial strain to cells was modified to apply a uniaxial strain to 
cell-seeded scaffolds. Cells were seeded to the smooth luminal surface in order to 
enable immunocytochemical analysis of cell alignment due to the difficulty in 
imaging cells seeded to the fibrous abluminal surface. Clearly, there was alignment 
of cells on the luminal surface of the scaffold as a result of cyclic uniaxial strain in 
comparison to the random orientation of static sections, see Figure 5.21. Of further 
interest would be the proliferation and alignment of infiltrated cells, in particular 
mesenchymal stem cells, under uniaxial cyclic strain. This method will enable such 
studies to be carried out in future following an initial culture period to enable cell 
infiltration.  
The natural matrix scaffold of PCA demonstrated the ability to withstand 
physiological blood pressures and pulsatile flow for a period of 30 days without 
rupture or aneurysm formation. There was, however, an alteration in the 
biomechanical properties with time. Roy et al. [36] reported that increasing the     
pre-stretch of intact non-decellularised and decellularised porcine carotid arteries 
 
Figure 5.35: Effect of increasing pre-stretch on non-decellularised (N) and 
decellularised (D) porcine carotid arteries [36].  
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decreased the compliance of the vessels, see Figure 5.35. Therefore, an inability to 
apply an accurate pre-stretch in this current study potentially had an impact on the 
resulting compliance data. A decrease in external diameter and a corresponding 
increase in compliance were observed after day 15 for both non-decellularised and 
decellularised sections, see Figure 5.28. However, the cell infiltration and the 
biomechanical analysis of the cell seeded scaffolds have demonstrated that BASMC 
cell infiltration of the PCA scaffold at 15 days can decrease vessel distensibility 
when compared to non-seeded decellularised sections. These observations suggest 
that a cell-seeded scaffold within the bioreactor environment may prevent the 
compliance and dimension alterations observed after 15 days.  
Overall, the results presented demonstrate that vascular smooth muscle cells can 
infiltrate the medial and adventitial layers of the PCA scaffold from the abluminal 
surface and, in particular, from the lateral edges of the scaffold. Additionally, a 
confluent endothelial layer can be formed on the internal elastic lamina which can act 
as a barrier to cell infiltration from the luminal surface irrespective of 
decellularisation treatment time or length in culture. Xenogeneic cells, including 
bovine, murine, and human cells, survived for periods of between 15 to 45 days on 
the porcine scaffold. A combination of factors indicates that the most appropriate 
method to maximise scaffold repopulation is through end-to-end or end-to-side 
anastomosis. Seeding of a tubular length of PCA scaffold by circulating cells 
demonstrated that whilst an almost confluent cell layer forms on both the luminal and 
abluminal surfaces, there is limited potential for infiltration of the cells into the 
medial layer, see Figure 5.20. Successfully maintaining the PCA scaffold under 
pressure in a bioreactor for 30 days confirmed that the scaffold remains viable with 
time under pulsatile flow at physiological pressure. Therefore, the PCA scaffold has 
potential as a biologically and biomechanically compatible in vivo bypass graft, with 
or without pre-population with cultured cells.  
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Chapter 6 Final Discussion 
A small-diameter tissue engineered blood vessel (TEBV) with appropriate 
biomechanical and structural properties is required for procedures such as coronary 
artery bypass grafting (CABG). Biomechanical mismatch between the native blood 
vessel and the bypass graft is a leading cause of bypass graft failure. In particular, 
compliance mismatch causes anastomotic flow instabilities potentially resulting in 
thrombus formation and intimal hyperplasia. In order to improve the long-term 
outcome of bypass grafts, it is vital to identify the appropriate biomechanical 
properties required of the native vessel to develop an equivalent graft. The 
development of compatible scaffolds from synthetic and natural materials is hindered 
by the complex anisotropic structure and interactions of the extracellular components 
within the arterial wall and has proven difficult to achieve. Decellularisation of 
allogeneic or xenogeneic blood vessels offers the greatest prospect of achieving a 
biomechanically and structurally equivalent scaffold for TEBV as the source tissue 
already contains all the required elements. Provided decellularisation can be achieved 
within an appropriate timeframe and without significant degradation of the 
extracellular matrix (ECM), it provides a platform to achieve the natural matrix 
scaffold potentially maintaining native architecture and biomechanical properties.  
The small-diameter coronary arteries are difficult to harvest due to their location 
within the coronary and interventricular sulci of the heart and their numerous 
branches. However, as they are the vessels most likely to be bypassed, an 
investigation of their potential as TEBV scaffolds was warranted. In fact, in porcine 
hearts where the circulations system is almost identical to that of human hearts, 
lengths of coronary arteries can be successfully harvested and decellularised. As 
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demonstrated in the present study, the left anterior descending (LAD), right (RCA), 
and left circumflex (LCX) porcine coronary arteries can be excised with all branches 
ligated and decellularised. However, the LCX tapers more rapidly than the LAD and 
RCA and is unsuitable for lengths greater than 25 mm. Consequently, the LAD and 
RCA offer the greatest potential for use as a TEBV graft. The short-term 
decellularisation method successfully implemented in the current study could be 
applied to other blood vessels; however, it would require customisation for differing 
vessel dimensions and also for different vessel structures. For example, muscular 
arteries do not contain elastic laminae in the medial layer; therefore, if applied to 
similarly sized elastic arteries an increase in treatment time may be required to 
ensure perfusion through the elastic laminae. Furthermore, the removal of cells from 
the scaffold may be hindered by these additional barriers. This is demonstrated by a 
repopulation study where cells seeded between elastic lamina of the media were 
unable to infiltrate other layers [92].  
Sodium hydroxide (NaOH) treatment of porcine coronary arteries (PCA) alters the 
biomechanical properties such that a less stiff, more distensible low load response 
and a stiffer high load response results, see Table 4.1 (pg. 81). The reduction in 
stiffness in the low load range is not statistically significant and, in fact,               
non-decellularised PCA tested 9 hours after excision also exhibited a reduction in the 
low load stiffness although to a lesser extent. Essentially, the increased distensibility 
can be recovered upon scaffold repopulation through cell-matrix interactions and the 
activation of smooth muscle tone. The increase in stiffness in the high load region, 
where collagen dominates the response, is the most significant alteration as a result 
of NaOH decellularisation. However, the normal physiological pressure range of 
120/80 mmHg corresponds to 0.011/0.016 MPa, which is in the low load region of 
the stress-strain response. Therefore, this increase should not adversely affect the 
biomechanical response under normal conditions. Infiltration of BASMC into the 
media and adherence of other cell types to the luminal and abluminal surfaces of 
decellularised scaffolds indicates that cytotoxic NaOH has been completely removed 
from the scaffold. Moreover, 0.1м NaOH immersion for 24 hours has been shown to 
disrupt the collagen network and alter the stress-strain response of decellularised 
arteries [92]. In this current study, after 30 days of static culture, there is no further 
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degradation of decellularised tissue (D30) demonstrated by no statistically significant 
difference of D30 in comparison to the final slope and final x-intercept of 15 hour 
decellularised sections (D15), see Table 6.1. This further demonstrates the removal of 
NaOH from the scaffold and, additionally, the preservation of the elastin and 
collagen matrix of decellularised tissue with time. Consequently, long-term storage 
of decellularised PCA is viable and therefore strengthens the argument for its use as 
a graft. Storage and preservation of decellularised vessels would allow for       
patient-specific grafts to be developed; as a range of lengths, diameters and 
thicknesses could be available. The availability of synthetic materials as              
“off-the-shelf” grafts, despite the negative implications of biomechanical mismatch, 
was a significant advantage over natural materials; however, this outcome 
demonstrates that natural materials can also be stored.  
Recent studies of the repopulation of elastic arteries have shown recovery of the 
biomechanical properties that occurred as a result of decellularisation [90,104]. This 
current study hypothesised that the same trend may be applicable to small-diameter 
muscular coronary arteries. Non-decellularised tissue cultured for 30 days (N30) 
exhibits statistically significant less stiff, more distensible properties than             
non-decellularised arteries tested immediately post mortem (N0), see Table 6.1. 
Essentially, N30 exhibits biomechanical properties comparable to decellularised 
tissue, D15 and D30. The migration of smooth muscle cells from the tissue, similar to 
the removal of cells by decellularisation, results in a tissue with greater distensibility. 
Although, the effect is more pronounced in non-decellularised PCA as the 
distensibility of N30 occurs at a statistically significant higher value than D15. 
Additionally, the decreased stiffness of the high load region illustrates a degradation 
of the collagen fibres. Furthermore, the increase in final stiffness of decellularised 
sections can therefore be linked to the decellularisation protocol rather than purely 
the removal of vascular cells. The alteration of N30 in comparison to N0 also suggests 
that the alteration in biomechanical properties observed in non-decellularised tissue 
frozen for extended periods [23,93] is a result of damage to the vascular cells in 
combination with a deterioration of the extracellular matrix. A limitation of this work 
includes the use of a low resolution imaging technique which cannot provide 
conclusive data on disruption of collagen or elastin fibres following decellularisation 
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with NaOH. It should be noted however that the degradation of collagen cross-links 
is highly unlikely given that the final slope of the stress-strain curve, where collagen 
predominantly bears the load, is stiffer for the decellularised arteries when compared 
to non-decellularised tissue. Of greatest significance is the effect of repopulation of 
the scaffold on the stress-strain response. Similar to D15 and D30, the final slope of 
BASMC-seeded decellularised PCA (S30) after 30 days remains stiffer than          
non-decellularised tissue. However, the final x-intercept is comparable to             
non-decellularised (N0) sections indicating a recovery of the alteration that occurred 
as a result of decellularisation. Restoring the native biomechanical properties is 
important for compliance matching of a decellularised bypass graft to the native 
vessel. The compliance of blood vessels and blood vessel grafts at 100 mmHg are 
demonstrated in Figure 6.1. There is a 4-fold increase in the compliance of           
Table 6.1: Uniaxial tensile test data comparison of sections tested within 24 hours 
of slaughter and after 30 days culture. Non-decellularised (N0) and 15 hour 
decellularised (D15) sections were tested within 24 hours of slaughter.               
Non-decellularised (N30), 15 hour non-seeded decellularised (D30) and 15 hour 
seeded decellularised sections (S30) were tested after 30 days of culture. 
 Final Slope, mf 
(MPa) 
Final 
X-Intercept 
N0, n=25 7.35 ± 2.71 0.40 ± 0.08 
N30, n=6 4.23 ± 1.23
1 
0.58 ± 0.04
1 
D15, n=19 8.08 ± 4.45
 
0.48 ± 0.07
1, 2
 
D30, n=10 11.10 ± 6.38
2 
0.50 ± 0.23 
S30, n=10 10.34 ± 2.56
1,2 
0.42 ± 0.12
2 
Significance,   
1
 p < 0.05 from non-decellularised (N0) sections 
                                  2
 p < 0.05 from non-decellularised (N30) sections 
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non-decellularised and decellularised PCA in comparison to other vessels and grafts. 
Although the graph demonstrates the distensibility of vessels and grafts within the 
normal physiological pressure range, the compliance over a range of pressures is 
important. Dacron exhibits a higher compliance measure than human saphenous vein 
at 100 mmHg, however, over a range of pressures it is in fact the stiffest material 
demonstrating minimal change in diameter. 
Another limitation for the commercial viability of a TEBV scaffold production is the 
time it takes to repopulate the scaffold. After 45 days of static culture, a significant 
area of the scaffold remains acellular, see Figure 5.12 (pg. 117). In addition to 
providing a suitable environment for cell attachment and growth, the scaffold must 
have appropriate biomechanical properties to withstand physiological blood pressure 
upon implantation. However, PCA scaffold has demonstrated the ability to withstand 
physiological pressures and pulsatile flow in a bioreactor and maintains the          
non-linear stress-strain response, see Figure 5.27 (pg. 134) and Figure 5.28 (pg. 135). 
Additionally, the internal elastic lamina remains intact and is a suitable             
blood-contacting surface [76]. Consequently, PCA scaffold could be implanted in 
vivo without pre-seeding and cells in the adjacent tissue and circulating cells could 
repopulate the scaffold with time. This is supported by the repopulation of the medial 
layer of the scaffold by infiltration of the lateral edges and migration of cells across 
the luminal and abluminal surfaces, see Figure 5.12 (pg.117) and Figure 5.14 (pg. 
119). Alternatively, pre-seeding of the scaffold with autologous mesenchymal stem 
cells (MSCs) offers great potential due to their ability to differentiate into smooth 
muscle cells in a cyclic uniaxial strain environment [82]. Attachment and infiltration 
of MSCs to the PCA scaffold was achieved, see Figure 5.31 (pg. 138). In 
combination with the uniaxial strain environment of the Flexercell, using the set up 
described in this current work, see Figure 5.2 (pg. 104), or the 3D environment of the 
bioreactor the repopulation of the media and the generation of ECM proteins could 
be enhanced. 
Porcine coronary arteries are three times more elastic than human arteries [13]. 
Decellularisation of PCA results in a further increase in vessel distensibility. 
Interestingly, non-seeded decellularised (D30) and seeded decellularised (S30) 
uniaxial tensile sections which demonstrated early recruitment of collagen fibres 
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exhibited elastic behaviour similar to that of human coronary arteries. This can be 
attributed to a breakdown of the internal elastic lamina. A main objective of this 
work, which was ultimately achieved, was to maintain the native architecture of 
coronary arteries throughout decellularisation and repopulation. Unlike other studies, 
where adventitia was removed to improve either decellularisation or repopulation 
[65,91,92,99] or the media was disrupted to aid repopulation [92], in this current 
study the media and adventitia were maintained in their native configuration. 
However, controlled degradation of the internal elastic lamina, for example through 
uniform perforations of the surface, could reduce the distensibility of porcine tissue 
to bring it in line with human arteries. However, this would require careful 
consideration as the positive outcomes of maintaining the internal elastic lamina 
could potentially be lost.  
 
Figure 6.1: Compliance at 100 mmHg for non-decellularised and decellularised 
porcine coronary arteries in comparison to other blood vessels and grafts (human 
external iliac artery, Dacron, human saphenous vein, and ePTFE data adapted 
from [122]).  
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The insights gained into coronary arteries and the corresponding natural matrix 
scaffold can be used to guide the development of other synthetic or natural materials 
for small-diameter TEBV scaffolds such as bacterial cellulose [79]. The properties of 
decellularised PCA and cell-seeded decellularised PCA are compared to human 
coronary arteries, current bypass grafts, and other small-diameter tissue engineered 
blood vessels in Table 6.2. Based on the results of this study, prior to cell seeding a 
scaffold with increased distensibility at low loads, decreased thickness, and increased 
permeability in comparison to the native artery may prove to be the optimum 
environment for cell growth and infiltration. Furthermore, upon cell seeding, the 
biomechanical properties of the native vessel can be recovered resulting in a 
biomechanically compatible TEBV in the long-term, see Table 6.1. 
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Chapter 7 Conclusions and Future Work 
7.1 Main Findings 
The aim of this study was to establish a short-term decellularisation method for 
porcine coronary arteries (PCA) and to determine the biomechanical properties and 
cell repopulation viability of this natural matrix scaffold to assess its suitability as a 
tissue engineered blood vessel (TEBV) scaffold. In addition, the data obtained can be 
used to inform the development of alternative TEBVs and TEBV scaffolds for use in 
small-diameter bypass application. The following key contributions have been 
established in this study: 
 The removal of the vascular cells from porcine coronary arteries has been 
achieved through a short-term decellularisation method. This study presents a 
protocol which results in the successful decellularisation of fresh tubular 
sections of PCA within 9 hours of excision. Given the short time for 
decellularisation, natural degradation of the arterial tissue is minimised during 
the process. Despite widespread decellularisation of other blood vessels, this 
study is the first to successfully obtain the natural matrix scaffold of the 
muscular coronary artery.  
 The characterisation of the biomechanical properties of PCA scaffolds in 
comparison to non-decellularised PCA provides an insight into the alteration 
that occurs as a result of the removal of vascular cells. The resulting scaffold 
maintains a non-linear response to stress and the ability to withstand 
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pressures in excess of the physiological blood pressures. The excellent 
biomechanical properties of the porcine natural matrix scaffold, and the short 
timeframe within which this scaffold was achieved, establishes the potential 
of this natural matrix scaffold for use as a vascular tissue engineering 
scaffold. Furthermore, the scaffold exhibits a less stiff, more distensible low 
load and a stiffer high load response in comparison to the native vessel. This 
provides a suitable benchmark for the development of other vascular grafts 
for CABG and similar applications. 
 The PCA scaffold is a suitable environment for xenogeneic cell growth, 
infiltration, and migration. Scaffold repopulation via the lateral and abluminal 
surfaces, the maintenance of the internal elastic lamina as a barrier to smooth 
muscle cell infiltration, and the short-term formation of an almost confluent 
layer of endothelial cells all provide evidence of the suitability of this scaffold 
for use as an in vivo vascular graft. 
 The repopulation of the PCA scaffold reversed the changes in biomechanical 
properties that were due to removal of vascular cells, restoring the native 
characteristics. Additionally, the preservation potential of the decellularised 
matrix, as demonstrated from the longer-term tests, shows that tissue could be 
stored with the biomechanical properties preserved. This could enable a bank 
of tissue to be generated from which a scaffold could be chosen to match the 
compliance of patient-specific host vessels.  
 The PCA scaffold has potential for use simply as a vascular graft given that 
its acellular nature does not initiate an immune response, it retains its 
structural strength and it has biomechanical properties very close to that of 
the native artery whilst also maintaining sufficient burst strength. 
7.2 Future Work 
Following on from the significant contributions outlined above, there is wide ranging 
potential for further development and analysis of the porcine coronary artery natural 
matrix scaffold as a tissue engineered blood vessel:  
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 Assessment of an in vitro anastomosis of non-decellularised and 
decellularised vessels in the bioreactor to validate the ability to repopulate the 
scaffold through the lateral edges, followed by in vivo animal models of    
pre-seeded and bare scaffolds.  
 Adaptation of PCA scaffolds to achieve equivalent elasticity to human 
coronary arteries by controlled degradation of the internal elastic lamina. A 
further alignment of the biomechanical properties of PCA scaffold to human 
coronary arteries would enhance the compliance matching capabilities of the 
scaffold. 
 Further analysis of human cell seeding of the PCA scaffold and, in particular 
of human mesenchymal stem cells. The ability of MSCs to be differentiated 
into vascular smooth muscle cells (vSMCs) and endothelial cell (ECs) using 
cyclic strain and shear stress, respectively, within the 3D scaffold 
environment could establish a suitable autologous cell source for TEBV 
development. 
 Further exploration of the effect of the application of a cyclic strain 
environment on cell-seeded decellularised scaffolds, in particular cell 
alignment and extracellular matrix production in the media, and the 
corresponding impact on the biomechanical properties. The Flexercell® 
system could be used to analyse the uniaxial strain environment and the 
bioreactor could establish the effect of a biaxial strain environment. 
Furthermore, co-culture of smooth muscle cells and endothelial cells can be 
accomplished in the bioreactor. This work could develop an optimum loading 
regime to achieve controlled alteration of the natural matrix scaffold by cell 
growth and extracellular matrix production. In this way, the decellularised 
constructs could be tuned to have matching biomechanical properties for a 
range of different host vessels. 
These findings would more conclusively establish the potential of the PCA scaffolds 
for use as vascular grafts or replacement blood vessels in humans. 
In addition to its potential for tissue engineering applications, the bare and            
cell-seeded PCA scaffold could be established as a model system to investigate 
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pathological conditions such as the development of atherosclerosis, intimal 
hyperplasia, and aneurysms. Physiological versus pathological stain environments 
can be simulated in the Flexercell® and bioreactor environments [128]. Additionally, 
controlled degeneration of the scaffold, such as localised degradation of tissue 
simulating an aneurysm or stent deployment to initiate in-stent restenosis, could also 
be applied. This could further establish the role of the extracellular matrix and 
vascular cells, in particular circulating endothelial progenitor cells and resident 
vSMCs and ECs, in the pathogenesis of vascular disease. 
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Appendix A 
Histological Protocol 
Fixing  
10% formalin (4% formaldehyde) at 4 °C    12 hours 
For storage after fixing 
70% ethanol        Up to 3 days 
Dehydration, Clearing and Paraffin Embedding 
Volume of liquid should be 10 – 20 times that of the tissue 
Dehydration 
1. 70% ethanol       45 minutes 
2. 95% ethanol        45 minutes 
3. 100% ethanol       45 minutes 
4. 100% ethanol       45 minutes 
Clearing 
5. Xylene         60 minutes 
6. Xylene        60 minutes 
Paraffin Embedding 
7. Paraffin        60 minutes 
8. Paraffin        60 minutes 
9. Embed 
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Storage 
Can be frozen at -20 °C indefinitely 
Microtome 
Float 5 µm sections in distilled water at 37 °C before mounting on slide. Allow slide 
to dry out overnight before staining, otherwise section will be removed from slide 
once placed in xylene as water is immiscible with xylene. For quick drying the slides 
can be placed in the oven at 65 °C for 1 – 2 hours. Slides should be cooled to room 
temperature before beginning staining procedure. 
Deparaffinisation and Rehydration 
After each step remove excess fluid by shaking and blotting slides.  
Liquids can be used repeatedly and should be renewed when traces of sludge 
(precipitated wax) appears in the 100% ethanol. 
 
1. Xylene   Agitate (3 or 4 times)   2 – 3 minutes 
    (Stationary    5 minutes) 
2. Xylene   Agitate    1 minute 
3. 100% ethanol  Agitate    1.5 – 2.5 minutes 
4. 95% ethanol  Agitate    1 minute 
5. 70% ethanol  Agitate    ≥ 1 minute 
Slides can be left for several hours or days in 70 % ethanol, preventing fungi and 
bacterial growth. This will not remove sections from the slides or make the 
sections brittle. 
6. Distilled Water  Agitate    30 seconds 
    (Stationary    2 – 3 minutes) 
7. Distilled Water  Agitate    Dip 
Hematoxylin and Eosin Staining 
Hematoxylin should be protected from light. 
Hematoxylin can be reused many times. 
Eosin can be used repeatedly; however moulds can grow but can be removed by 
filtration. 
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1. Hematoxylin       10 – 15 minutes 
As Hematoxylin is diluted with repeated use, the time required to stain the tissue 
increases with used Hematoxylin. 
2. Running Tap Water      10 minutes 
3. 0.1% hydrochloric acid      Dip 3 times 
4. Tap Water        Dip 3 - 4 times 
5. Scott’s Tap Water Substitute     Dip 3 times 
6. Tap Water        Dip 3 – 4 times 
7. Eosin        30s – 3 minutes 
Dehydration, Clearing and Mounting 
Dehydration 
1. 95% ethanol        30 seconds 
2. 100% ethanol       30 seconds 
3. 100% ethanol       30 seconds 
Clearing 
4. Xylene         30 seconds 
5. Xylene        30 seconds 
6. Mounting media and cover slide 
 
